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Upon agonist occupation of a receptor, the G protein undergoes 
a conformational change causing GDP, which is bound to the a  subunit in its 
inactive state, to be released and allowing GTP to enter the nucleotide binding 
pocket, causing release from the receptor and dissociation of the G protein into a 
free a  subunit and a py dimer. These moieties then interact with their target 
effector systems before the intrinsic GTPase activity of the a  subunit hydrolyses 
the GTP to GDP, allowing heterotrimer reformation and receptor interaction, 
returning the system to its resting state. It was originally thought that the a  
subunit solely contained the sites for interaction with both the receptor and the 
effector. It is now apparent however that the py dimer plays an important role in 
governing the specificity of G protein-receptor interaction, and can affect second 
messenger generating systems such as adenylyl cyclase, phosphoinositidase C 
and certain ion channels.
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Abstract
Heterotrimeric guanine nucleotide binding proteins function to
,
couple seven transmembrane spanning serpentine receptors to effector systems 
governing the regulation of intracellular second messengers. The basic 
molecular mechanism by which these G proteins operate has been known for I
several years, but the precise details of their functions, specificities and 
regulation is at present unresolved. These G proteins are characterised by being 
composed of three non-identical subunits termed a , P and y. Molecular cloning 
techniques have revealed the presence of 17a, 4p and lOy genes encoding these r S
subunits. The a  subunits have been classed into 4 groups termed the Gg, Gi,
Gq and G 12 families.
G proteins are membrane associated proteins. The initial theory 
that the role of the py complex was to anchor the a  subunit to the membrane, via 
prenylated residues at the C terminus of the y subunit is largely outdated. The 
presence of the 14 carbon saturated fatty acid, myristic acid, at the N terminus of 
some Gi family members was thought to hold the key to this dilemma, 
Myristoylated peptides however do not have sufficient free energy to interact 
with the membrane. Also, not all myristoylated proteins are membrane 
associated and all of the other G proteins lack the necessary consensus sequence 
for N-myristoylation. Another mechanism must exist to account for the 
membrane interactions of G protein a  subunits.
Recently it has been demonstrated that the 16 carbon fatty acid, 
palmitic acid, is also present in the N terminal region of the majority of G 
protein a  subunits, as well as several other proteins involved in intracellular 
signalling, notably Src family members. This lipidation is thought to be a post 
translational, reversible modification, generally occurring via labile thio-ester 
bonds. This is in contrast to N-myristoylation, which is co-translational and 
generally irreversible.
This thesis aimed to determine the effect of mutating the target 
palmitoylation sites of rat G oia and murine G n a  on their ability to interact with 
the plasma membrane when transfected into heterologous cell systems. To do 
this, it was necessary to develop a system in which it was possible to 
unambiguosly detect the relevant G ^ a  or G n a  polypeptide by western 
blotting. It was found that acrylamide gels containing urea in the resolving gel 
could sufficiently resolve the polypeptides to enable detection by nonspecific 
antisera against Gga isoforms and G q /na  .
XVlll
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Use was made of a 4M-8M urea gradient in a 12.5% 
acrylamide/0.0625% bisacrylamide SDS-PAGE gel system to resolve isoforms 
of Goa from rat brain membranes and from membranes of the neuroblastoma x 
glioma hybrid cell line NG108-15. Following separation of membranes of Rat-1 
cells transfected with wild type and palmitate negative mutants of rat G o ia  , 
immunoblots with an antiserum directed against Goa were able to detect an 
immunoreactive band which corresponded to a band in rat brain and NG108-15 
membranes, which had previously been identified as G oia  .
To detect m urine Gi i a  unam biguously , a 10% 
acrylamide/0.24% bisacrylamide SDS-PAGE gel containing 6M urea was 
employed to separate species variants of this a  subunit. This system has been 
reported to separate murine G n a  from the simian form of the polypeptide, such 
that the murine form would migrate more rapidly through the gel matrix. Thus 
when the cDNA encoding murine G n a  was transfected into simian COS-1 
cells, it could be detected using an antiserum which recognises Gqa and G n a .
It has been reported in the literature that introduction of the 
cysteine-to-serine mutation at position 3 (C3S) into rat G o ia  would abolish 
palmitoylation and reduce the ability of this polypeptide to interact with the 
plasma membrane of transiently transfected COS-1 cells. In this thesis it was 
decided to assess the membrane association of this C3S G o ia  polypeptide in 
comparison to the wild type protein in a stably transfected rat cell line. It was 
found that approximately 30% of the immunoreactive C3S G oia  was present in 
the cytosolic fraction of these cells, following homogenisation and separation 
into membrane and cytosolic fractions, while all the wild type protein was 
present in the membrane. These figures agreed well with prior experiments in 
which membranes of NG108-15 cells were chemically depalmitoylated with IM
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hydroxylamine and immunobiotted for Goa. Both the wild type and palmitate 
negative mutant of G o ia  were substrates for pertussis toxin catalysed ADP- 
ribosylation, indicating a|3y heterotrimer formation. Evidence was also found 
that C3S G oia  was cycling between a membrane compartment and the cytosol 
of the cell.
G l ia  does not contain a cysteine at position 3 but does possess 
two cysteines at positions 9 and 10 which align with the sites of palmitoylation 
of other G proteins. To determine whether these cysteine residues were the sites 
of palmitoylation of murine G n a , mutants of the protein were created by site- 
directed mutagenesis in which cys9, cyslO or both were mutated to serine. 
Upon transient transfection into simian COS-1 cells, all three mutants showed a 
similar membrane:cytosol distribution; approximately 30% of immunoreactive 
murine G n a  was found in the cytosol, which again agreed well with chemical 
depalmitoy lation experiments.
When [^H] palmitate incorporation studies were carried out on 
these mutants following transient transfection it was found that no palmitate was 
incorporated into C9SC10S G n a . The C9S and CIOS single mutants of G n a  
only incorporated palmitate to some 20% of that found on wild type G n a . This 
indicated that both cysteine residues at positions 9 and 10 were targets for 
palmitoylation and suggested the possibility of cooperativity in the transfer of 
palmitic acid to G n a .
These studies have demonstrated the role that palmitoylation 
plays in the membrane association of these two polypeptides and may aid the 
elucidation of the wider issue of how palmitoylation affects the function of G 
proteins in general. It may be that palmitoylation could affect the interaction of a
X X
subunits with receptors or effectors or it could be a regulatory signal for 
uncoupling of the G protein from the signalling cascade.
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Chapter 1. 
Introduction.
Chapter 1. 
Introduction. 
1.1. Historical Perspective.
It is now apparent that a family of highly homologous guanine 
nucleotide binding proteins (G proteins) play a pivotal role in coupling agonist 
liganded receptors to the alteration of a corresponding, effector mediated, 
change in the levels of an intracellular second messenger.
The hypothesis that hormones could produce changes in second 
messenger levels by regulating the enzyme responsible for its production was 
first postulated following a series of experiments demonstrating that the 
actions of adrenaline on canine liver could be mimicked by cAMP [Rail et al., 
1957; Sutherland et al., 1962]. Sutherland proposed that adrenaline bound to 
specific cell surface receptors and, once liganded, these receptors could cause 
a conformational change in the catalytic moiety of adenylyl cyclase resulting 
in an activation of the enzyme.
The involvement of GTP in this signalling event was 
demonstrated in 1971 when Rodbell and co-workers noted the requirement of 
GTP in glucagon mediated activation of adenylyl cyclase [Rodbell et al., 
1971b] and that GTP enhanced the dissociation of glucagon from its adenylyl 
cyclase coupled receptor [Rodbell eta l., 1971a; Harwood et al., 1973]. Non- 
hydrolysable analogues of GTP (GTPyS and GppNHp) were shown to 
irreversibly activate adenylyl cyclase in the absence of agonist [Schramm &
Rodbell, 1975], the presence of which increased the rate of formation of the 
irreversibly activated complex [Cautrecasas et al., 1975], suggesting that the 
role of liganded receptor was to facilitate the guanine nucleotide mediated 
activation of the enzyme.
The role of GTP in regulating the receptor-effector interaction 
was shown by Cassel & Selinger who demonstrated an increase in high 
affinity GTPase activity associated with p -adrenergic stimulation of adenylyl 
cyclase [Cassel & Selinger, 1976]. The ability to reconstitute this activity into 
membranes of the murine S49 lymphoma mutant, eye-, lead to the purification 
of this entity, known as G s for its stimulatory effect on adenylyl cyclase.
The cycle by which these G proteins turn on and off the signal 
from an activated receptor was first postulated by Gilman [1984]. He 
suggested that in the resting state, the receptor was coupled to a GDP liganded 
G protein, and that hormonal activation of the receptor caused a 
conformational change in both proteins leading to the exchange of GDP for 
GTP. This guanine nucleotide exchange promoted dissociation of the G 
protein from its trimeric form into a free active a  subunit and a py dimer. The 
a  subunit, which bound the guanine nucleotide, could then interact with the 
effector system before the a  subunits' intrinsic GTPase activity hydrolysed the 
GTP to GDP promoting reformation of the holomeric protein, re-association 
with the receptor and turning off of the signal [Gilman, 1984; Gilman 1987] .
Since this groundbreaking work, much effort has been 
expended in studying the role the G protein plays in regulating transmembrane 
signalling. Since the advent of molecular cloning techniques many variants of
the three subunits of G proteins have been identified. The control of these 
distinct, yet highly homologous, proteins is evidently crucial to how the cell 
collects and correlates extracellular stimuli.
The G protein cycle postulated by Gilman [Gilman, 1984;
1987] indicates a purely sedentary role for the Py dimer. Work over recent 
year s has demonstrated that this is not the case and a functional role for this 
dimer in interacting with a wide range of effector systems including adenylyl 
cyclase, phosphoinositidase C, phospholipase A 2 and the MAP kinase cascade 
has been shown [Clapham & Neer, 1993; Stemweis, 1994].
These heterotrimeric G proteins are, however, members of a 
larger superfamily of guanine nucleotide binding proteins of which elongation 
factor Tu (EF-Tu) and the pZl#^ proto-oncogene product are notable 
members. This Introduction will concentrate mainly on the role of the 
heterotrimeric G proteins. However, the small molecular weight G proteins 
have many similarities to the heterotrimeric ones and reference to them will be 
made.
1. 2 . The structure and function of 
heterotrimeric G proteins.
All the heterotrimeric G proteins involved in hormonal 
signalling share a basic structure consisting of one a  subunit, one p subunit 
and one y subunit, in order of decreasing molecular mass [Gilman, 1987]. 
These polypeptides range in mass from 39-52kDa for a  subunits, 35-36kDa 
for p subunits and 8 -lOkDa for y subunits and couple serpentine receptors to
one or more intracellular second messenger generating systems such as 
adenylyl cyclase, phosphoinositidase C, phospholipase A2 and various ion 
channels and pumps.
Since the advent of molecular cloning techniques, the family of 
heterotrimeric G protein genes has expanded, and to date there are now 17 
separate genes encoding a  subunits [Simon et aL, 1991; McLaughlin et al., 
1992], 4 genes encoding p subunits and 10 genes encoding y subunits. To 
create even more diversity, GgOi and Go a  undergo alternative splicing of the 
primary transcript, and there is evidence to suggest a functional role for these 
splice variants. The presence of these different gene products indicates a 
complexity in terms of cellular signalling that is only now beginning to be 
understood.
1 .2 .1 . G a subunits.
All a  subunits share sequence homology to a greater or lesser 
degree, which reflects the similar function of these proteins. Simon et al. 
[1991] have grouped 16 ot subunits, according to amino acid sequence 
homology, into 4 subfamilies (figure 1. 1.) termed the Gg , Gi, Gq and G 12 
families. The subsequent discovery of gustducin, an a  subunit related to 
transducin, indicated that it belonged to the Gf family [McLaughlin et al.,
1992].
The homology between the a  subunits is not uniform over the 
length of the polypeptide but regions of high and low identity exist between all 
a  subunits. The four areas of highest identity represent regions critical for
Figure 1.1. Amino acid identity of the cloned G 
protein a  subunits.
The G a  subunits so far identified have been grouped into 4 families based on 
their amino acid identity as shown. The subsequent discovery of gustducin 
placed this a  subunit in the Gj family. The two splice variants of GgCi are also 
shown. All other a  subunits shown are products of specific genes. This figure 
was taken from Simon et al., [1991].
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binding of guanine nucleotides and site the GTPase activity of the a  subunit. 
Areas of greatest diversity may represent areas of functional differences in 
coupling of the a  subunits to Py subunits, receptors or effectors [Simon et al., 
1991]. The areas of the a  subunits which are responsible for the particular 
functions of the proteins will be discussed later. What follows is a 
consideration of the functions and properties of the various subunits.
1 .2 .1 .1 . Members of the Gs family.
GgCt: The most studied of the two members of this family, and
perhaps the most studied a  subunit of all is G^a. So called for its stimulatory 
effect on adenylyl cyclase, this a  subunit was first identified by Cassel & 
Selinger [1976] who demonstrated the requirement of a honnone sensitive 
GTPase in the stimulation of adenylyl cyclase and that the hydrolysis of GTP 
served as the turn-off mechanism behind the stimulation [Cassel & Selinger, 
1978]. Ross & Gilman [1977] demonstrated that the disruption of hormone 
stimulated adenylyl cyclase in the cyc" mutant of S49 lymphoma cells was due 
to the absence of a GTP-binding protein. By reconstitution of p adrenergic 
stimulated adenylyl cyclase activity into membranes of the cyc“ cells, Northup 
et al. [1980] were able to purify the protein, now termed Gga. The protein was 
found to be a trimer of a , p, and y subunits and has been shown to be a mixture 
of two oligomers made up of two distinct a  subunits and indistinguishable Py 
dimers. The a  subunits, of apparent Mr 52 and 45kDa respectively, vary in 
relative concentrations between cell types although any functional differences 
between the two have yet to be identified.
cDNAs corresponding to Gga have been obtained from various 
sources. Deduced amino acid sequences for these cDNAs indicate few amino 
acid differences between human and murine forms of the protein [Simon et al.,
1991]. This high degree of cross species conservation is evident in all a  
subunits. The first cDNA isolated encoded a protein of 394 amino acids, with a 
predicted molecular weight of 46kDa, but upon expression in either 
mammalian COS-M6  cells [Robishaw et al., 1986a] or prokaryotic E.coli 
[Gilman, 1987] the cDNA directed the synthesis of the 52kDa form of the 
protein, indicating that the mobility of the protein in SDS-PAGE is anomalous 
[Gilman, 1987]. The cDNA for the second form of Ggcx encodes a polypeptide 
with a predicted molecular weight of 44.5 kDa and directed the synthesis of 
the 45kDa form in both COS-M6  cells and E.coli [Robishaw et al., 1986b; 
Gilman, 1987].
Four distinct cDNAs encoding Gga proteins have now been 
isolated [Bray et al., 1986]. The isolation of the GgCt gene has shown the 
presence of 13 exons and 12 introns covering about 20kb of DNA [Kozasa et 
al., 1988]. The four cDNAs encoding Ggoc are produced by alternate splicing 
of this single gene. Ggo-l and GsCx-2 are identical except for a single 45 
nucleotide stretch absent in Gga-3 and G^a -4. Ggcx -2 and GsCc-4 have an 
additional 3 nucleotides located 3' to the above 45 nucleotides. This is due to 
the alternate splicing of exon 3 of the gene such that G ^a-l and -2 have exon 3 
and Gg(%-3 and -4 do not [Bray et al., 1986; Kozasa et a l ,  1988; Kaziro et al.,
1990]. The production of an additional serine residue in Gga-2 and -4 by this 
splicing may represent an potential phosphorylation site on GgO for protein 
kinase C. Ggot has been shown to be the target of phosphorylation by this 
kinase in vitro [Pyne et al. , 1992]
The function of G^a is, as has already been stated, to stimulate
ithe enzyme adenylyl cyclase to produce cAMP from ATP. The enzyme itself 
is a single transmembrane spanning polypeptide with both N- and C- termini 
located intracellularly. The protein spans the membrane twelve times and 
contains two large intracellular domains one between transmembrane helices 6  
and 7 and another located at the C-terminus [Taussig & Oilman, 1995]. These 
regions are both thought to form catalytic sites in the protein (termed C). This 
molecular architecture resembles that of ATP driven pumps such as the P 
glycoprotein [Cooper etal., 1995]. Indeed the adenylyl cyclase of Paramecium 
has been shown to be a K+ pump as well [Schultz et al., 1992]. It is entirely 
possible that adenylyl cyclases of other species also have ion conductance 
properties. Ggot is also known to regulate the plasma membrane Ca^+ ATPase, 
presumably due to its topological resemblance to adenylyl cyclase.
Two substances are commonly used to affect the interaction of 
Gga with adenylyl cyclase. The diterpene forskolin stabilises the interaction 
with Gga and C causing the constitutive activation of adenylyl cyclase 
[Gilman, 1987]. An exotoxin from Vibrio cholerœ, termed cholera toxin, also 
causes the persistent activation of the adenylyl cyclase system. It does so by 
the enzymatic transfer of ADP ribose from NAD+ to an arginine residue in 
Ggo, close to the site which houses the GTPase activity of the protein. The a  
subunit is locked in its GTP bound, active state causing constitutive activation 
of adenylyl cyclase [Gilman, 1987]. Both these effects give rise to chronically 
high levels of cAMP inside the cell which has a variety of effects on 
intracellular proteins. II
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Ggtt is ubiquitously expressed in all cells although the relative 
levels of expression of the splice variants vary from cell type to cell type and 
from tissue to tissue. The exact purpose of this differential expression is 
unclear at present as there has been no evidence of any functional difference 
between the splice variants.
Goifa: This a  subunit was isolated from a cDNA library from rat
olfactory neuroepithelium [Jones & Reed, 1989]. Its expression was originally 
thought to be restricted to olfactory tissues [Jones & Reed, 1989] but is now 
known to be found in other areas of the CNS and is particularly prevalent in 
striatum [Hervé etal., 1993]. Its function, to stimulate the production of cAMP 
by adenylyl cyclase, is the same as G ga, to which it shares 8 8 % amino acid 
identity [Simon et al., 1991]. An isozyme of adenylyl cyclase (type III) has 
been identified that is particularly rich in olfactoiy tissues. This may represent 
a specific G protein/effector subsystem.
1. 2 .1 .2 . Members of the Gi family.
Originally described as the G protein involved in the hormonal 
inhibition of adenylyl cyclase, G ia  has subsequently proved to be a mixture of 
3 a  subunits termed G n a , Gi2«  and G isa [Jones & Reed, 1987].
G ija: The largest member of the trio, at 41kDa, is G iia  and like most
of the other members of the family this protein is subject to modification by an 
exotoxin from the causative agent of Whooping Cough, Bordetella pertussis. 
This adds an ADP-ribose group, donated by NAD+, to a cysteine residue 4 
amino acids from the C-terminus of the a  subunit. This transfer occurs most
efficiently when the G protein is in its holomeric, heterotrimeric form, 
complexed to its receptor [Gilman, 1987; Milligan 1988]. This ADP- 
ribosylation causes a stabilisation of the trimeric form of the protein and 
causes the release of the inactive G protein from the receptor preventing 
transduction of the hormone signal to the appropriate effector system. This 
releases the tonic inhibition of effector systems regulated by Gi proteins, 
causing their constitutive activation.
Giict demonstrates a more limited tissue distribution compared 
to Gj2a  and G jaa, being concentrated in neuronal tissues and certain other 
tissues. This may indicate a role in regulating ion channels as opposed to 
adenylyl cyclase.
Gi2 a : This a  subunit is the smallest of the three Gi proteins. It too is a
substrate for pertussis toxin catalysed ADP-ribosylation and shares around 
8 8 % amino acid identity with G jia . Although other members of the Gj family 
of a  subunits have been shown to cause inhibition of adenylyl cyclase 
[Taussig & Gilman, 1995], there is more evidence to suggest that G 1 2a  is the 
physiological regulator of this process. Using antibodies against Gi2Ct to 
selectively uncouple Gi2«  from its adenylyl cyclase, McKenzie & Milligan 
[1990b] demonstrated that Gi2cx was responsible for the inhibition of forskolin 
stimulated adenylyl cyclase activity in NG108-15 neuroblastoma x glioma 
hybrid cells.
Another system which Gi2«  has been reported to interact with 
is the MAP kinase cascade [van Corven et al., 1993; Albas et al., 1993], a 
series of protein kinases ultimately leading to the phosphorylation and
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activation of Mitogen Activated Protein kinase, an enzyme which catalyses the 
phosphorylation of a variety of cellular proteins to cause, among other things, 
entry into the cell cycle and stimulation of transcription. It is probable however 
that this stimulation of MAP kinase is mediated by |3y [Crespo et a l, 1994].
Gi3a : The third of the Gj family of a  subunits is thought to stimulate
certain ion channels in the plasma membrane. Work showed a Gj protein 
purified from human erythrocyte membranes to be capable of stimulating 
receptor activated K+ channels in atrial and pituitary membrane patches 
[Yatani eta l, 1987]. This protein was subsequently found to be Gig. Work in 
recent years has identified another ion channel under the control of Gig a. The 
renal epithelial cell line A6  contains an amiloride sensitive Na+ channel which 
can be activated via Giga [Cantiello et aL, 1989] apparently via an activation 
of phospholipase A 2 [Cantiello et al., 1990]. The a  subunit was also present in 
a 700kDa complex which also contained the Na+ channel [Ausiello et al.,
1992].
Gigoc has also been demonstrated to be involved in trafficking 
of proteins from the Golgi to the plasma membrane. Overexpression of Giga 
under the control of an inducible promoter inhibited the secretion of heparin 
sulphate proteoglycan from LLC-PKi epithelial cells [Stow et al., 1991]. In 
the same study, these investigators found that in both these cells and NRK 
epithelial cells, Giga was localised to Golgi membranes and that the Giga 
found on isolated rat liver Golgi membranes was a substrate for pertussis toxin 
catalysed ADP ribosylation. Pertussis toxin treatment reversed the inhibition 
of secretion of heparin sulphate proteoglycan indicating a role for Giga in 
Golgi trafficking of a constitutively secreted protein.
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G oa: Originally identified as a 39kDa pertussis toxin substrate of
unknown function purified from bovine brain and termed Gq for G'other' 
[Stemweis & Robishaw, 1984; Neer et al., 1984; Milligan & Klee, 1985], this 
a  subunit has been the focus of intense research due to its limited tissue 
distribution; G o« is present mainly in neuronal and electrically excitable cells. 
Although the function of G oa was initially a mystery, an elegant series of 
experiments by Hescheler et al. [1990] demonstrated that activated Go a  could 
inhibit the opening of a voltage sensitive Ca^+ channel, which was 
subsequently shown to be an N-type Ca^+ channel. G oa has also been shown 
to gate K+ channels [van Dongen et al. , 1988].
The cDNA for G oa was initially isolated from a number of 
sources, both mammalian and insect. The gene encoding the protein is large 
and covers about 90kb in humans [Kaziro, 1990] and contains 10 exons. 
Alternate splicing of the gene was first demonstrated in 1990 by two groups 
who isolated cDNAs encoding the original clone, which they termed G o ia  or 
GoA^c, and a second splice variant termed Go2a  or Gog# [Hsu ttaL., 1990; 
Strathmann e ta l., 1990]. These two splice variants are identical at their N 
terminus but show considerable variation at their C terminus. Overall, these 
two splice variants share approximately 90% amino acid identity [Simon et al., 
1991]. Another form of G ^a, termed Go*a, has been purified from bovine 
brain [Goldsmith et a l ,  1988] although a cDNA for this form has never been 
isolated and no functional data has been reported for it. It does not migrate 
with either G oia  or Go2a  under SDS-PAGE conditions developed to resolve 
them [Mullaney & Milligan, 1990]. Recently a third splice variant has been 
purified from both porcine and bovine brain membranes [Nürnberg et al..
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1994], named Gogct- This form is not G o*a either as its electrophoretic 
mobility is closer to that of G oia.
Like the splice variants of Gga, the Goa splice variants show a 
differential tissue distribution. Asano et a l  [1992] described the distribution of 
G o ia  as being restricted primarily to neuronal cells while Go2«  was found in 
peripheral tissues such as pituitary, lung and testis.
Two groups have demonstrated the differential regulation of 
G oia  and Go20t during differentiation. Upon treatment with agents which raise 
intracellular cAMP, Mullaney & Milligan [1990] found that the pattern of G oa 
isoform expression in NG108-15 neuroblastoma x glioma hybrid cells 
changed. Using a 2D gel system, these workers found that differentiation of 
NG108-15 cells caused an increase in the more acidic isoform; the expression 
of the more basic form remained unchanged. Brabet et al. [1990] described a 
similar situation in the neuroblastoma cell line N lE-115 where upon 
differentiation, these cells began to express more of the acidic form of Goa. 
Subsequent use of isoform specific antisera indicated that the more acidic form 
of Goa was in fact G o ia  [Rouot et al., 1991]. The physiological relevance of 
this was demonstrated by Rouot et al. [1991] who showed the progressive 
decline of Go2«  and the concurrent increase in expression of G o ia  during the 
development of mouse brains from the 15th day of gestation to 15 days post 
partum. This regulation was shown to occur as a result of a change in the 
degradation rates of the two isoforms [Brabet etal., 1991].
Unlike the splice variants of Gga, those of G oa have been 
shown to have distinct functional differences. Using an antisense DNA
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approach to selectively eliminate the splice variants in GHg cells, Kleuss et al, 
[1991] demonstrated that while Gqioc could couple to a muscarinic 
acetylcholine receptor, Go2«  could not and conversely, that while Go2Ct could 
couple to a somatostatin receptor, Goiot could not. Sim ilarly, by 
microinjection of purified G o ia  and Go2«  into identified neurones of the pond 
snail Helisoma trivolvis, Man-Son-Hing et al., [1992] demonstrated that only 
Go2«  could inhibit the voltage sensitive Ca^+ current in these neurones, 
perhaps indicating a role for G oia  in regulating the other described role of Go, 
that of gating K+ currents. In their study identifying Gog a , Nürnberg et al. 
[1994] also indicated a distinct role for Goga in intracellular signalling, as the 
purified protein could not reconstitute the carbachol mediated inhibition of the 
voltage sensitive Ca^+ cunent in pertussis toxin treated SH-SY5Y cells, while 
both purified G o ia  and Go20t could fulfil this function.
G ta : Transducin, or G ta , was originally identified as the entity
which "transduced" the activation state of rhodopsin to the phosphodiesterase 
reponsible for the lowering of levels of cGMP, influx of Na from the outside 
of the cell, depolarisation and thus initiation of the nerve impulse to the brain. 
The protein was purified around the same time as Gg and found to consist of 
three distinct subunits, like Gg [Gilman, 1987]. Subsequent cloning of Gta by 
four groups produced two separate clones, named G ^ a  and Gt2a  [Lochrie et 
al, 1985; Tanabe et al., 1985; Yatsunami & Khorana, 1985; Medynski et al., 
1985]. Subsequent studies showed that G ^ a  was restricted to retinal rod 
membranes while Gt20t was found only in retinal cone membranes [Grunwald 
et al., 1986; Lerea et al., 1986]. Gtga and Gt20t share approximately 80% 
amino acid identity, bind to rhodopsin and cone opsin respectively and activate 
a cGMP specific phosphodiesterase. Recently G tia has been found in non-
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retinal taste tissue [Ruiz-Avila et al., 1995], where it functions to couple the 
bitter taste receptor to a phosphodiesterase.
The transducins are unique among the hetrotrimeric G proteins 
in that they can be washed from the retinal membrane in the absence of 
detergent [Spiegel, 1990]. This is not due to any known differences in the 
amino acid composition of G tia  or Gt2 0 , as will be elaborated upon later in 
this chapter, but is instead due to specific differences in the lipid environment 
of the retina causing laurylation of the a  subunit, and the expression of a 
specific retinal form of the y subunit, now termed y j, which is prenylated with 
a famesyl moiety. Both of these lipid moeities are less hydrophobic than the 
more common myristate and geranylgeranyl.
Gustducin a: The newest a  subunit to be isolated was obtained from a
taste tissue-cDNA library [McLaughlin eta l., 1992]. Analysis of the primary 
amino acid sequence of gustducin a  suggested that this a  subunit belongs to 
the Gi family as it contained a consensus sequence for pertussis toxin catalysed 
ADP-ribosylation. It showed particular similarity to the transducins. Rat 
gustducin demonstrates 81% and 90% identity to bovine G tia  and Gt2 0 t, 
respectively [McLaughlin et al., 1992] and 79% identity to rat G tia  [Ruiz- 
Avila e ta l ,  1995].
Analysis of the expression of gustducin a  indicated that it is 
only expressed in taste tissue. No message corresponding to gustducin was 
found in non-taste lingual tissue, olfactory epithelium, retina, brain, liver, heart 
or kidney. Gustducin was found in all three taste papillae, that is circumvallate, 
foliate and fungiform [McLaughlin e t a l ,  1992]. These workers postulated
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that, by analogy to the transducins, gustducin activation would also lead to the 
activation of a phosphodiesterase, although a peptide derived from gustducin a  
could not activate a taste cell phosphodiesterase when the corresponding 
peptide from G tia  could [Ruiz-Avila et al., 1995]. Baculovirus expressed 
gustducin a  could interact with bovine rhodopsin and bovine retinal cGMP 
phosphodiesterase and both bovine brain and retinal j3y [Hoon etal., 1995].
G^a: The most divergent of the Gi family of G proteins, sharing only
62% amino acid homology with other members of the family, G%a is unique as 
it is the only Gi family member that lacks the cysteine residue which acts the 
acceptor for the ADP ribose group transferred from NAD+ by pertussis toxin 
[Casey et at., 1990]. It was cloned from human brain and retina simultaneously 
[Matsuoka et al., 1988; Fong et al. , 1988]
G^a also has several properties that distinguish it from other a  
subunits. It has both a very slow guanine nucleotide release rate and a slow 
intrinsic GTPase activity [Hinton et al., 1990]. It also has a limited tissue 
distribution, being mainly restricted to neurones, particularly those with long 
axonal processes, and platelets [Hinton e ta l., 1990]. Like most other members 
of the Gi family it is, however, dually acylated by myristic acid on gly2  and 
palmitic acid on cys3. This will be elaborated upon in the following section 
and in subsequent chapters. As yet, however, G%a has no known signalling 
function assigned specifically, although it may inhibit type I and type V 
adenylyl cyclases [Taussig & Gilman, 1995] and has been reported to allow 
pertussis toxin insensitive inhibition of adenylyl cyclase.
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1 .2 .1 .3 . Members of the Gq family.
Gqa: The cloning of two distinct G protein a  subunits by Strathmann
& Simon [1990] opened a whole new era in the study of G proteins. The first 
of these, which they termed G qa, was predicted to encode a protein of 359 
amino acids, equivalent to approximately 42kDa under SDS-PAGE. It lacked 
the cysteine residue required for pertussis toxin catalysed ADP-ribosylation.
The protein was found ubiquitously, both in terms of tissue specificity and in Ig
organism specificity, from mammals and other vertebrates to invertebrates 
such as Drosophila. This alluded to a universal function for G qa and it
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subsequently transpired that it was the long sought after G protein regulator of «
3phosphoinositidase C [Smrcka etal., 1991].
Phosphoinositidase C is in fact a variety of isozymes which 
belong to a gene superfamily. All the isozymes function in the same manner, 
to hydrolyse phosphatidylinositol-4,5-bisphosphate (PIP2) yielding the second 
messenger moleeules 1,2-diradylglycerol (DAG) and inositol-1,4,5- 
trisphosphate (IP3). This bifurcation of the signal leads to the activation of two 
distinct pathways. The lipid molecule DAG causes the activation of a series of 
isozymes termed protein kinase C (PKC). PKC isozymes are serine/threonine 
protein kinases which affect many cellular processes including the activation
Î:of the Raf kinase, which is then able to activate another series of protein 3;
:g|"kinases ending in the phosphorylation and activation of MAP kinase. IP3 , 
being a polar molecule, is released from the membrane to bind to specific 
receptors, located on the endoplasmic reticulum. This causes the release of 
Ca2+ from stores in the ER, again leading to effects on cellular systems.
\
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The phosphoinositidase C isozymes differ in their regulation, 
however, and only those belonging to the p class are under direct G protein 
control [Rhee & Choi, 1992] although phosphoinositidase C ô i may be 
stimulated by Py [Park et a l, 1993]. Those of the y class are activated through 
their Src Homology 2 (SH2) domains by binding phosphotyrosine residues of 
growth factor receptors. The p isozymes are activated both by the a. subunit of 
Gq family members and the Py dimer (see later), which can be generated from 
any class of a  subunit. This dual regulation gives rise to both the pertussis 
toxin insensitive activation of PLCps, mediated by the a  subunit of Gq family 
members, and their pertussis toxin sensitive activation, caused by the release 
of Py from activated ot subunits of Gi family members. The sites of action on 
PLCp for G protein ot subunits and Py dimers are apparently distinct, however 
[Smrcka & Stemweis, 1993; Lee et al., 1993], and the efficacies of their 
activation differ between the different, known, members of the PLCp family, 
teimed PLCp 1-4 (see table 1 .1.)
G n a :  In the same paper that announced the cloning of G qa,
Strathmann & Simon [1990] reported the presence of another a  subunit, which 
they termed G n a .  This protein was very similar to G q a , sharing 
approximately 90% identity at the amino acid level [Simon et al., 1991] and 
also contained 359 amino acids. This protein too was not a substrate for 
pertussis toxin and to date little if any functional difference has been reported 
between G qa and G n a .  Purified G q /n  from brain can activate PLCp 1 in a 
reconstitution assay and the two a  subunits may have identical abilities to 
activate PLCp 1 [Blank etal, 1991].
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Table 1. 1. Comparison of the regulation of 
phosphoinositidase C by G protein a  and Py 
subunits.
The p isoforms of phosphoinositidase C (PIC) are regulated by G proteins. To 
date all are known to be activated by a  and Py subunits but to different 
degrees. This is displayed in this table such that the stimulations are of the 
order ++++>+++>++>+>+/-. This table was constructed by data from Smrcka 
& Stemweis [1993] and Lee e ta l  [1993].
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Table 1.1.
PLCp Isoform
pi
p2
P3
p4
Activation by G q/na Activation by Gpy
+++
+ / “
++++
+
*H+
+++
Despite the apparently similar function of the two proteins, the 
tissue distribution of G qa and G n a  shows some variation. Although both 
proteins are found almost ubiquitously, the exception being an apparent lack of 
G lia  in human haematopoietic cells [Milligan et ah, 1993], the relative 
amounts of the two proteins differ in both brain regions [Milligan, 1992] and 
peripheral tissues [Milligan etal., 1993].
Chronic activation of receptors linked to these a  subunits, such 
as the M l muscarinic acetylcholine receptor [Mitchell et al., 1993] or 
gonadotrophin releasing hormone (GnRH) receptor [Shah & Milligan, 1994], 
led to the downregulation of both G qa and G n a  equally and non-selectively 
without affecting the G protein a  subunits Gga and Gj2a . This would indicate 
an apparent lack of specificity in signalling through G qa and G n a . This begs 
the question, why does a receptor apparently activate two different G proteins 
to fulfil the same function? The answer to this question is unclear at present. 
The differences in primary structure between G qa and G ^ a  are mostly 
clustered near the N terminus of the proteins in regions concerned with Py 
binding and the relative rate of guanine nucleotide exchange and hydrolysis 
[Simon et al., 1991], perhaps indicating that Gqa and G n a  couple differently 
to different combinations of p and y.
G i4« : The third member of this family is also a PLCp activating
enzyme. Analysis of the distribution of mRNA encoding G 14a  indicates a 
more restricted pattern of expression, and is found primarily in stromal and 
epithelial cells [Wilkie et al., 1991]. Another groups who also reported the 
cloning of Gi4 a ,  found mRNA corresponding to the a  subunit in liver, lung 
and kidney and none in bovine eerebral cortex and atrium [Nakamura et al.,
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1991]. G i40c shares approximately 80% identity with G qa and G j ia  at the 
amino acid level.
G isa : This a  subunit has an even more restricted tissue distribution,
being found only in cells of a haematopoietic lineage; it is found in murine B 
cells and myeloid cells and shares a 57% amino acid homology with Gqoc, 
Giicx and G 14a  [Simon et al., 1991 ; A m a tru d a aL, 1991].
G iga: The final member of this class of G proteins is a human
homologue of G 15a  and shares approximately 83% amino acid homology to it. 
Its tissue distribution is restricted to haematopoietic cells such as T cells and 
myeloid cells [Amatruda et aL, 1991]. It contains structural differences from 
other a  subunits, namely two inserts near the C terminus, in the region 
proposed to house the effector contact site for a  subunits, and a divergent N 
terminus. The first insert (amino acids 317-323) is similar to the corresponding 
region in Gga while the second insert (amino acids 331-337) contains several 
charged residues not found in other a  subunits [Amatruda et a t ,  1991]. It also 
contains a proline residue at position 50, in the "A" site (see later), a region 
involved in GTP binding and hydrolysis, where other a  subunits contain 
alanine (Gg or Gi) or threonine (Gq). This may indicate an impaired capacity to 
bind guanine nueleotides and hydrolyse GTP as a  subunits with divergent 
amino acids at this point (G%a, G qa and G n a )  [Simon et aL, 1991] have 
reduced abilities to fulfil these functions [Pang & Sternweis, 1990; Casey et 
aL, 1990].
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1. 2 .1 .4 . Members of the G12 family.
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G i2a  and Giaa:
The final class of G protein a  subunits contains two known 
members, G 12a  and G^ga [Strathmann & Simon, 1991]. These polypeptides 
share relatively little primary sequence identity with the other ot subunits 
(approximately 45%) and have less than 70% identity with each other 
[Strathmann & Simon, 1991]. They are both expressed ubiquitously 
[Strathmann & Simon, 1991].
Comparatively little is known about either subunit and it has 
only been recently that the role of these two a  subunits has become clearer. 
Using constitutively activated mutants of G i2«  and G jg a  [Xu et aL, 1993] 
demonstrated an activation of arachidonic acid metabolism and Offermanns et 
aL [1994] have shown using photoreactive azidoanilide analogues of GTP that 
both G i2 0 l and G jga  are activated by the thrombin and thromboxane A2 
receptors in platelet membranes. Several recent reports have suggested a role 
for G i2«  and G iga in regulating Na+/H+ exchange [Voyno-Yasenetskaya et 
aL, 1994; Dhanasekaran et aL, 1994]. Like the activated mutant of G{2 Gl in Rat 
la  cells [Gupta et aL, 1992], activated mutants of Gyia and G 13a  have been 
shown to be focus forming in NIH-3T3 cells [Xu et at., 1993; Jiang et aL,
1993].
Like Gq family members and G ^a [Pang & Sternweis, 1990; 
Casey et aL, 1990; Wange et aL, 1991] G 120c and Giga have a slower basal 
guanine nucleotide exchange rate than Gga and most Gi family members 
[Offermanns etaL, 1994],
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1. 2. 2. The structure and function of the Py 
dimer.
Under non-reducing conditions, the p and y subunits of 
heterotrimeric G proteins are found exclusively, at the membrane, as a tightly 
associated complex. To date there exists four known p subunits ranging in size 
from 35 to 36 kDa and at least 10 y subunits of approximately 8  to lOkDa. The 
p subunits share approximately 80% amino acid identity with the differences 
spread throughout the sequence [Simon et aL, 1991; Gao et aL, 1987; von 
Weizsacker et at., 1992]. The y subunits on the other hand share relatively 
little sequence identity, yi is only 38% identical to y% and is similarly different 
from other y subunits [Clapham & Neer, 1993].
These subunits do not randomly form in any combination. Only 
certain allowed associations are found in cells. For example, the subunit, 
whose expression is restricted to the retina, will only associate with the p i 
subunit. On the other hand, the p i subunit can complex to y i j 2 , Y3> Y5 Y7 - 
p2 can associate with any of Y2 ,Y3 > Y5 ory7. p3 associates with neither y i or y 2 
[Pronin & Gautam, 1992; Schmidt et aL, 1992; Iniguez-Lluhi et aL, 1992; 
Ueda et aL, 1994]. These reports indicated that certain combinations of p and y 
subunits were either not formed or were unstable.
Perhaps one of the most interesting and revealing discoveries of 
recent years has been the active role of the Py dimer in signalling events. 
Originally, Py was thought to play a purely sedentary role in signal 
transduction, by acting as an anchor for the more active a  subunit. The first
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evidence of an active role for Py was presented by Jelsema & Axelrod [1987] 
who demonstrated an activation of phospholipase A 2 by Py in outer rod 
segments of bovine retina. Around the same time came a report of the 
activation of a cardiac K+ channel, the ÏK .A C h  channel, which is activated by 
the muscarinic acetylcholine receptor. The channel can be activated, in patch 
clamp experiments by either the a  subunit or the Py complex, and this 
activation by one of the two proteins was not conditional upon preactivation 
with the other [Logothetis et ah, 1987; Godina et ah, 1987; Logothetis et aL,
1988]. The Py dimer activates the lK.ACh channel more successfully than the a  
subunit, while G a  alone can activate another K+ channel the I k .A T P  channel in 
the same patch [Ito et aL, 1992]. It is unclear whether the activation of the K+ 
channel is direct or whether it is via the prior activation of phospholipase A 2 
[Kim et aL, 1989; Clapham & Neer, 1993].
Since these pioneering studies, it has become apparent that Py 
carries out a number of diverse functions. Perhaps one of the best documented 
is the activation of the p isoforms of phosphoinositidase C. This was first 
demonstrated by Camps et aL [1992] using purified or partially purified 
com ponents. These w orkers dem onstrated the stim ulation  of 
phosphoinositidase C from HL-60 cell cytosol by bovine retinal Py and 
showed that this stimulation was blocked by GDP liganded G ta, was additive 
to the stimulation by GTPyS, was not dependent on prior actiavtion of 
phospholipase A2 and was specific for one isoform of phosphoinositidase C.
The intricacies of this regulation are still being worked out. It is 
apparent, however, that the degree of stimulation of the various p isoforms of 
phosphoinositidase C by the py dimer are not the same (see table 1. 1.). It has
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been suggested that the sites of interaction on phosphoinositidase C for a  and 
Py differ [Smrcka & Sternweis, 1993; Lee et aL, 1993] and it has been shown 
that while the a  subunit interacts with a site at the C terminal region of 
phosphoinositidase C p2 and that this region is probably distinct from the Py 
contact site [Lee et aL, 1993]. Wu et aL [1993] demonstrated that the py 
contact site was found in the N terminal part of phosphoinositidase C p2 while 
the a  contact site was in the C terminal portion of the enzyme.
Wu et aL [1993] also demonstrated that different combinations 
of p and y could activate phosphoinositidase CP2 to different degrees, thus 
PlYl>PlY5>P2Y5 (P lYl caused a 10 fold stimulation of inositol phosphate 
production while p iy5 caused an 8 fold stimulation and P2Y5 caused a 4 fold 
stimulation) while P2Y1 did not cause activation (presumably because this 
dimer cannot form [Pronin & Gautam, 1992]). Ueda et aL [1994] 
demonstrated that Piy2 , P m , PlY5, PlY7, p2Y2, P2Y3, P2Y5 or p2Y7 were equally 
effective in activating phosphoinositidase CPg while Piyiwas less effective.
Adenylyl cyclase has also been shown to be regulated by the Py 
complex. This regulation is not as all encompassing as that for the p isoforms 
of phosphoinositidase C but resembles more the type specific regulation of 
cardiac K+ channels by py. This regulation adds yet another dimension to the 
regulation of adenylyl cyclase (see table 1. 2.). The Py complex can not only 
activate certain isoforms of adenylyl cyclase but can also cause the inhibition 
of certain other isoforms. In insect Sf9 cells transfected with recombinant 
baculoviruses encoding adenylyl cyclase isoforms, Tang & Gilman [1991]
I
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Table 1.2. The regulation of adenylyl cyclase.
Adenylyl cyclase is present as many different isoforms, each the product of 
distinct genes, sometimes with many isoforms being present in a single cell 
type. The regulation of these isoforms is complex involving Ca^+ and 
calmodulin (Ca^+ZCalmod), protein kinase C (PKC) as well as G protein 
subunits. This is displayed here for the type I-VIII isoforms. No data was 
available for more recently isolated clones. This table was taken from Cooper 
etal. [1995].
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Table 1. 2.
Adenylyl Gga
Cyclase Stimulation
I Mild
Py 
Effect
Inhibition Stimulation
Ca2+/CaImod. PKC
Effect Stimulation
No
II Yes Stimulation No Yes
III Yes Stimulation No
IV Yes Stimulation No No
Y Yes No Inhibition No
VI Yes No Inhibition No
VII Yes No Yes
VIII Mild Stimulation No
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demonstrated that py purified from bovine brain caused inhibition of type I 
adenylyl cyclase while causing activation of type II adenylyl cyclase. This 
inhibition of type I adenylyl cyclase was demonstrated to be due to a direct 
interaction of py with the enzyme [Taussig et aL, 1993] as opposed to via 
sequestration of calmodulin by py as had been suggested previously [Katada et 
aL, 1987]. It has also been demonstrated that while the stimulation of type II 
[Tang & Gilman, 1991] and type IV [Gao & Gilman, 1991] isoforms of 
adenylyl cyclases by py is only modest and requires large concentrations of the I
dimer, this stimulation can be significantly enhanced in the presence of
activated Ggcc [Tang & Gilman, 1991; Gao & Gilman, 1991]. Experiments 
with chimeric adenylyl cyclase indicated that the site of interaction with py on 
adenylyl cyclase was present at the C tenninal region of the enzyme [Tang & 
Gilman, 1991;Clapham & Neer, 1993]. It has also been shown that specific 
dimer compositions can differentially regulate isoforms of adenylyl cyclase 
Piyi is only approximately 10% as effective as P m , P lys, P lys, P lyy, P2Y2 , 
P2Y3 , p2Y5 or p2Y7 [Iniguez-Lluhi etaL, 1992; Ueda etal., 1994].
The Py dimer also has a role in the regulation of the 
transduction of the signal from a serpentine receptor to certain members of the 
growing family of G protein linked receptor kinases (GRKs). These kinases 
have an important role in the desensitisation of serpentine receptors by 
phosphorylating the receptors and preventing their interaction with, and 
activation of, G proteins. In this case the Py dimer acts to recruit the GRK (for 
example pARK) from the cytosol to the plasma membrane and this binding of 
py to PARK increases the catalytic activity of the enzyme [Pitcher et aL, 1992; 
Kameyama et aL, 1993]. The binding of py to pARK may be facilitated via the 
Pleckstrin homology (PH) domain of PARK [Touhara et aL, 1994]. The PH
-----------
domain of pARK is thought to lie in or near the Py binding site of pARK 
[Musacchio et a l,  1993; Shaw, 1993], which has been mapped to a 125 amino 
acid region near the C terminus of pARK [Pitcher et a l ,  1992; Koch et a l ,
1993]. The Py complex has been shown to bind several PH domains when they 
were expressed as fusion proteins with glutathione~S-transferase [Touhara et 
a l,  1994]. This meehanism is not universal, however, as some of the GRKs 
have lipid moieties attached to them in order to target them to the plasma 
membrane. Rhodopsin kinase is modified by a farnesyl moiety at its C terminus
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[Inglese et a.l, 1992] and GRK5 is palmitoylated [Stoffel e ta l ,  1994]. This 
role for py points to the complex series of feedback mechanisms which exist to 
"fine tune" the signals produced by serpentine receptors.
A recent report has also shown the activation of the MAP kinase 
cascade by py. Crespo et al. [1994] found that Py caused a p2 P’^ s dependent 
phosphorylation of myelin basic protein, a substrate for MAP kinase. The basic 
cascade is displayed in figure 1. 2. They hypothesised that this may be due to 
interaction of Py with p21*'^ ^^ , the direct upstream activator of Raf [Van Aelst et 
a l ,  1993; Vojtek et a l,  1993], the first kinase in the MAP kinase cascade, 
although recently the direct interaction of Py with Raf-1 has been demonstrated 
[Pumiglia n/., 1995].
The precise mechanism by which one single complex can 
regulate so many apparently diverse proteins is unclear. The exact combination 
of P and y may dictate which proteins the complex will interact with, although 
there is little evidence to suggest this is so, with the exception of the p iy i 
combination. One system where ihis has become evident is the modulation of 
the N-type Ca^+ channel of G Hi rat pituitary tumour cells. Using an antisense
Figure 1. 2. The MAP kinase cascade.
The classical method of activation of MAP kinase involved the binding of the 
adaptor molecule GRB-2 to phosphotyrosine residues of activated growth factor 
receptors, via its Src homology-2 domain. This in turn recruited SOS, which 
bound to the Src homology-3 domains of GRB-2, which in turn activated Ras, 
an immediate upstream regulator of Raf-1. This kinase then phosphorylates and 
activates another enzyme, MAP kinase kinase, the immediate upstream activator 
of MAP kinase. This causes a myriad of cellular responses. Recently it has been 
shown that activation of G |2  could also activate the MAP kinase cascade, 
although this activation may in fact be due to the release of py, which then may 
act upon Ras. However, py has recently been shown to interact with Raf-1 and 
it may be this interaction which causes the activation of the cascade. Please note 
that Src homology-2 and Src homology-3 domains are regions, first identified 
in the Src non-receptor tyrosine kinase which have been shown to bind to 
phosphotyrosine residues and short poly proline regions, respectively, of may 
proteins involved in cellular signalling and the cytoskeleton.
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oligonucleotide approach to specifically target G protein subunits, Kleuss etal.
[1991] demonstrated that G o ia  could only mediate muscarinic acetylcholine 
receptor mediated inhibition of the Ca^+ channel while the somatostatin 
receptor used only Go2Ct- In n further extension of this, Kleuss et al. [1992;
1993] demonstrated that only G oiaP 3Y4  caused the muscarinic receptor 
mediated inhibition of Ca^+ currents, while the somatostatin receptor used 
only Go2«|3iY3 to achieve this. It has been proposed that, due to the high 
degree of sequence identity found in the |3 subunits, it is the y subunits, with a 
lower identity, which dictates the majority of the specificity in coupling to 
receptors and effector systems [Clapham & Neer, 1993], and so regulates the 
different effects of py in signalling systems.
1. 2. 2. Structural determinants in G protein 
function.
Much of the early work done on the structure of G protein a  
subunits and how it correlated to function was by extension of work on the 
small molecular weight G proteins p2F’^® and Ef-Tu, 3 dimensional structures 
for which were known [Pai et at., 1989; 1990; Mil burn et al., 1990; 
Schlichting et al., 1990], such that a 3D structural model for G protein a  
subunits could be inferred [Holbrook & Kim, 1989; Berlot & Bourne, 1992; 
Thomas et al., 1993]. It has only been recently that the crystal structures of 
GTPyS and GDP liganded Gta have been available [Noel et al., 1993; 
Lambiight e ta l ,  1994].
Upon activation of the receptor, the heterotrimeric G protein 
undergoes a series of steps leading to interaction with effector systems, known
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as the G protein cycle (fig u re  1. 3.). Activated receptor causes a 
conformational change in the G protein a  subunit such that the bound GDP is 
released and GTP enters the nucleotide binding site. Binding of GTP triggers 
two events; the G protein has a lower affinity for receptor in its GTP bound 
state and thus is released from it, and the trimer dissociates into free a  subunit 
and the Py complex. These entities can then interact with their effector systems 
before the intrinsic GTPase activity of the a  subunit hydrolyses the GTP to 
GDP. In the GDP bound state, the a  subunit has a lower affinity for effector 
and is released to bind once more to py and subsequently interact with receptor 
ready to be activated once more [Gilman, 1987].
The recent publication of the crystal structure of GTPyS 
liganded Gtoc indicated that this was indeed correct. Noel et al. [1993] 
demonstrated that two distinct domains of G ta, one of which acts as the 
nucleotide binding domain while the other restricts movement into and out of 
the binding pocket, co-operated to form a "lid" which the activated receptor
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The guanine nucleotide binding site on the a  subunit is 
composed of 5 separate stretches of amino acid sequence spread throughout 
the protein which come together to form a pocket in 3 dimensions. These 5 
regions, termed "G" regions share significant homology to the equivalent 
regions of p 2 D ^  and other members of the GTPase superfamily [Conklin & 
Bourne, 1993]. The C terminal region of the a  subunit, which is thought to be 
the contact site for the receptor (see later), was thought to form a mobile 
region that prevents release of bound GDP. Upon agonist activation of 
receptors, it was proposed that this region may move aside to allow GDP to 
leave the binding site and allow GTP to enter [Denker et al., 1992b].
.1
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Figure 1.3. The G protein cycle.
Receptor activation (R*) by ligand induces the release of GDP from the G 
protein in its holomeric from (1). GTP can then enter the nucleotide binding 
site causing activation of the G protein. This then dissociates into free a  and 
Py subunits (2). The activated a  subunit and the py dimer can then interact 
with their effector systems (3) before the intrinsic GTPase activity of the a  
subunit hydrolyses the GTP to GDP (4) causing re-association of the «Py 
heterotrimer (5) which is then ready to be reactivated by the receptor. This 
figure was adapted from Conklin & Bourne [1993].
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must pry apart to allow guanine nucleotide exchange. The structure also 
validated much of the work implied by the p2 F^s and Ef-Tu structures and 
that done using bacterial toxins, antibodies, peptides and mutagenic strategies; 
the surfaces which contacted receptors and effectors were in the predicted 
locations. Following the structure of GTPyS complexed G ta , the same group 
of workers determined the structure of the GDP liganded a  subunit [Lambright 
et a l ,  1994]. This gave an insight into the way which the a  subunit transmits 
its activation status to receptors, effectors and Py. This will be discussed later.
The N terminal region is thought to be important in Py 
interactions. Limited tryptic cleavage of GqO, such that the first 21 amino 
acids of the protein were removed, prevented Py binding to GqO [Fung & 
Nash, 1983; Neer et al., 1988]. Monoclonal antibodies against, and a 
myristoylated peptide corresponding to, the N terminus of G tia  compete for 
Py binding [Mazzoni & Hamm, 1989; Mazzoni et at., 1991; Kokame et aL, 
1992]. Denker et al. [1992a] demonstrated that amino acids 7-10 of GqO were 
important for p y  binding. A second site in the a  subunit is also thought to 
contact p y .  A mutation of G^a, G226A, which prevented GTP induced 
conformational change [Miller et aL, 1988], also prevented GTP from 
triggering Py dissociation [Miller etal., 1988; Lee et aL, 1992]. This region of 
GgO is the most highly conserved area in G protein a  subunits [Conklin & 
Bourne, 1993] suggesting a crucial role in the function of the a  subunit. 
Thomas et al. [1993] demonstrated, using a chemical crosslinking approach, 
that this region of G oa was in close proximity to p y .  Although the direct 
interaction of a  and p subunits has only been demonstrated by crosslinking 
experiments [Bubis & Khorana, 1990], the direct interaction of a  and y  has 
been experimentally demonstrated by Rahmatullah & Robishaw [1994] using
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an affinity agarose column chromatography based strategy. These workers 
demonstrated the interaction of Ggo with Y2> and postulated that this 
interaction was mediated via the N terminal region of GqCc , due to the 
trypsinolysis protection effect of 7 2  on the a  subunit, and the C terminal region 
of the Y subunit, due to the requirement for prénylation of 72 [Rahmatullah & 
Robishaw, 1994].
Several areas of the a  subunit are thought to contact the
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serpentine receptor. One of the earliest to be identified was the C terminal tail.
-The Bordetella pertussis exotoxin pertussis toxin, which is known to 
specifically catalyse the transfer of ADP-ribose to a cysteine residue 4 amino 
acids from the C terminus of most members of the Gi family of a  subunits 
[Gilman, 1987], causes the G protein to become dissociated from the receptor 
[West et ah, 1985]. Mutations in the C terminal tail and antibodies directed 
against it can also cause uncoupling of the receptor G protein complex 
[Sullivan et aL, 1987; Simonds et aL, 1989b; Gutowski et aL, 1991; Hirsch et 
aL, 1991; Shenker et a l ,  1991]. An elegant set of experiments by Conklin et 
aL [1993] changed the receptor specificity of G qa to that of Gi%a by 
substitution of 3 amino acids at the C terminal end. The presence of a glycine 
3 amino acids from the C terminus was thought to be important in defining this 
specificity [Conklin et aL, 1993] and this residue in G tia  is thought to form 
part of a p turn which directly contacts rhodopsin [Hamm, 1991]. It is thought 
therefore that these p turns, which are important for protein-protein 
interactions [Bansal & Gierasch, 1991], provide signals for recognition by 
specific receptors [Conklin & Bourne, 1993].
The second site on the a  subunit which may contact the 
receptor is the N terminal region [Conklin & Bourne, 1993]. The N and C 
termini are thought to be in close proximity in 3 dimensional space [Conklin & 
Bourne, 1993]. A N terminal G tia  peptide inhibited the interactions of Gt with 
rhodopsin while apparently not affecting interaction of G tia with Py [Hamm 
et ah, 1988; Conklin & Bourne, 1993]. Furthermore, mastoparan, a peptide 
from wasp venom which can mimic the receptor causing activation of Gi 
family proteins, can be cross-linked to a cysteine residue near the N terminus 
of G oa [Higashijima & Ross, 1991]. The binding of receptor to an N terminal 
region of the a  subunit would suggest that the Py complex may also contact 
receptor. Receptors can cause GDP release from the aPy trimer much more 
efficiently than from the dissociated a  subunit [Fung, 1983; Fung & Nash, 
1983; Florio & Sternweis, 1989] probably due to the direct interaction of 
receptor and Py [Kelleher & Johnson, 1988; Phillips & Cerione, 1992; Phillips 
etaL, 1992].
The third site for receptor-a interaction is a site near the C 
terminus represented by amino acids 311-328 of G tia .  A peptide 
corresponding to these residues blocked the activation of Gt by rhodopsin. It 
also acted synergystically with the extreme C terminal peptide of G tia  [Hamm 
e ta l ,  1988; Hamm, 1991].
To identify areas of the a  subunit which may interact with 
effector proteins, Rarick et al. [1992] used peptides to mimic the activation of 
the retinal cGMP-PDE by G ^ a . One peptide representing amino acids 293- 
314 stimulated the PDF with an efficacy close to that of GTP liganded G ^ a . 
This peptide couesponded to the effector activating residues of Gga identified
I
35 I
by Berlot & Bourne [1992]. An elegant set of experiments by Berlot & Bourne
[1992] demonstrated an effector contact site on Gga, part of which was 
thought to undergo GTP induced conformational changes. These workers 
extended work by Osawa et al. [1990] by creating chimeric proteins of Gi2a  in 
which residues in the region 236-356 were replaced by cognate areas of Gga. 
By this approach Berlot & Bourne identified 4 areas of Gga, corresponding to 
amino acids 236-240, 261-262, 277-285 and 349-356, which when mutated 
resulted in a protein which did not stimulate adenylyl cyclase. Of these the 
first three areas did not affect the expression or GTP induced conformational 
change of the chimeras. These areas were thought to fonn a surface in 3 
dimensions, based on the 3D structure of p2P’^ s, part of which was thought to 
undergo a GTP induced conformational change [Berlot & Bourne, 1992]. This 
presumption has been confirmed by the crystal structures of GDP and GTPyS 
complexed Gta. Binding of GTP caused the a  subunit to protrude slightly such 
that areas which contact py and effectors bulge. These areas overlap indicating 
that in order to interact with effectors, the a  subunit must first release py 
[Lambright e ta l ,  1993; Noel e ta l ,  1994; Bourne, 1994].
1.3. G protein linked receptors.
Although this Introduction focuses mainly on G proteins, it may 
be prudent to consider the receptors to which they couple. All the receptors 
which couple to G proteins are thought to exibit a distinct molecular 
morphology consisting of seven transmembrane spanning a  helices, and hence 
are referred to as serpentine receptors. The sole known exception to this 
general rule is the insulin-like growth factor II receptor which has an intrinsic
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tyrosine kinase activity but can also activate G proteins through an 
amphipathic cc helix [Higashijima e ta l ,  1988; Higashijima e ta l ,  1990].
The present understanding of the structure of serpentine 
receptors is based on the structure of the photoactivated proton pump of 
Halobacterium halobium. This protein, termed bacteriorhodopsin, is folded in 
such a way that the N terminus of the protein is located on the extracellular 
surface of the cell and the C terminus is intracellular. Between these two areas 
are seven regions of high hydrophobicity which electron microscopy and high 
resolution electron diffraction indicate as being transmembrane spanning 
domains arranged in a bundle perpendicular to the plane of the lipid bilayer 
[Henderson & Unwin, 1975; Engleman et al. , 1980; Henderson et al. , 1990]. G 
protein linked receptors are also thought to contain these distinctive seven 
transmembrane spanning regions (figure 1. 4.) [Dohlman et al., 1992; 
Savarese & Fraser, 1992].
1. 3. 1. Structure-function relationships in 
serpentine receptors.
The following sections represent an outline of aspects of ligand 
binding to receptor and receptor activation. It is not intended to be an 
exhaustive review of the subject.
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Figure 1. 4. Putative topology of serpentine 
receptors.
Ali G protein coupled receptors are thought to share the same basic membrane 
topology, namely the presence of seven transmembrane spanning helices. The 
model for these receptors places the N terminus extracellularly and the C 
terminus intracellularly. The receptor shown is the human (32 adrenergic 
receptor, an archetypal serpentine receptor. Sites of glycosylation are shown as 
crosses on the N terminal tail. The sites of phosphorylation and palmitoylation 
of the C terminal tail are not shown. Other members of the family can contain 
very large extracellular and intracellular domains, but still share this basic 
structure. This figure was adapted from Lefkowitz et a l ,  [1993]
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1. 3. 1. 1. Structural determinants for ligand 
binding.
Although serpentine receptors share the same basic structure, 
differences exist in the method of binding agonist. The receptors for small 
molecules such as light (using ll-c/5-retinal as a chromophore ligand) 
[Khorana, 1992] catecholamines and acetylcholine [Dohlman et al., 1992; 
Savarese & Fraser, 1992] bind these agonists in a cleft formed by the folding 
of the transmembrane helices of the receptor. Other serpentine receptors bind 
their agonists in different ways and these are illustrated in figure 1 .5.
The p2 adrenergic receptor has been used for many years as a 
model system for studying the function and regulation of serpentine receptors 
in transmembrane signalling. Large parts of the intracellular and extracellular 
domains can be deleted without appreciably altering the ligand binding 
properties of the receptor. Studies using alkylating agents [Dohlman et al., 
1988] and photoaffinity labels [Wong et al., 1988] and a fluorescent antagonist 
[Tota & Strader 1990] have shown that the ligand binding pocket, formed from 
the seven transmembrane helices, is located approximately one third of the 
way down into the core of the protein.
Receptors for peptide agonists appear to recognise these 
agonists on their exofacial surface [Fong et a t ,  1992a & Fong et a t ,  1992b] 
while glycoprotein hormones such as thyrotropin bind to the N terminal tail 
[Moyle et a t ,  1991; Nagayama et a t ,  1991] of the receptor causing a 
conformational change in the receptor causing the tail to bind to the 
extracellular loops of the receptor.
Figure 1. 5. Graphical representation of the 
mechanism of ligand binding to varions types of 
serpentine receptors.
It is thought that receptors for light in the eye, recognise the light photons via 
an 11-c/y-retinal molecule bound in a cleft formed by the transmembrane 
helices (panel a) Receptors for small ligands such as catecholamines also bind 
agonists in a cleft formed by the seven transmembrane helices (panels b). 
Receptors for peptide agonists utilise a surface formed by the extracellular 
loops of the helices to bind agonists (panel c), while others utilise a large N 
terminal tail (panel d) to bind large glycoprotein agonists. The metabotropic 
glutamate receptor contains an extremely large N terminal tail which is 
thought to bind glutamate and cause a large pincer-like conformational change 
in the N terminus. This complex is then thought to act as a “tethered ligand” 
on the seven transmembrane helices (panel e). Thrombin, rather than being an 
ligand for its receptor is actually a specific protease which cleaves part of the 
N terminus off the thrombin receptor leaving the remaining portion of the N 
terminus to act on the transmembrane helices as a tethered ligand (panel f). 
This figure was adapted from Coughlin [1994].
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The thrombin receptor detects agonist in a different way. The 
thrombin molecule is actually a protease which binds to the N terminal tail of 
the thrombin receptor and cleaves the first 25 amino acids of the receptor to 
create a new amino terminus which then acts as a "tethered ligand" for the 
receptor [Vu et a l ,  1991a; Vu et a l ,  1991b], at a site as yet undefined.
The metabotropic glutamate receptors and the parathyroid Ca^+ 
sensing receptor utilise yet another mechanism to detect their ligands [Tanabe 
et al., 1992; Brown et al., 1993]. These receptors contain extremely large N 
terminal domains which have stretches resembling bacterial transporters for 
small molecules such as amino acids [O'Hara et al., 1993]. Studies on these 
bacterial periplasmic binding proteins (PBPs) [Oh et al., 1993] suggest that 
glutamate and Ca^+ binding to these PBP domains induce a large 
conformational change in the metabotropic glutamate receptors and Ca2+ 
sensing receptor. This conformational change may then form yet another 
tethered ligand which binds to the exofacial surface of the receptor. More 
extensive reviews on the regions of serpentine receptors involved in ligand 
binding are available [Savarese & Fraser, 1992; Baldwin, 1994; Coughlin, 
1994]
1. 3. 1. 2. Regions involved in receptor 
activation.
Following binding of a hormone to a receptor, the receptor is 
thought to undergo a conformational change causing an associated activation 
of the protein. This activation is responsible for the facilitation of the induction 
of the corresponding G protein activation. It is thought that regions of the
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receptor involved in the activation of the polypeptide may be distinct from 
those involved in receptor-G protein coupling.
Based on the work done on the aspartate residues of 
bacteriorhodopsin and the human P2  adrenergic receptor, a model for agonist 
activation of receptors has been proposed [Venter et al., 1989]. It has been 
postulated that several acidic amino acids present in the transmembrane helices 
of the p adrenergic receptor (asp79 in helix II, asp 113, glul22 and aspl30 in 
helix III) bind water molecules or mono- or di- valent cations in the 
unliganded receptor. Upon agonist binding these residues may start an ion 
transfer across the membrane analogous to bacteriorhodopsin, a process which 
may in turn facilitate receptor-G protein interactions. Given the similarities 
between eukaryotic serpentine receptors and bacteriorhodopsin it may be that 
serpentine receptors may also act as proton pumps [Nerderkoom etal., 1995].
It is clear that the presence of a conserved aspartate in 
transmembrane helix II, near the centre of the transmembrane domain is 
obligatory for receptor activation. Virtually all receptors of this family possess 
an aspartate at this position. Mutagenesis of this residue in the human p% 
adrenergic receptor [Chung et a l ,  1988], the human « 2  adrenergic receptor 
[Wang et al. , 1991], the rat D2 dopamine receptor [Neve et al. , 1991] or the rat 
M l muscarinic receptor [Fraser et al., 1989] decreased the ability of these 
receptors to interact with their effectors. This aspartate residue is thought to 
play a role in the allosteric actions of monovalent cations, such as Na+. These 
ions are known to increase the affinity of « 2  adrenergic receptors for 
antagonists yet decrease the affinity for agonists [Limbird, 1984].
:
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receptor [Robbins et al., 1993] and asp578 of the luteinising hormone receptor
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Several mutations in serpentine receptors, both naturally 
occurring and engineered, have indicated the importance of other residues in 
receptor activation. While some of these are thought to be involved in G
protein binding and activation, others are found deep in the transmembrane 
helices of the receptor, and so are thought not to involve G proteins [Baldwin,
1994]. Mutations engineered in rhodopsin, in the third and seventh helices at
positions g lu ll3  and lys296 [Robinson et al., 1992; Cohen et al., 1993], and
ithe naturally occurring mutation at ala292 [Dryja et a l ,  1993] are thought to 
relieve a constraint on the receptor, which normally holds the receptor in an 
inactive state until activated [Robinson e t a l ,  1992; Cohen et a l ,  1993]. This 
is also apparently true for glu92 of the melanocyte stimulating hormone <
[Shenker et a l , 1993].
The « lb  and a. 2  adrenergic receptors both contain single amino 
acids at the junction of the third intracellular loop and transmembrane helix VI 
which cause constitutive activation of the receptors and increase the affinity of 
the receptor for agonist. Kjelsberg et al. [1992] substituted all possible amino 
acids for ala293 of the «ib  adrenergic receptor while Ren et al. [1993] created 
five substitutions at the equivalent position of the «2 adrenergic receptor. 
These results indicate that the receptor must first overcome a constraint in 
order to adopt an activated state to stimulate the G protein into guanine 
nucleotide exchange and trimer dissociation, and that agonist provides the 
necessary conformational change to faciliate this [Kjelsberg e t a l ,  1992; Ren 
e ta l ,  1993; Baldwin, 1994].
1 .3 .1 .3 . Receptor regions involved in G protein 
coupling, activation and specificity
The intracellular loops and the C terminal tail fonned by the 
folding of the receptor polypeptide are thought to be the main sites of receptor- 
G protein interaction. The precise nature of this interaction is still being 
investigated but it is already apparent that the nature of receptor selection of a 
G protein is located in this region and that even slight alterations in this area 
can alter the fidelity of interaction.
Most work in this area has focused on the third intracellular 
loop and the C-terminal tail of the receptor. It is within these regions that most 
diversity exists in the cytoplasmic areas of the protein. By contrast, the first 
and second intracellular loops are relatively conserved [Lefkowitz & Caron, 
1988] and so have been the focus of less research. However, rhodopsin, which 
normally couples to Gt, possesses a relatively small third intracellular loop 
[Weiss et al., 1988] yet Gt can also couple to «2 adrenergic receptors and 
muscarinic M2 receptors, which have much larger third intracellular loops 
[Tsai, et al., 1987]. The implication is that large areas of the loop have little to 
do in determining G protein-receptor coupling [Savarese & Fraser, 1992].
a) The second and  th ird  in tracellu lar loops.
Adrenergic receptors have been model systems for studying 
serpentine receptors and their mechanism of interaction with G proteins. 
Studies employing deletion mutants of the p2 adrenergic receptor indicate that 
a large portion of the third intracellular loop is important in activation of Gg 
and hence adenylyl cyclase. Deletion of residues 239-272 [Dixon et a l,  1987]
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of the hamster P2 adrenergic receptor, almost two thirds of the third ;
intracellular loop, produced a receptor which could not activate adenylyl
cyclase. Deletion of two relatively small segments of the receptor, residues
222-229 and 258-270 both greatly reduced the activation of adenylyl cyclase .
by the receptor [Strader et al., 1987]. These residues are thought to be in the |
region proximal to the lipid bilayer The attenuation of the activation of |
adenylyl cyclase was shown to be due to an interruption of receptor Gg i
coupling [Strader et al., 1987]. In addition, deletion of the residues at the C-
terminal end of the third cytoplasmic loop of the human p2 adrenergic receptor !
also resulted in stimulation of adenylyl cyclase to only a fraction of the level I
produced by the wild type receptor [Hausdorff et al. , 1990].
Kobilka et al. [1988] have attempted to address the role of the 
third cytoplasmic loop of the P2  adrenergic receptor in mediating activation of 
Gg by constructing chimeric receptors where portions of the human P 2 
adrenergic receptor were replaced with the corresponding regions of the 
human « 2  adrenergic receptor and assessing the chimeras’ ability to stimulate 
adenylyl cyclase when expressed in Xenopus  oocytes. If a portion of 
transmembrane helix V, all of helix VI and the intervening third cytoplasmic 
loop of the p2 adrenergic receptor was introduced into the (%2 adrenergic 
receptor, the chimera could stimulate adenylyl cyclase to approximately one 
third the level of that produced by the wild type ^ 2  receptor [Kobilka et al.,
1988]. If only a portion of the third cytoplasmic loop of the receptor was 
introduced, however, then the ability to activate adenylyl cyclase was lost 
[Kobilka et al., 1988]. These results indicate that the third cytoplasmic loop of 
the p2 adrenergic receptor plays an important role in governing the interaction 
of the receptor and G g and thus stimulation of adenylyl cyclase, but also that
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this loop is insufficient on its own to fully activate the G protein. A highly 
conserved aspartate residue at the junction of transmembrane helix III and the 
second intracellular loop (aspl30 in the human p 2 adrenergic receptor) may be 
one of these additional determinants for G protein binding. It is thought that 
the conformational changes which occur upon receptor activation may mask or 
unmask this residue, as it is located in or near the cytosol. Mutagenesis of this 
residue and corresponding residues in bovine rhodopsin, the rat M l muscarinic 
receptor and the human « 2  adrenergic receptor either prevent receptor-G 
protein interaction or move the dose-effect curves for the receptors to the right 
[Fraser etal., 1988; Fraser etal., 1989; Franke etal., 1990; Wang etal., 1991].
Formation of chimeric a i  adrenergic receptors has also been 
performed in order to delineate the domains of this Gq-linked receptor. When 
amino acids 252-259 of the third intracellular loop of the a j  receptor, near the 
centre of the loop, were replaced by corresponding regions of the p 2
the agonist induced conformational change of the receptor which activates the 
G protein.
adrenergic receptor the a j  receptor was only able to induce phosphoinositide %
' i t
hydrolysis to 10% of the wild type receptor [Cotecchia et al., 1990].
Replacement of amino acids 288-294 caused a 100 fold increase in affinity for 
noradrenaline and a 300 fold increase in efficacy of phosphoinositide 
breakdown [Cotecchia et al., 1990]. This replacement caused only 3 overall 
mutations and when each of these was examined in isolation, it was found that
Ithe K290H and A293L mutations were responsible for this increase in efficacy 
[Cotecchia et al., 1990]. These mutant receptors also displayed an increase in
'abasal inositol phosphate levels leading to the conclusion that these mutations
lock the receptor in its activated state, suggesting a role for these residues in f
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Franke et al. [1990] have found evidence to suggest that both 
the second and third intracellular loops of bovine rhodopsin function to bind 
Gt- Two mutants in which the sequence Cys-Lys-Pro-Met-Ser-Asn-Phe-Arg- 
Phe-Gly-Glu-Asn-His found in the central region of the second intracellular i
loop was replaced by the sequence Gly-Thr-Glu-Gly-Pro-Asn-Phe-Tyr-Val - 
Pro-Phe-Thr-Ser, and another in which residues 237-249 of the third 
intracellular loop were deleted, could bind Gt but could not cause guanine 
nucleotide exchange in the presence of GTP. It was postulated that these 
mutants could cause the release of GDP from Gt but not the formation of the
iGTP binding conformation of the G protein [Franke et al., 1990]. The deletion 
mutant of Gt corroborated an earlier study in which lysine-248 was mutated to 
leucine. This mutant receptor was completely unable to activate the GTPase 
activity of Gt [Franke etal., 1988].
b) The C-terminal tail.
The C-terminal tail of the a t  adrenergic receptor is also thought 
to play a role in governing receptor-Gq interactions as substitution of a thirteen 
amino acid stretch near the cytoplasmic section of the tail (residues 353-365) 
with the corresponding section of the human P2 adrenergic receptor produced a 
chimeric receptor whose capacity for activating phosphoinositidase C was I
impaired by 40% [Cotecchia etal., 1990]. 1
*The C-terminal tail may be involved in governing the fidelity of
I
:'q
Ïinteraction of serpentine receptors and G proteins. The splice variants of the 
EP3 prostanoid receptor display a marked infidelity in G protein coupling.
These receptors are spliced so that they have different C terminal tails; the rest
■i
Ï
' I
of the protein is unaffected. These splice variants show remarkable 
promiscuity in coupling to G proteins. Namba et al. [1993] isolated 4 splice 
variants of the EP3 receptor and showed that they varied in their G protein 
specificity. EP3A, with the longest tail, coupled to Gi family members, EP^p
Itand EP3C, which had the shortest tails, both coupled to Gs while EP3D coupled
to Gi, Gs and Gq. In a subsequent series of experiments, it was shown that the ïIEP3C receptor coupled to Go as well as Gs, but while it stimulated the GTPase a
activity of Gs it inhibited the GTPase activity of Go by increasing the binding 
affinity of Go for GDP [Negishi et al., 1993]. This may lead to the attenuation 
of signals generated through Go by the EP3C receptor.
An approach similar to that used by Dal man & Neubig [1991] 
to identify the receptor-G protein interaction points on the « 2A adrenergic 
receptor was used originally by Takemoto et al. [1985] to investigate the role 
of cytoplasmic domains of bovine rhodopsin in rhodopsin-Gt interactions. A 
number of peptides corresponding to regions of the intracellular loops and 
cytoplasmic tail of the receptor were tested. Those peptides derived from the 
intracellular loops were incapable of inhibiting the GTPase activity of Gt in 
this system. Three peptides corresponding to amino acids 333-339, 324-331 
and 317-321, all within the C-terminal tail, did however inhibit Gt activation; 
the 333-339 peptide was the most potent inhibitor. This region is, however, not 
conserved among other opsins and proteolysis of the C-terminal 12 amino 
acids had no effect on Gt binding to rhodopsin [Kuhn, 1984].
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1. 4. Covalent modifications of signalling 
proteins by lipid moieties.
It has become apparent that lipid modification of proteins plays 
a major role in regulating their subcellular location and function [Deschenes et 
al,  1990; Turner, 1992]. Many proteins involved in cellular signalling undergo 
one or more modifications by one or more lipid molecules [Resh, 1994; Casey, 
1994; Wedegaeitner e ta l ,  1995].
There are four known lipid modifications which occur on 
proteins, myristoylation, palmitoylation, polyisoprenylation and addition of 
glycosylphosphatidylinositol (GPI) [Turner, 1992].
1. 4 .1 . Addition of glycosylphosphatidylinositol 
to proteins.
The addition of GPI to proteins was first documented following 
the observation that a soluble phosphoinositidase-C activity from certain 
bacterial species could release certain proteins from the plasma membrane 
[Ikezawa et a l ,  1976; Low & Zilversmit, 1980]. This modification is thought 
only to occur on proteins expressed on the external surface of the cell. This 
then has very little to do with intracellular signalling, although a few cell 
surface proteins involved in receptor function have GPI anchors [Turner, 
1992]. GPI anchors may be responsible for functions other than membrane 
anchorage, and may include cell-cell interaction and targeting of proteins.
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The GPI anchor comprises a core phospholipid-glycan chain 
c o n s is tin g  o f p h o sp h a tid y l!n o s i to i -g lu c o sam in e -m an n o se -3 -
phosphoethanolamine attached to the C-terminal amino acid of the mature 
protein. This amino acid can be one of asp, gly, ala, cys or ser, suggesting that 
the donor amino acid must be small and aliphatic. The fatty acid associated 
with the core chain is apparently species specific. It would appear that the 
immature protein is transiently associated with the membrane via a 
predominantly hydrophobic region of 10-35 amino acids at the C-terminus. 
This region is then rapidly exchanged for the GPI anchor by an unidentified 
transamidase activity [Turner, 1992].
1 .4 .2 . Polyisoprenylation of proteins.
Of far more importance in terms of transmembrane signalling is 
the addition of isoprene units to the C terminus of polypeptides. Many proteins 
involved in cellular signalling are modified by the addition of either farnesyl 
or geranylgeranyl groups [Deschenes et aL, 1990; Casey, 1994]. The 
prerequisite for the addition of isoprene units is the presence of a motif 
consisting of a cysteine-aliphatic-aliphatic-any amino acid (CAAX) or 
occasionally CC or CXC [Deschenes e ta l ,  1990; Casey, 1994]. This however 
is not the only requirement. The a  subunits of G ii, Gj2 , Gig and Gq have 
CAAX motifs at their C terminus yet are not substrates for isoprenylation, 
although the C terminal CAAX motif of Giiot can support the isoprenylation 
of p2D’^ s, one of the small molecular weight G proteins, when fused to this 
protein. [Cox et al., 1993]. This would indicate that the environment 
surrounding the CAAX motif is also important in determining specificity of 
prenoid transfer.
so
The farnesyl and geranylgeranyl units are derived from 
isopentenyl pyrophosphate. This molecule is the precursor to many important 
lipid molecules such as squalene (which goes on to form cholesterol), plant 
terpenes and carotenoids, vitamin K 2  and mitochondrial coenzyme Qiq. The 
condensation of two isopentenyl pyrophosphate groups forms the ten carbon 
geranyl pyrophosphate. Successive condensations of isopentenyl 
pyrophosphate gives rise to the fifteen carbon farnesyl pyrophosphate and the 
twenty carbon geranylgeranyl pyrophosphate. It is these two prenoid groups 
which are subsequently added to proteins [Turner, 1992].
A complex series of events accompanies the isoprenylation of 
proteins. In terms of the CAAX motif, addition of the isoprenoid group to the 
cysteine residue is followed by the removal of the AAX residues of the motif 
[GutieiTez et al., 1989; Hancock et al., 1989], leaving the prenylated cysteine 
residue at the extreme C terminus. This cysteine residue is then modified by 
carboxymethylation [Clarke etal., 1988].
The process of isoprenylation is cytosolic and two separate 
enzymes have been identified specific for the addition of either farnesyl or 
geranylgeranyl groups to CAAX proteins, termed protein famesyltransferase 
(FTase) and protein geranylgeranyltransferase-1 (GGTase-I) respectively. 
These enzymes contain two polypeptides, a common a  subunit of 48kDa and 
different p subunits of 46kDa (FTase) and 43kDa (GGTase-I) [Casey, 1994]. 
The proteolytic cleavage and subsequent carboxymethylation reactions are 
carried out in the microsomal membrane fraction by as yet uncharacterised 
enzymes [Casey, 1994]. The result of this complex series of modifications and
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cleavages is believed to cause the targeting and/or anchoring of isoprenylated 
proteins to the plasma membrane. In some cases, most notably members of the 
Ras family, hydrophobicity of the protein is further increased by the addition 
of one or more palmitate groups to cysteine residues close to the C terminal 
isoprenylated cysteine residue [Hancock et al., 1989], while others, notably 
p2 lK-rasB have a series of basic residues which are thought to interact with the 
lipid head groups of the phospholipids of the membrane.
A second geranylgeranyl transferase enzyme has also been 
identified which differs considerably from GGTase~I. This enzyme termed 
GGTase-I I catalyses the transfer of the geranylgeranyl group members of the 
Rab family of small molecular weight G proteins, amongst others. These 
proteins, rather than containing the CAAX motif have the sequence CC or 
CXC at their C temiini [Casey, 1994].
The addition of either farnesyl or geranylgeranyl groups to 
CAAX containing polypeptides is not a random process, but is instead 
governed by the exact composition of the CAAX motif. The G protein y 
subunits yi and y2 have the C terminal sequences CVIS and CAIL 
respectively, yet y i is modified by the addition of a farnesyl residue while y2 , 
like all other y subunits, is modified by a geranylgeranyl group [Casey et al.,
1994]. It is believed that the extreme C terminal residue is responsible for the 
direction of the isoprenylation. If the residue is methionine, serine or 
glutamine then a farnesyl residue is added, while a leucine directs the addition 
of geranylgeranyl residues. All of the nonretinal y subunits terminate in a 
leucine residue and are therefore modified by a geranylgeranyl isoprenoid 
while retinal y subunit tenninates in a serine and is thus farnesylated.
52
Transient co-expression studies using wild type and a cys-to- 
ser geranylgeranyl negative mutant of 7 2  and a p subunit indicate that 
isoprenylation is required for the membrane localisation of the Py complex 
[Simonds, 1994]. Studies to determine whether isoprenylation of y2 is required 
to fonn the Py complex have also been carried out. Some expressed p subunits 
localised in the cytosolic fraction along with unisoprenylated y subunits 
indicating that the Py dimer can form in the absence of geranylgeranyl groups. 
Limited trypsinolysis of cellular extracts of these cells expressing p and y2  
support this conclusion as the expected pattern of digestion was seen in the 
cytosolic fraction only of cells expressing the p and mutant y 2 subunits but not 
in cells expressing p alone [Simonds etal., 1991; Iniguez-Lluhi eta l., 1992]. It 
was noted in these studies however that p subunits on their own could localise 
to the membrane in the absence of y subunits. This was thought to be due to p 
subunits aggregating.
It is believed that differences exist between farnesylated and 
geranylgeranylated y subunits. The farnesylated y 1 subunit behaves somewhat 
differently to y2 . It exists in two forms, a truncated form which does not 
contain farnesyl residues and a normal farnesylated form. Both of these forms 
associate with the membrane indicating the presence of determinants other 
than isoprenylation are important for the membrane localisation of transducin 
Py [Fukada et al., 1990]. Transducin Py can be released from the membrane in 
the absence of detergent [Spiegel, 1990] indicating that farnesylation of yi may 
have a roles other than, or in addition to, regulating membrane interaction. 
Functionally, farnesylation may have a role to play in activating the holomeric 
G protein. The farnesylated form of y 1 is 30 times more efficient in promoting
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binding of GTP to transducin [Fukada et al., 1990]. Also carboxymethylation 
of farnesylated yi enhances its binding to rhodopsin [Fukada etal., 1994].
1.4. 3. Addition of myristic acid to proteins.
Many cellular and viral proteins are now known to be acylated 
by the 14 carbon saturated fatty acid myristate [Towler et al., 1988; Deschenes 
et al., 1990]. The exact purpose of this modification is unclear at present 
although various hypotheses have been put forward. Being a hydrophobic 
molecule, the addition of myristic acid to proteins has been suggested to 
determine, or at least aid in, the regulation of the membrane association of the 
target protein. This simplistic view is at best only partially true as some 
myristoylated proteins are not membrane associated. In addition, myristic acid 
is only a relatively rare fatty acid in eukaryotic cells [Deschenes et at., 1990], 
indicating perhaps another, more specialised, role for myristoylation. While 
myristoylation of many proteins, including viral proteins, MARCKS protein 
and some proteins involved in cellular signalling can cause their membrane 
association, others such as the catalytic subunit of protein kinase A, are not. 
Indeed, myristoylation of ppôO^ r^c jg not essential for membrane association 
[Resh, 1988; Kaplan et al., 1990]. It has been proposed that specific receptors 
exist for myristoylated proteins [Schultz et al., 1988] given that interaction of 
pSglck wrtb CD4 is enhanced when p56^^^ is myristoylated. A putative binding 
protein for myristoylated ppôO^^ '^^  ^has been identified [Resh & Ling, 1990].
The addition of myristic acid to proteins occurs co- 
translationally as addition of cycloheximide to cells prevents the incorporation 
of pH] myristate into cellular proteins but not lipids [Olson & Spizz, 1986;
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Deichaite et ah, 1988]. The requirements for the addition of myristic acid to 
proteins appears very simple yet only a few proteins are actually modified 
therefore determinants other than those so far identified must be involved. A 
glycine at position 2 is absolutely essential. Once the initiating methionine 
residue has been removed, this becomes the N terminal residue and is then 
modified by myristic acid [Turner, 1992]. The enzyme responsible, myristoyl - 
Co-A:protein N-myristoyltransferase (NMT; EC 2.3.1.97), also prefers a serine 
at position 6  (position 5 in the mature protein) although this is not essential 
[Turner, 1992]. A lysine residue at position 8  has also been shown to be 
prefeixed by NMT to catalyse myristate transfer [Towler et ah, 1988]. The 
lipid substrate for NMT is more specific. The chain length of the lipid seems to 
be the governing factor as opposed to hydrophobicity as oxygen containing 
derivatives of myristic acid are specific inhibitors of the enzyme [Paige et a t ,  
1990]. Increases in the chain length of the lipid group are not tolerated, 
although shorter chain fatty acids such as 1 auric acid can serve as substrates 
[Towler et al., 1987; Glover et al., 1988]. This phenomenon allowed for the 
discovery of a degree of heterogeneity in acylation of Gta as described below.
Some G protein ot subunits have been demonstrated to 
incorporate pH] myristic acid. Ggoi, G^ a , Gi2 a , Gig a , G ta, GgU and G%a all 
have the required glycine residue, yet only G ^ a , Gi2 a , Giga, G ga and G%a 
incorporate myristate. Gga contains a leucine residue at position 6  as opposed 
to the serine residue preferred by the transferase and so this is not 
myristoylated.
The myristoylation of G protein a  subunits has been assessed 
by both site-directed mutagenesis of the target glycine residue and by
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inhibition of NMT. These studies indicate a role for the addition of myristic 
acid in governing the association of the polypeptide with the plasma 
membrane and in the interaction of the a  subunit with the py complex. Jones et 
a l,  [1990] and Linder et a l ,  [1991] have demonstrated that myristoylation of 
Gil a  and GqCx causes a decrease in the affinity of these two a  subunits for py. 
The myristoylation of Gi2 a  was also required for it to inhibit adenylyl cyclase 
and for the activating mutant of the polypeptide, the gip2 oncoprotein, to cause 
plaque formation in Rat-1 fibroblasts [Gallego e ta l ,  1992]. Th&gip2 protein 
is a mutant form of Gi2 a  in which a mutation inhibits the GTPase activity of 
the protein causing a constitutive activation of Gi2 a  [Pore et a l ,  1991; Gupta 
et a l ,  1992]. Thus, acylation of a  subunits has an important function in 
determining the protein-protein interactions with other signalling molecules.
Although Gga is not myristoylated, the glycine residue at 
position 2  is nevertheless important in the signalling properties of the 
molecule. Site-directed mutagenesis of the glycine, replacing it by an alanine 
residue, or deletion of the N terminal region of GgCt, causes a reduction in the 
ability of Ggoc to activate adenylyl cyclase and to interact with Py [van der 
Neut et a l ,  1993]. This may be due to an inhibition of palmitoylation as gly2 
is required for proper palmitoylation of G jia  [Galbiati et a l ,  1994] and G^a 
[Hallak et a l ,  1994]. This region of Gg« may not, however, be required for 
membrane association of the molecule. A region near the C terminus of the 
polypeptide may be important in regulating the interaction with the membrane, 
although the N terminus is still necessary for py binding and has a role in 
effector activation [Journot et a l,  1991]. This C terminal region, termed the 
TENIR sequence, is thought to regulate membrane association of Gga [Journot 
et al, 1991], although if this sequence is inserted into G iia , it apparently does
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In retinal membranes, Gta is not myristoylated, even though it 
has both the required gly2 and preferred ser6  residues. It is, however.
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not alter the membrane association of this a  subunit [Degtyarev et al, 1994a]. |
•ÎCFusion of this sequence to an N terminally truncated G ^ a , which is located in
'the cytoplasm, does however restore the membrane association of the fusion 
protein. G qa and G n a  also contain this TENIR sequence, but the function of 
it in these polypeptides is not known.
a
Care must be exercised in interpreting the results obtained for
„!■these proteins in terms of mutational analyses of the role of myristoylation.
Recent reports have demonstrated that the G2A mutation of G iia  and G%a I
■Mactually abolishes the palmitoylation of these proteins as well as inhibiting 
myristoylation [Galbiati et al., 1994; Hallak et al., 1994]. This effect is not due ■I.to the lack of myristic acid on the protein as treatment of cells with the NMT |
inhibitor 2 -hydroxymyristate does not prevent addition of palmitate to G n a .
Therefore the presence of the glycine residue at position 2 may be obligatory 
for the as yet uncharacterised palmitoyl transferase.
myristoylated upon transient expression in COS-7 cells [Mumby et al., 1990].
The solution to this apparent discrepancy lay in the observation of |
heterogeneity of acylation of Gta occurred in retinal membranes. Kokame et 
al. [1992] and Neubert et al. [1992] demonstrated that G ta in retinal 
membranes was present as 4 distinct forms differing in the lipid attached to the 
protein. These workers found that only around 5% of retinal G ta  contains
«2covalently attached myristic acid; the remaining molecules contain, in
iidecreasing amounts, lauric acid and two unsaturated 14 carbon fatty acids
1i(C14:2 and C14:1). This heterogeneity of acylation probably reflects differing i
Li I'Z." . l i
acyl CoA species in the retina [Johnson et al., 1994]. These lipids are less 
hydrophobic than myristic acid and so this could explain why Gta can be 
washed from the membrane without detergent [Spiegel, 1990]. The presence of 
fatty acids on gly2 affects the Py interaction of G protein a  subunits and 
Kokame et al. [1992] have also demonstrated that this heterogeneity of 
acylation may cause G ta  to dissociate more readily from Py as acylated 
peptides corresponding to the N terminus of G ta were less able to bind to py if 
lauric acid or the two unsaturated fatty acids were on the peptide.
1 .4 .4 . Protein Palmitoylation.
The addition of palmitate to proteins is distinct from 
myristoylation in that it is post-translational as opposed to the co-translational 
myristate transfer. Also myristate is always amidically linked to glycine while 
palmitate is generally esterified to cysteine residues via thio-ester bonds 
[Casey, 1994; Casey, 1995]. This difference in the attachment of these acyl 
groups brings about another important functional difference. The amide bond 
attaching the myristic acid is very stable and once attached, the fatty acid is 
essentially permanently bound and is attached for the lifetime of the protein, 
although there has been a report of a demyristoylation of mature MARCKS 
protein [Manenti et al., 1994]. The thio-ester bond linking the palmitic acid is, 
however, much more labile and can be enzymatically cleaved. This hints at the 
possibility of regulation of the process of palmitate transfer. Indeed a 
palmitoyl-esterase has recently been purified and has been demonstrated to 
cleave thio-ester linked palmitate from p2 fH-Ras and Goa [Camp & Hofmann,
1993] although this enzyme has subsequently been shown to be secreted
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The palmitoylation of some forms of p2U'^^ is, as described
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[Camp et al., 1994] and therefore could not be responsible for any intracellular 
regulation of palmitoylation.
earlier , part of the overall process of isoprenylation. Following the addition of 
farnesyl or geranylgeranyl groups, proteolysis and carboxymethylation, a 
palmitoyltransferase adds palmitate to specific cysteine residues near the site 
of isoprenylation [Hancock et al., 1989]. This enzyme is poorly characterised 
and has yet to be purified. The enzyme does, however, require the prior 
isoprenylation of p2H ^. Given this specificity, this enzyme is unlikely to be 
responsible for addition of palmitate to heterotrimeric G protein a  subunits and 
Src family members.
"'11
Many serpentine receptors have also been shown to be post- 
translationally and reversibly palmitoylated. This process occurs via cysteine :
residues located in the C terminal tail of the protein. At least for rhodopsin the 
palmitate attached to cys322 and cys323, is inserted into the lipid bilayer, |
forming a kind of 4th intracellular loop [Moench et al., 1994]. The role of 
palmitoylation of receptors is at present unclear. Several groups have 
attempted to ascertain what effect the palmitic acid has on receptor mediated 
second messenger generation. Mutation of the palmitoylated cysteine residue j
in the p2 adrenoceptor causes a marked decrease in efficacy of adenylyl 
cyclase stimulation [O'Dowd et al., 1989] while similar studies with the 0 2 A 
adrenergic receptor indicates that it has no effect upon receptor-G protein 
coupling [Kennedy & Limbird, 1993] and studies on rhodopsin indicate an 
increase in the efficacy of second messenger generation [Morrison et a l, 1991 ;
Weiss et al., 1994]. Perturbation of palmitoylation of the P2 adrenergic
I
i
receptor leads to a high degree of phosphorylation of the receptor in the basal 
state [Moffet et al., 1993], a phenomenon associated with activation and 
subsequent desensitisation of the receptor [Milligan et ah, 1995b]. Given the 
proxim ity of the palm itoylated cysteine residues to the sites of 
phosphorylation, it may be that palmitoylation of the P2 adrenergic receptor, 
which is an agonist regulatable process [Moffet et al., 1993], serves as a signal 
for desensitisation of the receptor [Moffet e ta l ,  1993; Bouvier e ta l ,  1995].
The palmitoylation of G protein ct subunits was simultaneously 
discovered by two groups when it was found that GgCt [Parenti et a l ,  1993; 
Linder et a l ,  1993], Gi2« ,  Go« and G q a /G n a  [Parenti et a l ,  1993] could 
incorporate pH] palmitate via a thio-ester bond. The a  subunits of G 12 and 
G 13 have since been shown to incorporate palmitate also [Viet et a l ,  1994] as 
has gustducin a  when expressed in insect Sf9 cells [Hoon et a l,  1995]. 
Mutagenesis studies by Parenti e ta l  [1 9 ^ ] and Degtyarev e ta l ,  [1993a] have 
identified cys3 as the residue which is palmitoylated in Go a  and Gga 
respectively. It has been demonstrated that G qa is in fact dually palmitoylated 
on cys9 and cys 10 [Wedegaertner et a l ,  1993].
The role of palmitoylation of G protein a  subunits has been the 
subject of intense speculation. Palmitate negative mutants of G oa have been 
shown to have a decreased avidity of interaction with the plasma membrane 
[Grassie et al., 1994]. The ability of this protein to still interact with the 
plasma membrane reflects the presence of other determinants for membrane 
attachment, e.g. the presence of myristic acid at the N terminus. The ability of 
palmitate negative mutants of Gga to interact with the plasma membrane is 
less clear cut. Degtyarev et al. [1993a] have found no effect on membrane
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attachment of C3S Ggoc when expressed in COS-7 cells while Wedegaertner et 
al., [1993] have found that palmitate is absolutely required for membrane 
association of Gga when it is expressed in Human Embryonic Kidney 293 
cells. The presence of the short sequence TENIR near the C terminus of the 
Gga was thought to contribute to the membrane association of Gga (see above) 
although this has been recently questioned. Work by Degtyarev et al., [1994a] 
has thrown doubt on the role of the TENIR sequence in promoting membrane 
association in isolation. When mutagenically inserted into G jia , the TENIR 
sequence was ineffective in promoting the membrane association of the 
polypeptide. Obviously there are other determinants which govern the 
membrane association of a  subunits, especially Gga. Wedegaertner et al., 
[1993] have also found that palmitoylation is mandatory for the interaction of 
G qa with the plasma membrane. This a  subunit was found to be doubly 
palmitoylated on cysteine 9 and cysteine 10. The mutagenesis of one of these 
cysteines to serine caused the majority of the immunoreactive G qa protein to 
localise to the cytosol, but if both were mutagenised, all of the protein was 
located in the cytosol.
Like the palmitoylation of other proteins, the palmitoylation of 
G proteins is a dynamic process. The half life of palmitate on Gga is 
approximately 50-90 mins [Degtyarev et al., 1993b; Wedegaertner & Bourne,
1994] while the half life of the protein is approximately ll-22hrs [Levis & 
Bourne, 1992; Degtyarev et al., 1993b]. Upon agonist activation of a receptor, 
the half life of the a  subunit decreases to around 6 hrs [Levis & Bourne, 1992] 
while the half life of the palmitate on the G a subunit decreases to around 
2mins [Wedegaertner & Bourne, 1994]. Clearly the regulation of the protein 
and the palmitate on it are under very different control processes. It may be
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that reversible palmitoylation serves as a dampener of serpentine receptor 
mediate second messenger generation. In removing the palmitate, the G
protein a  subunit may no longer be able to interact with the target effector 
system [Wedegaertner et al., 1993] and thus the second messenger generation 
would be curtailed [Wedegaertner et al., 1995].
At the same time as G protein a  subunits were found to be 
palmitoylated on cysteine residues, the src family members p5 6 ^^ k and p59fyi^ 
were also found to incorporate palmitic acid [Paige et al., 1993; Shenoi-Scaria 
et al., 1993]. Sequence analyses suggest that the other members of the family, 
with the exception of ppbO i^'  ^ and blk, are also palmitoylated [Resh, 1994] 
although like G proteins the precise motif for palmitoylation varies; some 
contain more than one cysteine residue which may be a target for 
palmitoylation. Interestingly, these proteins are also targets for N- 
myristoylation. This dual acylation has been suggested to target G protein a  
subunits and src family members to caveolae. Caveolae are invaginiations of 
the plasma membrane which have been shown to contain high proportions of 
receptors, GPI linked proteins, G proteins and other signalling molecules. 
Many of the signalling polypeptides in caveolae have been demonstrated to by 
modified by lipids. These modifications are thought to stabilise the interactions 
of caveolar proteins. Lisanti et al., [1994] have proposed that caveolin, a 
putative transmembrane polypeptide, forms a pH and cholesterol dependent 
co-clustering with GPI linked proteins. Lipid modified proteins such as G 
proteins and Src like tyrosine kinases may insert themselves along with lipid 
binding proteins at the cytoplasmic leaflet of the caveolae. Lipid modification 
of these proteins may act to anchor the proteins to the caveolar membrane and 
promote protein-protein interactions. In support of this finding, Shenoi-Scaria
j
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et al. [1994] have demonstrated the requirement of palmitate for localisation to 
caveolae. What role the palmitoylation of G protein a  subunits plays in their 
localisation to caveolae remains to be determined.
1.5. The regulation of transmembrane signalling 
through G proteins.
The cascade of events regulated by G proteins is not a random 
occurrence and its regulation is complex. From the receptors to the G proteins 
themselves, regulation occurs to keep the system from "overheating".
When an agonist liganded receptor activates a G protein, the 
subsequent release of the activated G protein leaves the receptor unoccupied 
and the target for phosphorylation by various serine/threonine kinases. 
Consensus sequences for protein kinase A and G protein linked receptor 
kinases (GRKs) are present on many serpentine receptors [Savarese & Fraser, 
1993]. The signal for phosphorylation by these kinases may be the removal of 
the palmitic acid on the C terminal tail of the receptor and the subsequent 
disappearance of the pseudo-4th intracellular loop [Bouvier et al., 1995]. The 
presence of phosphorylated residues on the receptor attracts one of a family of 
proteins termed arrestins which bind to the phosphorylated receptor 
uncoupling the receptor from its associated G protein [Lohse, 1993] leading to 
short term homologous desensitisation of the agonist induced second 
messenger generation.
G protein a  subunits by and large are not phosphorylated, the
exceptions being G^ct, Gi2«  and Ggoc. The phosphorylation of Ggcx has only
"2:
regulated by the Gq family of G proteins and those systems regulated by Gg 
and Gi family members [Strassheim & Malbon, 1994]
is insensitive to cycloheximide and not influenced by regulation of mRNA 
levels [McKenzie & Milligan, 1990a; Donnelly et a l, 1992]. It is likely that 
the reduction in levels of GgO and other a  subunits following chronic agonist
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been demonstrated in vitro [Pyne et al., 1992] so the physiological relevance 
of this is unclear at present. GgU and Gi^a are both phosphorylated by protein 
kinase C [Katada et al., 1985; Carlson et al., 1989; Lounsbury et al., 1991].
The sites for these phosphorylation events are thought to be located on ser247 
(Gi2«  ) [Kemp & Pearson, 1990] and ser27 (G ^a ) [Lounsbury et al., 1993].
The effect of phosphorylation on Gi2«  would appear to be negative; that is 
phosphorylated Gi2«  is less able to cause inhibition of adenylyl cyclase 
[Katada et al., 1985; Pyne et al., 1989; Gordeladze et al., 1989; Chen &
Iyengar, 1993]. The lack of a known effector for G ^a makes it difficult to 
assign a function for phosphorylation of this a  subunit. These results would
Ifindicate a level of cross-talk between the lipid signalling mechanisms #
Chronic agonist treatment of cells in culture produces a marked 
loss from the membrane of the specific G protein a  subunit linked to the 
activated receptor. The precise understanding of the mechanisms governing 
this loss is incomplete. Treatment of NG108-15 cells with the prostanoid 
receptor agonist iloprost lead to a reduction in the levels of Gga [McKenzie & I
Milligan, 1990a], while similar treatment of platelets with iloprost did not alter 
levels of the polypeptide [Molina et al., 1989], a phenomoenon with no 
explanation at present [Milligan et al., 1995a]. This change in NG108-15 cells
treatment reflects a change in the half life of the polypeptides. When CHO
S:cells stably expressing the H M l muscarinic acetylcholine receptor are æ
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chronically challenged with agonist, a decrease in the half-lives of G q« and 
G lia  is observed, from approximately 18 hours to approximately 2.5 hours. 
After around 8  hours of such a treatment the half-lives return to their normal 
value [Mitchell et al., 1993]. No change in the levels of G qa and G n a  mRNA 
were observed, as assessed by reverse transcription polymerase chain reaction 
[Mitchell et at., 1993]. Similar results have been observed for Gga [Levis & 
Bourne, 1992]. No change in the half life of Gi2a  [Mitchell et al., 1993], 
which is not activated by the HM l receptor in these cells, was observed . It 
was also seen that the effect of agonist on the levels of G qa could not be 
m im icked by phorbol m yristate acetate, a direct activator of 
phosphoinositidase C, or be blocked by the phosphoinositidase C selective 
inhibitor chelerythrine [Shah & Milligan, 1994], indicating that the effect was 
not mediated by a protein kinase activated by the production of a second 
messenger. This data and results using sucrose gradient density centrifugation 
has lead Milligan et al., [1995a] to propose the following mechanism to 
explain the agonist induced down regulation of G protein a  subunits. Within 
30 mins of receptor activation, there is a redistribution of the a  subunit from 
the plasma membrane fraction to a light vesicular membrane fraction [Svoboda 
& Milligan, 1994] followed by a reduction in the levels of the polypeptide 
upon sustained challenge with receptor. While this mechanism is true in HM l 
receptor expressing CHO cells and rat TRH receptor expressing HEK 293 
cells, both of which are linked to members of the Gq family of a  subunits, the 
universality or otherwise of this theory remains to be determined.
The mechanism of regulation of effector systems is less clear 
than for either receptors or G proteins. Upon chronic activation of p2 
adrenoceptor transfected NG108-15 cells with isoproterenol there is no
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reduction in the amount of adenylyl cyclase [Kim & Milligan, 1995] present in 
the cell, as there is with both the P 2 adrenoceptor and GgOt [Adie & Milligan, 
1994a; Adie & Milligan, 1994b] or with the IP prostanoid receptor and Ggot in 
wild type NG108-15 cells following challenge with the agonist iloprost [Adie 
et ah, 1992].
Modulation of effector systems is known to occur through 
phosphorylation of serine and/or threonine residues. For type II adenylyl 
cyclase, this causes an activation of the enzyme [Taussig & Gilman, 1995] ; no 
data yet exists for the other isoforms of adenylyl cyclase.
It is unknown how chronic agonist activation affects the levels 
the (3 isofoims of phosphoinositidase C, however sustained activation of 
protein kinase C, either by agonist or by phorbol esters, leads to marked 
decreases in the levels of the protein, due to enhanced proteolysis of the 
polypeptide [Young e ta L , 1987] giving rise to the down regulation of this 
particular arm of the lipid signalling system [Collins et a l ,  1984; Rodriguez- 
Pena & Rozengurt, 1984]. The signal for proteolysis may be an 
autophosphorylation event [Mitchell et al., 1989; Pears et aL, 1992; Hug & 
SaiTe, 1993].The other result of phosphoinositdase C activation, release of 
Ca2+ from intracellular stores by IP3 is also under control and the receptor for 
IP3 on the endoplasmic reticulum undergoes rapid desensitisation and down 
regulation [Wojcikiewicz et aL, 1994a; Wojcikiewicz etal., 1994b].
Certain ion channels are also subject to regulation by 
phosphorylation. Protein kinase A can selectively activate Ca^+ currents 
[Armstrong & Eckert, 1988; Artalejo et al. , 1992]. A delayed rectifier type K+
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channel, termed the RAK channel, can be negatively regulated by M l 
muscarinic receptor activation via a tyrosine phosphorylation event [Huang et 
al, 1993] both in Xenopus oocytes and in native NG108-15 cells. At least one 
isoform of the plasma membrane ATP driven Ca^+ pump, which is a target for 
activation by Ggot, is stimulated by phosphorylation by protein kinase A and 
protein kinase C, in addition to several other stimuli [Carafoli, 1992].
It is obvious that regulation of the various arms of signal 
transduction by G proteins is under many levels of control and much remains 
to be determined, such as the role of palmitoylation in G protein signalling. It 
is this question which this thesis aims to address.
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Materials and methods. #
:
2.1. Materials.
2 .1 .1 . Chemicals.
¥
Applied Biosystems, W arring ton , C heshire.
Amplitaq Dyedoexy terminato 
401150), phenol:water:chloroform reagent (68:18:14) (part no. 400765).
r cycle sequencing kit (part no.
?" m'rfAppligene, B irtley, Co. D urham . §
Aquaphenol. g
'
Boehringer M annheim  UK, Lewes, E ast Sussex.
BSA, aprotinin, DNase free RNase.
Calbiochem -Novabiochem  (UK) Ltd., Beeston, N ottingham shire.
Pansorbin cells, DTT.
1
;
J
Difco, D etroit, M ichigan, USA.
Y east extract, Bacto agar, Bacto tryptone.
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Gibco Life Technologies, Paisley, Strathclyde.
v 'V
DMEM, inositol free DMEM, glutamine, sodium bicarbonate, J |
newborn calf serum, penicillin/streptomycin solution, HAT, Lipofectin, 
ultrapure urea, agarose, Ikb DNA ladder, pSV Sport 1.
N ational Diagnostics, Aylesbury, Buckingham shire.
Sequagel-6 .
New E ngland Biolabs, H itchin, H ertfordshire.
Restriction endonuclease Bsa HI.
Porton  Products, Po rton  Down, W iltshire.
Pertussis toxin.
Prom ega L td., Southam pton, H am pshire.
DNA minipreps, DNA maxipreps, PCR preps, Klenow DNA 
polymerase, CIAP, T4 polynucleotide kinase, all restriction endonucleases 
(except Bsa HI and Eag I), pGEM® 7Zf(+).
Scottish A ntibody P roduction  Unit, L anarksh ire , Scotland.
Horseradish peroxidase conjugated donkey anti-rabbit IgG,
Sigma Chem ical Co. Ltd., Poole, Dorset.
Trypsin, ATP, arginine hydrochloride, NP-40, gelatine, o- 
dianisidine hydrochloride, 7-deoxycholic acid, bromophenol blue, TEMED, 
forskolin, Coomassie Blue R-250, hexamine cobalt chloride, hydroxylamine 
hydrochloride, GTP, thymidine, sodium azide, geneticin sulphate, soybean
trypsin inhibitor, PMSF, Triton X-100, thimerosal, ampicillin, CPSR-3, low 
melting point agarose.
Stratagene,
Pfu DNA polymerase.
All other reagents and chemicals were of analytical grade and 
obtained from Fisons Scientific Equipm ent, Loughborough, Leicestershire.
2 .1 .2 . Radiochemicals.
Du P ont NEN (UK) L td., Stevenage, H ertfordshire .
Nicotinamide adenine dinucleotide di(triethanolammonium) 
salt [ a d e n y l a t e - 3 2 p ] ,  ^29.6TBq (800Ci)/mmol (product no. NEG 023X), [9,10- 
^H(N)] palmitic acid, l.ll-2.22TB q (30-60Ci)/mmol (product no. NET-043).
IC N  Flovr, Irvine, S trathclyde.
T r a n 3 %  label, >37TBq (>1000Ci)/mmol (product no. 51006)
2 .1 .3 . Antisera.
All antisera used in this study are detailed in T able 2. 1 The 
method of production of the antisera has been described previously [Goldsmith 
e ta l ,  1987].
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Table 2. 1. Specificity of antisera employed in 
this study.
The antisera used during the course of this work are shown along with the 
peptide sequences to which they were raised, the corresponding areas of the G 
protein a  subunits which correspond to these amino acids, the ot subunits 
which the antisera identify and the references dealing with their production. 
All antisera were made in house apart from anti serum AS201, which was a 
kind gift of Dr G. Schultz, Institute of Pharmacology, Freie University, Berlin, 
Germany.
71
g B ICZ5I
K)<DK)IOJo
II_ 1
O J
Qo
hJ<D
h oI
O Jo
o p Q Q o Oon hQ o o o
P P P P p P
O J
g
w OJ K )
0 0
O l è 0 \ &
VOJ1
O J ô o
û> Ôj o »o o
kO O '■o 4^
0
1
I
o
P
oo
P
Q
*
P
o o o a o o
(A r z  ^  o  o  o  
P  P  P  P  P  Pb b
%
Ff
p
1 fil?ll
§
|i|
o
Rp
f§
R"
Rp
CJQ
K #CD il
s
I I
Rp Rp Rp f
IK)
2 .1 .4  Animals.
Adult Sprague-Dawley rats were killed by cervical dislocation, 
the brains removed and the cortex used in the preparation of crude plasma 
membranes as described in section 2. 3 .1 .
2.2. Cell Culture.
2 .2 .1 . Growth conditions.
The cells were grown in continuous monolayer culture in 
75cm^ sterile tissue culture flasks (Nunc, Roskilde, Denmark) in sodium 
pyruvate free Dulbecco's Modified Eagle's Medium supplemented with 10% 
(v/v) serum (as indicated for each cell line), 2mM L-glutamine, 100 I.U./ml 
penicillin, 100;^g/ml streptomycin. Buffering of the medium was achieved by 
the addition of 0.375% (w/v) sodium bicarbonate and growing the cells in an 
atmosphere of 0 2 ’.C0 2  in the ratio of 95%: 5%. Cells were incubated in 10ml 
of the above medium in a VSL incubator (Scotlab, Coatbridge, Strathclyde.) at 
37°C and allowed to reach confluency. The medium was changed regularly, 
generally every 2  days.
2 .2 .2 . Growth and maintenance of cells.
NG108-15 neuroblastoma x glioma hybrid cells were a kind gift 
from Dr. W. Klee (NIH, Bethesda, Maryland, U.S.A.). The cells were grown 
to confluency according to the method of Hamprecht et al. [1985], in DMEM 
medium supplem ented with 10% (v/v) Controlled Process Serum
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Replacement-3 (CPSR-3) and hypoxanthine, aminopterin, thymidine (HAT) at 
final concentrations of lOOpM, 10//M and 16jwM respectively.
Rat 1 fibroblasts and COS-1 cells were obtained from ECACC, 
Porton Down, Salisbuiy, Wiltshire. C5B and D3 cells were derived from Rat 1 
fibroblasts by transfection with the cDNA encoding, respectively, wild type or 
C3S mutant forms of rat G oia  in pcEXV-3 [Grassie et al. , 1994]. Parental Rat 
1, C5B, D3 and COS-1 cells were grown to confluency in DMEM medium 
supplemented with 10% (v/v) newborn bovine serum. To minimise cell 
reversion, C5B and D3 cells were routinely passaged in medium containing 
1 0 % (v/v) newborn bovine serum and 700^g/ml geneticin sulphate.
2 .2 .3 . P ass^ ii^  of confluent cell cultures.
Upon reaching confluency, each flask of cells was usually split 
1:5 into new flasks. Medium was removed and the monolayer trypsinised by 
addition of a solution containing 0.1% (w/v) trypsin, lOmM glucose, 0.67mM 
EDTA, pH 7.4. When all cells had detached from the flask, trypsinisation was 
terminated by addition of 10ml DMEM containing 10% CPSR-3 (NG108-15 
cells) or NBS (Rat 1, transfectants and COS-1). The cell suspension was then 
decanted into a sterile 50ml polypropylene centrifuge tube (Nunc, Roskilde, 
Denmark) and centrifuged in a bench top centrifuge (MSE) at lOOOrpm for 
5mins. The supernatant was discarded and the pellet of cells resuspended in 
5ml of serum containing DMEM and 1ml added to 5 new flasks containing 
9ml of medium and placed in an incubator.
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2 .2 .4 . Freezing and storage of cells.
2 .2 .5 . Recovery of cells from liquid Nz.
Vials were removed from liquid N2 , thawed at 37°C and the 
contents placed in a 50ml centrifuge tube and diluted with 13ml of DMEM 
medium containing 10% serum and centrifuged at lOOOrpm for 5mins as 
above. The supernatant was then discarded and the pellet resuspended in 10ml
the cells handled as normal.
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To provide a stock of cells for further use, cells were 
cryogenically stored in liquid N2 . After trypsinisation and centrifugation as 
above, cells were resuspended in 1ml per confluent flask of freezing medium. :
This was DMEM medium supplemented with 20% (v/v) of the appropriate 
serum and 8 % (v/v) dimethyl sulphoxide. 1ml of the cell suspension was 
added to sterile freezing vials (Nunc, Roskilde, Denmark). To prevent
formation of ice crystals in the cells, the freezing vials were placed in a 
polystyrene box packed with cotton wool and frozen slowly overnight at - 
80°C. The cells were then tranfened to liquid N 2 .
DMEM medium plus 10% serum and the whole added to a 75cm^ flask and
2. 2. 6. Differentiation of NG108-15 cells.
f'i
Differentiation of NG108-15 cells was carried out using
.forskolin as previously described [Mullaney & Milligan, 1990]. Briefly,
NG108-15 cells were trypsinised and centrifuged as described above and
.resuspended in 1ml per flask of serum reduced DMEM medium containing 1%
or changing the medium. Cells were harvested as described in section 2. 2 .10 .
2. 2 .7 . Treatment of cells with pertussis toxin in
Cells which were to be pretreated with pertussis toxin were
bovine serum, 5mM sodium pyruvate and incubated for 4hrs. Cells were then
I
iff
I
¥(v/v) CPSR-3 and HAT. A further 4ml per confluent flask of serum reduced 
DMEM medium was added and 1ml of the cell suspension was then added to 
8 ml of serum reduced DMEM medium. Forskolin was prepared as a 1 Ox stock Iin serum reduced DMEM medium by taking an appropriate volume of lOmM 
forskolin stock in ethanol and filter sterilising through a 0 .2 2 /<m syringe filter.
1ml of this stock was added to each flask to give a final concentration of
ii'ïÿlOpiM. The cells were incubated as normal for 6  days without disturbing them
s
VIVO.
■f
grown to approximately 70% confluency and the medium aspirated. 9ml of
:#fresh DMEM medium was then added to each flask. Pertussis toxin was 
prepared fresh as a lOx stock in DMEM medium and filter sterilised as 
described above. 1ml was added to each flask to a final concentration of 
25ng/ml. Cells were then grown for a further 16hrs before being harvested as 
described in section 2. 2 .10 .
2 .2 .8 . Labelling of cells with 3H palmitic acid.
COS-1 cells were transfected for approximately 70hrs, as
;
described in section 2. 2. 12., before 200/fCi/ml of [9, lO-^H] palmitate was 
added to the flasks in DMEM medium containing 5% (v/v) dialysed newborn II
575
 _ ____
harvested and total cell lysates immunoprecipitated as described in section 2. 
5. 3.
2 .2 .9 . Labelling of cells with Tran^ss label.
When COS-1 cells had been transfected for approximately 
56hrs, cells were treated for 16hrs with 50^Ci/ml of Tran^^S label. To 
maximise the incorporation of radioactivity into newly synthesised protein, 
DMEM, without methionine and cysteine, was supplemented with antibiotics 
as before, and 5% (v/v) dialysed newborn calf serum. This labelling was 
allowed to continue overnight before whole cell lysates were 
immunoprecipitated as described in section 2. 5. 3.
2.2 .10 . Harvesting of cells.
After cells reached confluency, or the particular treatment time 
had elapsed, they were harvested by scraping the monolayer into the medium 
and the cells collected in a 50ml centrifuge tube on ice. The tubes were 
centrifuged at 2000rpm for 5mins at 4°C in a Beckman TJ- 6  benchtop 
centifuge. The supernatant was discarded and the cell pellet resuspended in 
25ml of ice-cold PBS (137mM NaCl, 4mM Na^HPO^., 0.27mM KCl, 0.15mM 
K H 2PO 4 , pH7.4) and centrifuged as before. Again the supernatant was 
discarded and the pellet resuspended in PBS and re-centrifuged. The 
supernatant was again discarded and the pellet stored at -80°C until required.
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2. 2.11. Transient transfection of COS-1 cells.
COS-1 cells were grown to approximately 50% confluency in 
75cm^ flasks as described above. SOpig of DNA was added to a 13ml sterile 
polypropylene centrifuge tube containing 50/d of Lipofectin and sterile Milli 
Q H2O, to a final volume of 300/^1. DNA/liposome complexes were allowed to 
form for 15mins during which time the cells were washed twice with serum 
free DMEM medium. 10ml of serum free DMEM medium was then added to 
the DNA/liposome complexes and the whole added to one 75cm^ flask of 
COS-1 cells. Cells were then incubated for 8 hrs to allow the DNA to enter the 
cell before the medium was replaced with DMEM containing 10% newborn 
bovine serum. Cells were then incubated for approximately 70hrs before being 
harvested as described in the preceding section.
2.3 . Preparation of membrane fractions.
2 .3 .1 . Preparation of crude plasma membranes.
Membranes were prepared according to the method of (Koski & 
Klee, 1981). Frozen cell pastes were thawed on ice and resuspended in 2ml of 
ice-cold TE buffer (lOmM Tris HCl, pH7.5, 0.1 mM EDTA) and transferred to 
a pre-chilled glass homogeniser tube. The cells were then homogenised, on 
ice, with 20 strokes of a teflon homogeniser. Homogenates were transferred to 
polypropylene centrifuge tubes and the homogeniser tube washed with a 
further 1ml of ice-cold TE buffer and the contents added to the centrifuge tube.
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2. 3. 2. Preparation of membrane and 
cytoplasmic fractions.
Centrifuge tubes were placed in a type 50Ti rotor (Beckman)
■ff:and centrifuged at SOOx^av for lOmins at 4°C in a Beckman L5-50B f
ultracentrifuge. The pellet, which contained nuclei and unbroken cells, was
Idiscarded and the supernatant transferred to fresh pre-chilled centrifuge tubes 
and centrifuged at 48,000x^av for lOmins at 4°C. The supernatant was 
discarded and the pellet resuspended in 5ml of TE buffer and recentrifuged at 
48,000x^flv for lOmins at 4°C. Again the supernatant was discarded and pellet 
resuspended in TE buffer to give an approximate protein concentration of 1- 
3mg/ml. The samples were then frozen at -80°C in 100/d fractions.
Crude plasma membranes from rat brain was prepared as above 3,using cortex from brains of animals which had been sacrificed by cervical 
dislocation.
Cell pastes were homogenised as described above, except that 
homogenisation was carried out in 1ml to prevent excessive dilution of the 
resulting cytoplasmic protein. Homogenates were centrifuged at 500xgav as 
described above. The resulting supernatant was transferred to 11mm x 34mm 
centrifuge tubes and placed in a TLlOOa rotor and centrifuged at 200,000x^av 
for 30mins at 4°C in a Beckman TLIOO tabletop ultracentrifuge. The 
supernatant (designated "cytoplasmic fraction") was retained and stored in 
200^1 samples at -80°C. The pellet (designated "membrane fraction") was 
resuspended in TE buffer to give an approximate protein concentration of 
3mg/ml and samples of lOOj l^ were stored at -80°C.
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2 .4. Determination of protein concentration.
Protein concentrations were determined by the method of 
[Lowiy et al. [1951], using BSA as standard. The samples were read at 750nm 
on an LKB Biochrom Ultraspec II spectrophotometer.
2. 5. Preparation of samples for SDS - 
polyacrylamide gel electrophoresis (SDS -PAGE). 
2. 5. 1. TCA/deoxycholate precipitation of 
samples.
The required amount of crude plasma membranes, or membrane 
and cytoplasmic fractions, as indicated for each experiment, were taken and 
placed on ice in a 1.5ml microcentrifuge tube and 63}Â  of 2% (w/v) 7- 
deoxycholic acid, sodium salt added. 700jwl of dH2 0  and 250]A of 24% (w/v) 
trichloroacetic acid were added sequentially and the tubes were vortexed 
briefly and incubated on ice for 15mins before being centrifuged on an MSE 
microcentrifuge at 13,000rpm for 5mins. The supernatant was discarded and 
the pellet dissolved by the addition of 20jÂ of IM Tris base. 20//1 of sample 
buffer (0.3g/ml urea, 0.06g/ml DTT, 0.05g/ml SDS, SOpil/ml IM Tris HCl, 
pH8 , with a few crystals of bromophenol blue) was then added. The sample 
was ready for loading onto the gel.
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2 .5 .2 . Hydroxylamine treatment.
Hydroxylamine cleaves thio-ester bonds attaching acyl chains 
to proteins. Using a modification of the method of Magee et al. [1984] and 
Magee & Courtneidge [1985], we used hydroxylamine to remove any cysteine 
linked acyl groups from G protein a  subunits. The required amount of crude
plasma membranes, as indicated for each experiment, were transferred to a
.1.5ml microcentrifuge tube and the membranes pelleted in a microfuge at 4°C 
for 5 mins. The supernatant was discarded and the pellet resuspended in lOOjil 
of IM  hydroxylamine, pH8  or IQQpii of IM Tris HCl, pH8  as control, and 
incubated for 4hrs at 25°C. The membranes were then transferred to TLIOO 
centrifuge tubes and the microcentrifuge tubes washed with IOOjaI of PBS and
the washings added to the contents of the TLIOO tubes. The were placed in a 
TLlOOa rotor and centrifuged at 120,000xgav for 30mins at 4°C in a Beckman 
TLIOO tabletop ultracentrifuge.
The resulting supernatant was added to microcentrifuge tubes 
containing lOpig BSA to act as carrier protein. 100% (w/v) TCA was added, to 
a final concentration of 20%, and the tubes were left on ice for 15mins. The 
tubes were then centrifuged at 13,000prm for 5mins in an MSE 
microcentrifuge at 4°C. The pellet was then dissolved in 20]a \ of IM Tris base 
and 20pil of sample buffer added.
Î
2 0 jwl of sample buffer was added to the pellet from the 
ultracentrifugation step in the TLIOO tubes. The pellet was dissolved in the 
sample buffer by incubating at 37°C for Ihr. The samples were then loaded 
onto the gel.
Î
2. 5 .3. Immunoprécipitation of proteins.
The cell pellet from sections 2. 2. 8 . and 2. 2. 9. was
€resuspended in 200^1 of 1% (w/v) SDS containing 0.2mM PMSF and ly^g/ml
aprotinin. In vitro pertussis toxin catalysed ADP-ribosylation assays (see
i'Xsection 2.10.) were diluted to 200pi\ with 1.33% (w/v) SDS containing PMSF 
and aprotinin. Both samples were then processed identically.
Tubes were boiled for 4mins and SOO/d of ice cold solution I 
(1.25% (v/v) Triton X-100, 190mM NaCl, 6 mM EDTA, 50mM Tris HCl, pH
7.5, containing PMSF and aprotinin) added to each. Samples were centrifuged 
in an MSE microfuge for lOmins at 4°C and the supernatant transferred to
■"4'Ifresh tubes. 1/d  of anti serum/10 /^g of protein (ribosylation experiments) or y
15]a \ of antibody (palmitate and Tran^^S label experiments) was added to each
tube and incubated with constant rotation overnight at 4°C. 50/d of Pansorbin
■44
Cells was then added to each tube and the tubes incubated again for 2-4hrs at |:
4°C with constant rotation. The tubes were centrifuged briefly for 20secs and "Ithe pellet resuspended 3 times, with centrifugation between washes, with 44
solution I containing 0.2 volume of 1% (w/v) SDS. The Pansorbin was then
4;4washed once with 50mM Tris HCl, pH 6 .8 , as above and the final pellet .44
resuspended in 50pt\ of Laemmli sample buffer (see section 2. 5. 1.) and boiled
for 5mins. The suspension was then centrifuged at 13,000rpm for 2mins in an 4
MSE microfuge and the supernatant subjected to SDS-PAGE as described in
section 2. 6 .1 . 4
4l
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2 .6 . SDS-Polyacrylamide gel electrophoresis.
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2. 6. 1. SDS-PAGE lower resolving gel - 10% 
(w/v) polyacrylamide gels.
vv
SDS-PAGE was carried out as described by Laemmli, [1970] 
on 1.5mm wide slab gels. The gel plates measured 160mm x 180mm. The
slabs were run on a Bio-Rad Protean I electrophoresis system (Bio-Rad 
Laboratories Ltd, Watford, Herts.)
Resolving gels were prepared by mixing stock acrylamide 
solution (30% (w/v) acrylamide, 0.8% (w/v) N, N' -methylene bisacrylamide), 
buffer 1 (1.5M Tris HCl (pH 8 .8 ), 0.4% (w/v) SDS), 50% (v/v) glycerol and 
(IH2O to give final concentrations of 10% (w/v) acrylamide, 0.24% (w/v) N, 
N'-methylene bisacrylamide, 0.375M Tris HCl (pH8 .8 ), 0.1% (w/v) SDS, 3% 
(v/v) glycerol. Polymerisation of the gel was achieved by the addition of 8 /d of
5
TEMED and 90//1 of freshly prepared 10% (w/v) ammonium persulphate. 
Upper stacking gels were as described in section 2. 6. 4. and electrophoresis 
was carried out as described in section 2. 6. 5.
2. 6. 2. Lower resolving gel - urea gradient SDS- 
PAGE.
To achieve maximum separation of isoforms of GqCx, urea 
gradient SDS-PAGE was carried out as a modification of the method of 
Scherer et al., (1987) and Codina et a l ,  (1991). In order to maximise the 
separation, longer gels (160mm x 200mm plates, 1.5mm spacers) were used 
and ran as part of a Bio-Rad Protean II system. Resolving gels containing a
linear 4M-8M urea gradient were fashioned by preparing stock solutions of 
acrylamide (30% (w/v) acrylamide, 0.15% (w/v) N, N '-methylene 
bisacrylamide) and buffer 1 (as above) in both 4M and 8 M urea and mixing 
them with 4M or 8 M urea in separate containers, to a volume of 20ml. This 
gave final concentrations of 12.5% (w/v) acrylamide, 0.0625% (w/v) N,N'- 
methylene bisacrylamide, 0.375M Tris HCl (pH8 .8 ), 0.1% (w/v) SDS. 
Polymerisation of the two mixtures was initiated by the addition of 3/d of 
TEMED and 15//1 of freshly prepared 10% (w/v) ammonium persulphate and 
quickly added to the chambers of a gradient maker. The mix was then pumped 
into the gel plates and the gel allowed to polymerise, undisturbed, overnight. 
Ultrapure urea was used to avoid the usual Amberlite deionisation step 
involved. Upper stacking gels were as described in section 2. 6. 4. and 
electrophoresis was carried out as described in section 2. 6. 5.
2. 6. 3. Lower resolving gel - 6M urea SDS- 
PAGE.
In order to separate species variants of G hoc, SDS-PAGE was 
carried out in the presence of 6 M urea [Kim & Milligan, 1994]. Urea was 
added to the acrylamide mix described in section 2. 6. 1. to a final 
concentration of 6 M and polymerised with ISOjdl of freshly prepared 10% 
(w/v) APS and 12/d TEMED. 37.5ml of this was loaded into the Bio-Rad 
Protean II gel plates described in section 2. 6. 2. and allowed to polymerise 
overnight. Upper stacking gels were as described in section 2. 6. 4. and 
electrophoresis was carried out as described in section 2. 6. 5.
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2 .6 .4 . Upper stacking gels.
The upper stacking gel was prepared by mixing stock 
acrylamide solution (30% (w/v) acrylamide, 0.8% (w/v) N, N'-methylene 
bisacrylamide), buffer 2 (0.5M Tris HCl (pH 6 .8 ), 0.4% (w/v) SDS) and H 2O 
to give final concentrations of 3% (w/v) acrylamide, 0.08% (w/v) N, N'- 
methylene bisacrylamide, 0.125M Tris HCl (pH6 .8 ), and 0.1% (w/v) SDS. 
This was polymerised by adding S]a\ of TEMED and 150/d of freshly prepared 
10% (w/v) ammonium persulphate. Samples were loaded onto the gels using a 
Hamilton microsyringe (Hamilton Co., Reno, Nevada, USA.).
2.6 .5 . Electrophoresis Running Buffers.
The running buffer contained 25mM Tris HCl (pH8.5), 0.192M 
glycine and 0.1% (w/v) SDS. Electrophoresis was toward the anode at 40V, 
25mA per slab until the bromophenol blue dye front was 0.5cm from the 
bottom (standard 10% gels) or 160V, 60mA per slab until the prestained lactic 
dehydrogenase molecular weight marker was 5cm from the bottom (urea 
containing gels).
2.7 . Staining of SDS-PAGE gels.
2. 7. 1. Staining of SDS-PAGE gels with 
Coomassie Blue.
Following electrophoresis, gels were soaked, with gentle 
shaking on a rotary shaker, for Ihr in 45% (v/v) methanol, 10% (v/v) acetic
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acid containing 0.25% (w/v) Coomassie Blue R-250. Gels were destained by 
washing with 45% (v/v) methanol, 10 % (v/v) acetic acid with frequent 
changes of the wash solution.
2 .7 .2 . Staining of [3H] containing gels.
Following electrophoretic separation of [^H] palmitate labelled 
samples, gels were subjected to ENTRANCE, according to the manufacturers 
instructions, before being dried and subjected to autoradiography as described 
in section 2 .11 .
2. 8. Western blotting. 
2. 8.1. Transfer of proteins to nitrocellulose.
After SDS-PAGE, gels were transferred to nitrocellulose 
membranes essentially as described by Towbin et al. (1979). The sandwich 
was prepared by taking the plastic cage and submerging it in transfer buffer 
(25mM Tris, pH8.3, 192mM glycine, 25% (v/v) methanol). A sponge was laid 
on top and a piece of Whatman 3mm chromatography paper, cut slightly larger 
than the gel, laid on top of this. Next, the gel was placed on the 
chromatography paper followed by the nitrocellulose membrane (Costar, 
Cambridge, MA, USA). Another piece of chromatography paper was laid on 
top followed by a second sponge. The top half of the cage completed the 
sandwich. All manipulations were carried out with the sandwich completely 
submerged in the blotting buffer to minimise the formation of air bubbles 
which would interfere with transfer of the proteins. The sandwich was then
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closed up and the proteins subjected to electrophoresis toward the anode at 2A 
for 1.5hrs.
2. 8. 2. Incubation of nitrocellulose membranes 
with antisera.
Following transfer of proteins, the nitrocellulose membranes 
were incubated in 5% (w/v) porcine gelatine in PBS, pH 7.4, containing a 
pinch of thimerosal, at 37°C for a minimum of 2hrs. The gelatine/PBS was 
removed and the membrane washed three times with 100ml dH2 0 . The 
nitrocellulose was then incubated overnight at 37°C with the appropriately 
diluted anti-G protein antiserum in 1% (w/v) porcine gelatine in PBS, pH 7.4, 
containing 0.2% (v/v) NP-40 (gelatine/PBS/NP-40). The dilutions of primary 
antisera were removed and the blots washed three times with PBS containing 
0.2% (v/v) NP-40 for lOmins and then three times with PBS for lOmins. 
Secondary antiserum (horseradish peroxidase conjugated donkey anti-rabbit 
IgG), at a dilution of 1:200 in gelatine/PBS/NP-40, was added and the 
nitrocellulose membranes ineubated for 2hrs at 37°C. The secondary antiserum 
was removed and the nitrocellulose washed with PB S/NP-40 and PBS as 
before.
2. 8.3. Development of immunoblots.
1ml of freshly prepared 1% (w/v)c-dianisidine hydrochloride 
was added to 40ml of PBS, pH7.4, and the whole added to the newly washed 
nitrocellulose membranes. Development of the immunoblot was initiated by 
addition of 20/d of stock H 2O2 (30% v/v) and stopped by immediately
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immersing the membranes in 1% (w/v) sodium azide. The developed 
immunoblot was rinsed in dH2 0  and allowed to dry.
2. 9. Densitometric analysis of immunoblots.
Following development, immunoblots were densitometrically 
scanned on a Bio-Rad GS-360 imaging densitometer and analysed on an Apple 
Macintosh Quadra 800 microcomputer.
2.10. Mono ADP-ribosylation of cell membranes 
with pertussis toxin.
Mono ADP-ribosylation of G-proteins was performed 
essentially as described by Hudson & Johnson, [1980]. Pertussis toxin was 
obtained as an 200/tg/ml stock solution in 50mM phosphate buffer, pH 7.2, 
500mM NaCl and 50% (v/v) glycerol. For in vitro ADP-ribosylations, 
pertussis toxin was first preactivated by taking equal volumes of stock solution 
and lOOmM DTT and incubating at room temperature for 90 mins. 5/d (lOOng) 
of this was added to each incubation tube.
The appropriate amount of membranes or cytoplasm, in a 
volume of 15-20/d, was added to each tube along with buffer containing 
20mM thymidine, O.lmM GTP, 250mM sodium phosphate buffer, pH7.0, 
ImM ATP, 20mM arginine hydrochloride and spiked with IpiCi of p2p] 
NAD+ per assay tube. Reactions were started by the addition of preactivated 
pertussis toxin. The tubes were placed in a water bath at 37°C for 2hrs. The 
tubes were then placed on ice and either TCA precipitated as described in
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section 2. 5. 1. or immunoprecipitated as described in section 2. 5. 3. The 
samples were then subjected to SDS-PAGE as described in section 2. 6.
2.11. Autoradiography.
Destained gels from experiments containing P^P] labelled 
proteins, or EN^HANCE treated gels, were dried onto Whatman No.3 
chromatography paper under a vacuum line attached to a Bio-Rad 583 gel 
drier. Autoradiography was at -80°C P^P labelled proteins) or at room 
temperature ( %  labelled proteins), for an appropriate time on Fuji X-ray film 
in a Kodak X-o-matic cassette with intensifying screens. Films were developed 
in a Kodak X-o-mat developing machine.
2.12. Phosphoriuiagiug.
Some gels containing p^P] labelled proteins and experiments 
from Tran^^S labelled proteins were dried as described in the preceding 
section and subjected to phosphor imaging for the indicated time before being 
analysed on a Fujix BAS 1000 phosphorimager linked to an Apple Macintosh 
Quadra 650 microcomputer.
2.13. Gel Filtratiou.
Separation of cytoplasmic proteins derived from D3 cells was 
achieved by gel filtration on a Superose 12 column (Pharmacia, Uppsala, 
Sweden) linked to a Pharmacia Fast Protein Liquid Chromatography (FPLC) 
system. The column was equilibrated overnight in buffer consisting of lOmM
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Tris HCl, pH7.4, ImM EDTA, 150mM NaCl. 200pt\ of crude cytoplasm, 
derived from the fractionation described in section 2. 3. 2., was loaded onto 
the column and the column washed with the Tris/EDTA/NaCl buffer at a rate 
of Iml/min, SQOpil fractions were collected in microcentrifuge tubes containing 
lOjWg of BSA, to prevent loss of protein, and TCA precipitated as described in 
section 2, S. 2. The fractions were then run on SDS-PAGE gels as described 
and immunoblotted as described in sections 2 .6 .1 .  and section 2. 8.
2.14. Growth of Escherichia coli. strain JM109.
E xoli were routinely grown in L broth. This consisted of 
lOg/litre Bacto-tryptone, 5g/litre yeast extract, 0.17M NaCl, pH 7.0. 
Depending on the strain and the plasmid, antibiotics were also included. The 
cultures were grown at 37°C with continuous shaking at 120-150 rpm.
When working with E.coli., all media and solutions, unless 
otherwise stated, were sterilised by autoclaving for llm in s  at 126®C, 
Ampicillin was prepared as a 50mg/ml stock in dH2 0  and sterilised by 
filtration through a 0 .2 2 /<m syringe filter.
Stock JM109 E.coli cells were purchased from Promega 
Corporation and streaked onto an LB agar plate (15g/litre Bacto-agar in L 
broth) in the absence of any antibiotics. The agar plate was incubated 
overnight at 37°C. A single colony was picked for expansion and grown up 
overnight at 37®C in 10ml of L broth. 5ml of this was used to make competent 
cells and 5ml was used to make glycerol stocks.
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Transformed JM109 cells were grown in the presence on 
antibiotics to prevent loss of the particular plasmid of interest. JM109 cells 
transformed with pCMV, pGEM® 7Zf(+) or pSV Sport 1 or recombinant 
plasmids derived from them were grown in L broth or on LB agar plates 
supplemented with 60^g/ml of ampicillin. The plasmid pCMV containing the 
cDNA for murine a l l ,  cloned into the Cla I/Xho I sites, was a kind gift from 
Dr. Melvin I. Simon, California Institute of Technology, California, USA. 
Routinely, glycerol stocks of JM109 cells transformed with pCMV, pGEM 
7Zf(+) or pSV Sport 1 or their recombinant derivatives were prepared.
2. 15. Preparation of chemically competent 
JM109 cells.
A stab from a glycerol stock of JM109 cells was grown up 
overnight in 5ml of L broth and 3ml of this used to inoculate 500ml of L 
broth. The OD^oo was monitored until it reached approx. 0.25 (equivalent to 
approx. 1x10# cells/ml). The cell suspension was then decanted into two 
250ml centrifuge tubes, allowed to cool on ice for approximately 30mins and 
spun at 10,000rpm for lOmins at 4°C on a Beckman J2-21 centrifuge 
containing a JA14 rotor. The supernatant was discarded and the pellets 
resuspended in 20ml each of ice-cold sterile buffer I (lOOmM RbCl, 50mM 
MnCl2 .4 H2 0 , 30mM potassium acetate, lOmM CaCl2 . 2 H2O, 15% (w/v) 
glycerol, pH 5.8). The suspension was left on ice for ISmins at 4®C and 
recentrifuged as before. The supernatants were again discarded and the pellets 
resuspended in a total volume of 3.5ml of ice-cold buffer II (lOmM RbCl, 
lOmM MOPS, 75mM CaCl2 .2 H 2 0 , 15% (w/v) glycerol, pH6 .8 ) and pooled
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into one tube. The suspension was left on ice for 15mins before 250/d aliquots 
were snap frozen in liquid N2 and stored at -80®C.
2. 16. Transformation of chemically competent 
E.colL with plasmid DNA.
An aliquot of chemically competent JM109 cells were thawed 
on ice and an appropriate amount of DNA added. DNA and bacteria were 
mixed in a sterile 13ml polypropylene centrifuge tube. This was lO-lOOng of 
supercoiled plasmid DNA or 5/d of a ligation reaction. The cells were 
incubated on ice for 15mins before being heat shocked at 42®C for exactly 
90secs and returned to ice for 2mins. 800/<l of SOC medium (20g/l Bacto- 
tryptone, 5g/l yeast extract, 20mM MgCl2 , 8.5mM NaCl, 2.5mM KCl, pH7.0) 
was added and the tubes incubated, with shaking at 150rpm, for 45-60mins at 
37®C.
lOOjWl and 200/d were spread onto LB agar plates containing 
60]Aglm\ ampicillin. The plates were incubated overnight at 37®C and 
antibiotic resistant colonies picked and grown up overnight in 10ml L broth 
containing the required antibiotics as above. 3ml of this was used to prepare 
plasmid DNA and the remainder used to make glycerol stocks.
2.17. Preparation of glycerol stocks.
Sterile 80% (v/v) glycerol was added to the overnight culture to 
15% (v/v) and the suspension mixed gently to ensure thorough dispersion of 
the glycerol. 1ml aliquots of this were added to sterile microcentrifuge tubes
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and snap frozen in liquid N 2 . The tubes were stored at -80®C until required. 
The stocks were not allowed to thaw and scrapings from these frozen samples 
were used to inoculate fresh cultures.
2.18. Preparation of plasmid DNA.
2 .18 .1 . Preparation of double stranded plasmid 
DNA by alkaline lysis.
This method of plasmid DNA isolation was used to prepare 
plasmid DNA for diagnostic restriction digestion and not for subcloning or 
PCR reactions. The method used was as described in Sambrook et a l, (1988). 
3ml of the overnight culture of interest was centrifuged in microcentrifuge 
tubes in an MSE microcentrifuge at 13,000rpm for Imin. The supernatant was 
discarded and the pelleted cells resuspended in lOOjWl of sterile, ice-cold 
solution I (50mM glucose, 25mm Tris HCl, pH 8.0, lOmM EDTA). 200pi\ of 
freshly prepared solution II (0.2M NaOH, 1% (w/v) SDS) was added and the 
tubes inverted several times to mix. Solution II was prepared by diluting stock 
solutions of lOM NaOH and 10% (w/v) SDS. 150/fl of ice-cold solution III 
(60ml of 5M potassium acetate, 11.5ml of glacial acetic acid and 28.5ml 
dH2 0 , giving final concentrations of 3M K+and 5M acetate) was added and 
the tube mixed by inversion again. The suspension was centrifuged at 
13,000rpni for 5mins and the supernatant transferred to another 
microcentrifuge tube and ethanol precipitated as described in section 2. 19. 
Precipitates were resuspended in SOpil of 20/<g/ml DNase-free RNase in sterile 
H 2O.
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2 .18 .2 . Preparation of double stranded plasmid 
DNA by Promega Minipreps.
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This was carried out as described by the manufacturer. 3ml of j
overnight culture was centrifuged as described in section 2. 18. 1 and the
Iresulting pellet resuspended in 200y l^ buffer 1 (50mM Tris HCl, pH 7.5, lOmM 
EDTA, lOO/^g/ml RNase A). 200/^1 of buffer 2 added (0.2M NaOH, 1% (w/v) 
SDS) and the tube mixed by inversion. 200jA of buffer 3 (1.32M potassium 
acetate) was added to this and the tube mixed, again by inversion, and 
centrifuged at 13,000rpm in a MSE microcentrifuge. The supernatant was 
transferred to another tube and 1ml of Wizard purification resin added. The 
tubes were vortexed briefly and the contents transferred to a 2 ml syringe barrel
fitted with a Minicolumn. The resin was pushed through the column with the 
syringe plunger. The resin in the Minicolunln was washed with 2ml of wash 
buffer (0.09M NaCl, 9mM Tris HCl, pH 7.5, 2.2mM EDTA, 55% (v/v) analar
ethanol) and the column attached to a microcentrifuge tube and centrifuged at 
12,000rpm in a Sorvall MC12C microcentrifuge for 20secs. The Minicolumn 
was then transferred to a fresh microcentrifuge tube and 50^1 of sterile Milli Q 
H2O, preheated to 65®C, added. The column was allowed to sit at room 
temperature for at least Imin before being centrifuged as before. The resulting
%aqueous DNA solution was stored at -20®C until required.
2.18 .3 . Preparation of double stranded plasmid 
DNA for automated DNA sequencing.
This was done by a modification of the method in the preceding 
section. An entire 10ml overnight culture was centrifuged in a Beckman TJ6
benchtop centrifuge for 20mins at 3000rpm. The pellet was resuspended in 
300/fl of buffer 1 as above and the suspension transferred to a microcentrifuge 
tube. The lysis was carried out as described in section 2. 18. 2. using 300]a \ of 
each of buffers 2 and 3. Following centrifugation of the lysate, the supernatant 
was split into 2 microcentrifuge tubes (450/<l each) and SOOpil of resin added to 
each. The resins were then recombined into one syringe barrel and processed 
as described previously, except that 3ml of wash buffer was used and the 
column was centrifuged for Imin. The DNA was eluted with lOOpil of 
preheated water followed by another Imin centrifugation step.
2. 18. 4. Large scale preparation of double 
stranded plasmid DNA by Promega maxiprep.
5ml of a 10ml overnight culture was used to inoculate 500ml of 
L broth containing 60/<g/ml of ampicillin. Following incubation overnight at 
37®C with shaking at 150rpm, the culture was decanted into 250ml centrifuge 
buckets and centrifuged at 10,00rpm in a Beckman JA14 rotor at 4®C for 
lOmins. The pellet was resuspended in 10ml of buffer 1 (50mM Tris HCl, pH
7.5, lOmM EDTA, 100/fg/ml RNase A) and lysis carried out by the addition of 
10ml of buffer 2 (0.2M NaOH, 1% (w/v) SDS). The lysate was neutralised by 
adding 10ml of buffer 3 (1.32M potassium acetate). The lysate was centrifuged 
at 10,000rpm for 20mins at 4®C in a Beckman JA14 rotor.
The supernatant was filtered through two layers of cheesecloth 
and the DNA precipitated by the addition of 0.6 volumes of iso-propanol. 
DNA was collected by centrifugation at 10,00rpm in a Beckman JA14 rotor at 
4®C for lOmins and the pellet resuspended in 2ml of lOmM Tris HCl, pH 7.5,
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ImM EDTA. 10ml of Wizard purification resin added and the whole added to 
a Wizard maxi column connected to a Vac-Man vacuum manifold (Promega).
centrifugation for lOmins at 2500rpm at 4®C in a Beckman TJ6  benchtop
DNA was precipitated from solution by addition of 0.1 volumes
I
The resin was collected by drawing a vacuum through the column and washed
*
by the addition of 25ml of wash buffer (0.09M NaCl, 9mM Tris HCl, pH 7.5,
2.2mM EDTA, 55% (v/v) analar ethanol) followed by 5ml of 80% (v/v) analar 
ethanol.
i
The resin was dried by centrifugation for lOmins at 2500rpm at
4°C in a Beckman TJ6  benchtop centrifuge. The DNA was eluted by addition 5
Tof 1.5ml of sterile H2O, preheated to 65-70®C, waiting Imin followed by |I
centrifuge. DNA was then ethanol precipitated as described in section 2.19.
Î
2 .19. Ethanol precipitation of DNA.
a
■ÿiof 3M sodium acetate pH 7.0 and 2.5 volumes of analar absolute ethanol at -
20®C. The tubes were then placed at -80®C for 30mins before being 3
centrifuged at 13,000 rpm in an MSE microfuge for lOmins. The supernatant
was discarded and the pellet washed with 1ml of 70% (v/v) analar ethanol at -
i
2 0 ® C. The tubes were recentrifuged for 5mins and the supernatant discarded. I
The resulting pellet was dried under vacuum for 15mins then resuspended in f
Ian appropriate volume of sterile Milli Q H 2O.
3
£DNA from the preparation of plasmid DNA described in
t:;section 2 .1 8 .1 . was precipitated at room temperature without the addition of 
3M sodium acetate. I95
DNA obtained from PCR amplification which was to be used in 
automated sequencing was precipitated on ice in the presence of 0.1 volumes 
of 3M sodium acetate, pH 5.2.
2 .20. Quantitation of DNA.
The amount of DNA in a given sample was quantitated by 
measuring the absorbance at 260nm (A260) of a 1:200 dilution of the sample in 
sterile Milli Q H 2O. An A 260 of 1 was assumed to be equal to 50^g/ml of 
double stranded DNA or 20jWg/ml of single stranded oligonucleotide. The 
purity of the DNA was assessed by measuring the A 2 8O in parallel and 
calculating the A260: A 280 ratio. A ratio of approximately 1.8 was considered 
to be sufficiently pure for use otherwise a phenol: chlorofonn extraction was 
carried out as described in section 2 , 2 1 .
2. 21. PhenoI:chIoroform extraction of DNA.
DNA was brought to a volume of 300pi\ with sterile Milli Q 
H2O and 0.5 volumes of both Aquaphenol, pH7.3, and chlorofonn:isoamyl 
alcohol (24:1) was added. The suspension was vortexed for 15secs and 
centrifuged for 2mins at 13,000rpm in an MSE microcentrifuge. The upper 
phase was transferred to a fresh tube and extracted again with 0.5 volumes 
each of aquaphenol and chloroform: isoamyl alcohol and centrifuged as before. 
The resulting upper phase was extracted once with an equal volume of 
chloroform:isoamyl alcohol and again centrifuged. The upper phase was
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ethanol precipitated as described in section 2.20. and the DNA stored at -20®C 
until required.
2. 22. Digestion of plasmid DNA with restriction 
endonucleases.
Plasmid DNA, generally Ipig, was digested in a volume of 
lOpil. The buffer used depended on the restriction enzyme used and was 
supplied with the enzyme as a lOx stock, thus Ipii was used per lOpil digestion. 
Digestion was carried out with 4-10 units of enzyme, depending on the 
concentration of enzyme supplied. One unit was defined as the amount of 
enzyme required to digest IjAg of supercoiled dsDNA in one hour at 37°C. The 
volume was made up to lO/rl with sterile Milli Q H 2 O and the digests 
incubated at 37®C for a minimum of Ihr, although digestion for longer was not 
detrimental and was considered prudent to ensure complete digestion. The 
composition of the buffers used is indicated in table 2. 2. a. and the enzymes 
used in these buffers are indicated in table 2. 2. b.
2. 23. Separation of digested plasmid DNA by 
electrophoresis.
Once digestion was completed, 2/d of loading buffer (30% 
(v/v) glycerol, 0.25% (w/v) bromophenol blue) was added to each tube and 
the samples electrophoresed in an agarose gel. For fragments of >500bp and 
<6 kbp, electrophoresis was on a 0 .8 % (w/v) agarose gel, while for fragments 
of <500bp, the percentage was increased to 1.2% (w/v) agarose. The gel was 
prepared by melting an appropriate weight of agarose in 25ml of IxTAE buffer
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Table 2. 2. Restriction enzyme buffer 
compositions and use by varions restriction 
enzymes.
Restriction endonucleases vary in their buffer requirements and so a panel of 
buffers in supplied commercially to allow the most efficient digestion of DNA 
by various enzymes. Panel A gives the composition of the buffers required by 
the enzymes used during this study while panel B lists the buffers used by 
these enzymes
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Table 2. 2.
A *
Buffer pH(at 37°C)
Tris HCl 
(niM) MgCl2(mM) NaCl(mM) MgOAc(mM)
A 7.5 6 6 6 -
B 7.5 6 6 50 -
C 7.9 10 10 50 -
D 7.9 6 6 150 “
J 7.5 6 7 50 -
M 7.8 25§ - 1 0 0 " 10
NEB 4 7.9t 2 0 § - 50* 10
(mM)
b.
Buffer
A
B
C
D
Enzymes
Apa I 
N hel
Cla I Xho F  
X hol
Buffer
J
M
NEB4
Enzymes
Sac I S ma I 
Sac I Nhe n  
Bsa HI
§ Tris Acetate Potassium Acetate t  at 25°C
Sac I and Nhe I both exhibit full activity in buffer M. This buffer was used only in double digests 
using both these enzymes.
$ Xho I exhibits 75-100% of its full normal activity in buffer C as opposed to its recommended Buffer, 
buffer D. Buffer C was only used in double digests with Cla I.
samples were flanked by a 1 kb DNA ladder.
Following electrophoresis and excision of the desired fragment 
as described in section 2 . 2 2 ., the agarose containing the fragment was melted 
in a heating block (Techne) at 70®C for 5mins. Immediately, 1ml of Promega
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(40mM Tris acetate, ImM EDTA, pH 8.0) in a 700W microwave oven I
(Sanyo) for approximately 90secs. The solution was allowed to cool until it
was hand hot and ethidium bromide was added to a final concentration of
12.5/fg/ml. The solution was poured into the electrophoresis mould containing a 
comb with an appropriate number of teeth (5, 8  or 14) and any air bubbles 
removed with a yellow pipette tip. Once set, the gel was submerged in IxTAE 
buffer and the samples loaded. To allow estimation of the fragment sizes, the
Electrophoresis was carried out, towards the anode, at 75-100 i
mA at room temperature until the bromophenol blue dye front was 0.75 of the 
way along the gel. The fragments were visualised under UV light and 3
photographed.
Occasionally, the fragments were to be purified from the 
agarose, in which case low melting point agarose of an appropriate final 
concentration was used. The samples were electrophoresed at 50mA at 4®C to 
prevent melting of the gel. Following photography, the fragment of interest 
was excised from the gel using a clean scalpel blade and placed in a sterile 
microcentrifuge tube. The gel was photographed again to unsure complete 
excision and that no carry over of unwanted DNA had taken place.
2. 24. Purification of DNA from agarose gels.
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1
1PCR purification resin was added and the contents vortex mixed for 30secs. 3
The resin was put into a Promega mini column attached to a 2ml syringe barrel 3
and the slurry pushed through the column. The resin was washed with 80%
(v/v) isopropanol and the mini column dried by centrifugation and the DNA 3
eluted with preheated sterile Milli Q H2 O as described in section 2. 18. 2. The
purified DNA was stored at -20®C until required.
2. 25. Phosphatase treatment of DNA fragments.
In some of the subcloning experiments (see C h ap te r S), DNA
fragments containing an antibiotic resistance marker could theoretically self |
«■s.
ligate, thus causing false positive transformants later. To prevent this, such
.1fragments were treated with CIAP to remove the 5' phosphate group required
by DNA ligase. CIAP was supplied with buffer as a lOx stock, so 0.1 final vol 3
III
of buffer was added to the linearised DNA fragment obtained in sections 2. 22 
. and 2. 23. 0.5units of CIAP was added and the volume made up to that 
required with sterile Milli Q H2 O. The final Ix buffer concentration was
50mM Tris HCl, pH9.0, ImM MgCl2 , 100/^M ZnCl2 , ImM spermidine. One 
unit of CIAP catalysed the hydrolysis of Ijwmole of 4-nitrophenyl phosphate Iper minute at 37®C in diethanolamine buffer, pH9.8.
The reaction was carried out at 37®C for 30mins at which point |
SDS and EDTA were added to final concentrations of 0.5% (w/v) and 5mM 
respectively. The reactions were heated to 75®C for lOmins before being iS
cooled to room temperature. As CIAP is an extremely hardy enzyme, not all
ji'ithe enzyme may have been inactivated by this treatment, so subsequently, a 
phenol:chloroform:isoamyl alcohol extraction was carried out as described in
:
!
section 2. 18. 1. followed by ethanol precipitation as described in section 2. 
19.
2. 26. Filling in of 5' overhangs to create blunt 
ends.
%
3
,3The large fragment of mammalian DNA polymerase I (Klenow 
fragment) can be used to fill in a 5' overhang of digested DNA to create a blunt :end. DNA obtained from sections 2. 21., 2. 22 and 2. 23. was treated as ,srecommended by the supplier. Buffer, prepared as a 5x stock (250mM Tris 
HCl, pH 7.2, 50mM Mg SO4 , 500/<M DTT) was added to the DNA to the
Irequired final concentration, 2.5units of Klenow polymerase, and sterile Milli
3; '
Q H2O were added to the required final volume. One unit of enzyme was 
defined as the amount required to catalyse the incorporation of lOnmoles of 
deoxyribonucleotides into TCA insoluble form at 37®C under the following 
conditions: 67mM potassium phosphate buffer, pH7.5, 6.7mM MgCl2 , ImMp-
3:3mercaptoethanol, 133/<M activated calf thymus DNA, 33//M dATP, 33/<M y
.:'ydTTP and enzyme.
The reaction was carried out at 37®C for SOmins before being 
terminated by heating to 75®C for lOmins. A phenol:chloroform:isoamyl
::;3alcohol extraction was then carried out as described in section 2. 18.1.
.,'-1
1
2.27. Ligation of DNA fragments.
The desired fragments of plasmid vector and insert were ligated 
together to produce recombinant plasmids ready for further subcloning or
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mutagenesis. T4 DNA ligase was used as this has the ability to catalyse the 
ligation of blunt ended DNA, something E.coli DNA ligase cannot. Three 
reactions were generally set up, varying the molar ratios of vector:insert DNA.
21.
2.28. Phosphorylation of oligonucleotides.
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Normally 1:1, 1:5 and 1: 10 ratios were considered. The required volumes of
gvector and insert DNA were added to sterile microcentrifuge tubes and the 
required volume of lOx ligase buffer added. Hexamine cobalt chloride was
added at a final concentration of 1/tM. 1.5 Weiss units (for sticky ended 
ligations) or 3 Weiss units (for blunt ended ligations) was added and the |
volume made up with sterile Milli Q H 2O. Ligation was carried out overnight 
at 4®C and transformation carried out as described in section 2 .1 6 .1 . J
Following transformation, the E. coli were grown up and 
plasmid DNA prepared as described in section 2. 18. 1., the presence of the
'3insert was assessed by restriction enzyme analyses as described in section 2.
I
500/d of deprotected oligonucleotides, supplied in aqueous 
NH 4OH, were dried under vacuum in an RC 10.22 centrivap refrigerated
'isolvent trap (Jouan) for 3hrs. The pellet was resuspended in 20/d of sterile 
Milli Q H2O and dried under vacuum as described in section 2. 20. and Iresuspended again in 20/d of sterile Milli Q H2 O. 5/d of this was |
aphosphorylated in the presence of 16 units of T4 polynucleotide kinase in a T
buffer consisting of 70mM Tris HCl, pH 7.6, lOmM M gC^, 5mM DTT
3;supplemented with ImM ATP. Phosphorylation was carried out at 37®C for 
2hrs after which time the reaction was terminated by heating to 75® C for
: .3.À.: : ...........     . ;
I
lOmins followed by phenol chloroform extraction of the phosphorylated 
oligonucleotide as described in section 2. 22.
2.29. Site-directed mutagenesis by PCR.
§ The annealing temperature was calculated to be 5°C lower than the melting temperature of 
the ohgonucleolides.
25ng of DNA was added to a tube containing 250/fM dNTP and 
25pmoles each of sense and antisense oligonucleotides (see Chapter 5). The 
buffer consisted of a final concentration of 20mM Tris HCl, pH 8.2, lOmM 
KCl, 6 mM (NH4 )2S0 4 , 2mM M gC^, 0.1% Triton X-100, 10/<g/ml BSA. The
'>3
Î
volume was made up to 50/tl with sterile H2O and the samples overlayed with 
light mineral oil. The tubes were preheated to 94®C for lOmins before 5 units 
of Pfu DNA polymerase were added. The PCR reaction was carried out on a 
Hybaid Omni gene temperature cycler. The cycles consisted of 94® C for 42secs 
(dénaturation), annealing for 60secs (see footnote^) , and 72®C for lOmins
:(extension), for SOcycles. 5/d of the amplified DNA was then analysed on an 
0.8% agarose gel. The oligonucleotides used are indicated in table 5.1.
The desired fragment of DNA was excised from an 0.8% low 
melting point agarose gel, purified, ligated and transformed into JM109 E.coli 
as described in sections 2. 25, 2. 28 and 2. 19. 2. To prevent excessive 
sequencing, a small fragment spanning the mutated region was subcloned into 
wild type vector.
103
2 .30. Sequencing of plasmid DNA.
2. 30. 1. PCR sequencing of double stranded 
DNA.
Sequencing was carried out by the dideoxy method using the 
Applied Biosystems Amplitaq Dyedoexy terminator cycle sequencing kit 
following the manufacturers instructions. Ipig of double stranded template 
DNA and 3.2pmol of primer were added to 500/d microcentrifuge tubes 
containing 9.5/d of reaction mix (4/tl of 5x TACS buffer, 1//1 of dNTPs, Ipii 
each of Dyedeoxy A, Dyedeoxy T, Dyedeoxy C and Dyedeoxy G terminators 
and 0.5/d of Amplitaq DNA polymerase). The volume was made up to 20/d 
with sterile Milli Q H2O and one drop of light mineral oil was overlaid onto 
the reactions. The DNA was amplified on a Hybaid Omni gene temperature 
cycler, by cycling, for 30 cycles, at 94®C (dénaturation) for 30secs, 50®C 
(annealing) for 50secs and 70®C (extension) for 4mins.
2. 30. 2. Extraction of amplified sequencing 
DNA.
Following cycling reactions, the amplified DNA was extracted 
by adding 90/d of sterile Milli Q H 2 O to the lower aqueous phase and 
transferring 105/d of this to a fresh tube. The DNA was separated from the 
terminators by extracting twice with 100/d of Applied Biosystems 
phenol : water: chloroform reagent, first removing 105/d of the upper aqueous 
phase and second 93/d of the aqueous phase. The DNA was precipitated with 
analar absolute ethanol as described in section 2. 19. and the resulting dry
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pellet either stored at -2 0 ®C until required or resuspended in formamide and 
run on the Applied Biosystems 373A DNA sequencer within a few hours.
2. 30. 3. Polyacrylamide gel electrophoresis of 
sequencing DNA.
Sequencing DNA was analysed on 0.5mm polyacrylamide slab 
gels using Sequagel 6 . The Applied Biosystems gels plates were washed twice 
each with Alconox detergent, sterile Milli Q H2O and analar ethanol and the 
spacers (0.5mm) placed between the two. 60ml of Sequagel 6  acrylamide 
solution was mixed with 15ml of buffer solution and the whole polymerised 
with 600/d of 10% (w/v) ammonium persulphate. This was quickly added to 
the plates and any bubbles removed with a Promega bubble getter. The gel was 
allowed to cure for at least 2hrs before being scanned and pre-run, in IxTBE 
buffer (90mM Tris borate, 2mM EDTA, pH8.3) , in the Applied Biosystems 
373A automated DNA sequencer according to the manufacturers instructions. 
Immediately prior to loading, the samples in formamide were heated to 90®C 
for 2 mins and subsequently loaded in alternating fashion as described by the 
manufacturer. The gel was run overnight at 1200V and the data collected and 
analysed on an Apple Macintosh Ilci microcomputer.
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Separation of closely related G protein a  
subunits by SDS-PAGE.
::£
Chapter 3.
___ _ _ ____  . . _ .___ .
'3
î
This approach of using pertussis toxin as a label for a  subunits 
has one drawback; only some a  subunits are targets for its enzymatic action.
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Chapter 3. 
Separation of closely related G protein a  
subunits by SDS-PAGE.
y
3.1. Introduction.
The high degree of amino acid sequence homology between G 
protein a  subunits has led to many difficulties in studying these proteins in
, .
isolation. Initial studies involving the use of an exotoxin from Bordetella 
pertussis, the causative agent of whooping cough, simplified the study of G 
proteins, as it could specifically modify members of the G\ family of a  
subunit proteins [Katada & Ui, 1982a; Katada & Ui, 1982b; Van Dop, et al.,
1984; Manning et al., 1984; Sternweis & Robishaw, 1984; Neer e ta l., 1984;
Milligan & Klee, 1985], adding ADP-ribose from NAD+ to a cysteine residue 
near their C terminus [West et al., 1985]. These a  subunits have very similar 
Mr values and the degree of separation achieved under standard 10% SDS- 
PAGE is small ; indeed G n a , Gi2cx and Gig a  all run as an apparent single 
protein species under these conditions. SDS-PAGE conditions do exist to 
allow separation of these a  subunits from each other and GqCx. Here 12.5% 
acrylamide is employed in a matrix with a lower amount of N,N’-methylene
bisacrylamide (0.0625%). Under these conditions G iia  and Giga run as a 
single band, Gi2a  migrau 
Go« migrates fastest of all
tes slightly more rapidly through the matrix, while
Only members of the Gi subfamily of a  subunits, with the exception of G^a, 
are substrates. All other a  subunits are insensitive to its actions.
The next advance in studying G protein a  subunits was the 
advent of antisera as specific probes for the various components. Initial studies 
using antisera targeted against purified proteins were less successful than 
subsequent studies employing antisera raised against short peptides derived 
from the primary amino acid sequences of the subunits [Milligan, 1990]. These 
sequences were made available from cDNA clones isolated from a number of 
sources.
These antisera were, and still are, very effective in detecting 
specific subunits. However these antisera are not infallible. Cross reaction 
between antisera derived against a sequence from one a  subunit which also 
recognises the a  subunit of a closely related a  subunit has sometimes been 
responsible for a certain ambiguity in interpreting results. For example the C- 
terminal decapeptide of G ^ a  was employed as a target antigen but the 
resulting antiserum also recognised the a  subunit of GoCt, possibly due to the 
presence of a tyrosine residue at the extreme C terminus [Milligan, 1990]. This 
problem can be overcome by using the 12.5% acrylamide/0.0625% 
bisacrylamide gel conditions mentioned above. These conditions however 
cannot separate Gqoc from G n a , two highly homologous a  subunits of the Gq 
family which are both thought to couple to the phosphoinositidase C catalysed 
hydrolysis of phosphatidylinositol-4,5-bisphosphate. The C-terminal 
decapeptides of these a  subunits are identical and the antisera raised against 
the C terminal decapeptide of Gqcc recognises G n a  equally [Mitchell et al., 
1991]. Attempts to raise antisera to specific regions of these polypeptides in
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our laboratory has met with mixed success, as have efforts to raise antisera to 
specific splice variants of GqCx.
We have therefore attempted to overcome this problem by 
developing SDS-PAGE conditions to separate Gqoc from G n a  and to separate 
splice variants of G oa in order that we could study them using the antisera 
available. To do this we have modified the method of Scherer et a l ,  [1987] 
and Godina et a l ,  [1991]. These workers employed a linear 4M-8M urea 
gradient incorporated into the acrylamide matrix of the gel. We have modified 
this to use the 12.5% acrylamide/0.0625% bisacrylamide conditions mentioned 
above. In this chapter we set out to demonstrate the use of these SDS-PAGE 
conditions in the analysis of Gqa, G n a  and G ga.
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3 .2 . Results.
3. 2. 1. Separation of pertussis toxin substrates 
on urea containing polyacrylamide gels.
35/tg of rat brain cortex membranes, prepared as described in 
section 2. 3. 1. were electrophoresed on an polyacrylamide gel containing a 
linear 4M-8M urea gradient in the 12.5% acrylamide/0.0625% bisacrylamide 
gel matrix, as prepared in section 2. 6. 2. These gels were transferred to 
nitrocellulose and probed with antipeptide antisera designed to recognise G iia  
and Gi2a  (SGI), Go« (IM l), G o ia  (OlA) and Go20t (AS201). Immunoblots 
were developed as described in section 2. 8. 3. and are displayed in figure 3. 
1. a.
Anti serum SGI recognised two immunoreactive bands. Since 
expression of G ta  is restricted to the retina, these polypeptides must represent 
G ita  and Gi2a .  As G n a  has a higher molecular weight, it is likely that the 
slower migrating band represents G n a  and the more rapidly migrating band is 
Gi2a . Indeed when rat brain cortex membranes were electrophoresed under the 
same conditions with plasma membranes of the NG108-15 neuroblastoma x 
glioma hybrid cell line, which are known to lack immunologically detectable 
G ita  [McKenzie & Milligan, 1990a], the single SGI reactive band in these 
membranes migrated with the more rapidly migrating band in rat brain cortex 
membranes (figure 3 .1 . b.) indicating that this was indeed Gi2a .
In figure 3. 1. a. an d  c. antiserum IM l recognised three 
polypeptides. As the antiserum directed against the Go2 «  splice variant
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(antiserum AS201) recognised the most rapidly migrating band (figure 3. 1. 
c.), this must represent the Go2«  splice variant. The slowest migrating band 
was assumed to represent the G o*a form of the protein described by 
Goldsmith et al. [1988] and Mullaney & Milligan [1990]. The broad centre 
band was thought to represent the Goict splice variant.
The antiserum raised to a peptide predicted from the cDNA 
sequence of G o i«  (antiserum OlA) to specifically recognise this splice variant 
[Hsu et al., 1990; Strathmann, et al., 1990] identified the broad Gqicx band and 
the slowly migrating Gq^oi polypeptide [Goldsmith et al, 1988; Mullaney & 
Milligan, 1990], but not the most rapidly migrating polypeptide which 
represents Go20t- The O lA  antiserum also produced a doublet from the Gqioc 
band. IM l, the other Gqcx anti serum which was predicted not to distinguish 
between GoCt splice variants, could not resolve the G oia band into this doublet 
perhaps due to the intensity of the staining of the two bands causing an 
overlap. Indeed if only 15/^g of rat brain membranes were electrophoresed 
under identical conditions and probed with antiserum IM l ( f ig u r e  3 . 1. d .) , a 
faint shadow could be seen under the Gqioc band. The nature of this doublet is 
unknown but proteolysis of the proteins can probably be excluded as there is 
no shadow under either of the bands corresponding to Gq^oc or Gq2«  and 
similar proteolysis of G o ia  and would be expected as they are similar at 
both the extreme N and C termini.
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Figure 3 .1 . Separation of Gi family members on 
urea gradient SDS PAGE.
In panel A, 35/tg of rat brain cortex membranes were subjected to urea 
gradient SDS-PAGE (lanes 2, 4 and 6 , separated by prestained lactic 
dehydrogenase in lanes 1, 3 and 5) and probed with antisera IM l, O lA  and 
SGI (lanes 1-3, 3-5 and 5-6 respectively) at dilutions of 1:400, 1:200 and 
1 :1 0 0 0  respectively.
To determine which of the two SGI reactive polypeptides represented G iia  
and which represented G 12a , lOOpg of membranes from NG108-15 cells 
(panel B, lane 1) were electrophoresed under identical conditions with I5pg  
and 35}4g of rat brain cortex (panel lanes 2 and 3 respectively). The 
resulting immunoblot was probed with SGI at a dilution of 1:1000.
To determine which of the three IM l reactive polypeptides represented Gq2«, 
35pig of rat brain cortex (panel c, lane 1) was electrophoresed with 200pg of 
rat brain cortex membranes (panel c ,  lane 3). The resulting immunoblot was 
probed with antiserum IM l at a dilution of 1:400 and with antiserum AS201 at 
a dilution of 1:100 (lanes 1-2 and 2-3 respectively). Lane 2 contained 
prestained lactic dehydrogenase as a marker.
The presence of a Gq la  doublet was determined by electrophoresing lOjdg 
(panel D, lane 1 and 30j4g (panel D, lane 2) under urea gradient SDS-PAGE 
conditions and probing the resulting,,immunoblot with antiserum IM l at a 
dilution of 1:400.
I l l
The mobility of the 37.5kDa marker is indicated and the identities of the 
polypeptides in panels B to D' are shown. These immunoblots are 
representative examples of 3 separate experiments.
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3. 2. 2. NG108-15 cell membranes contain only 
G oia and Go2Cx.
In figure 3. 2., different amounts of rat brain cortex membranes 
and plasma membranes from NG108-15 cells were electrophoresed as 
described in section 2. 6. 3 ., transfened to nitrocellulose and immunoblotted 
with antiserum IM l as described in section 2, 8. It can be seen that while 
Go*a, G oi« and Go2«  were present in rat brain cortex, as previously seen in 
figure 3. 1., only Goict and Gq2 «  were detected in membranes of NG108-15 
cells. This observation has previously been noted by Mullaney & Milligan 
[1990].
3. 2. 3. Differential expression of Go a  splice 
variants in rat brain regions.
Membranes of a series of rat brain regions were prepared and 
kindly donated by Dr. Christine M. Brown (Syntex Research Centre, 
Riccarton, Edinburgh, UK) and electrophoresed in urea gradient containing 
SDS-PAGE. As shown in figure 3. 3. a., differential expression of Go« splice 
variants was detectable in these rat brain regions. All regions contained 
detectable levels of G o ia  and Gq2 0 l but the relative expression of these 
polypeptides varied between the regions. Some areas contained no detectable 
Go*a immunoreactivity. Quantitation of a series of such immunoblots is 
displayed in figures 3. 3. b., c. and d. Expression of the Go*a splice variant 
was undetectable in membranes prepared from olfactory bulb and the frontal 
cortex, indeed expression of total Ggct was reduced in these two regions 
compared to that observed in other regions. The expression of Go*« was very
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Figure 3. 2. NG108-15 cell membranes contain 
only G oia  and Go2cu
30/<g of rat brain cortex membranes (lane 1) were electrophoresed under urea 
gradient SDS-PAGE conditions with 100;^g of NG108-15 cell membranes and 
the resulting immunoblot probed with anti serum IM l at a dilution of 1:400. 
The identities of the immunoreactive polypeptides are displayed. This 
experiment is a representative example of 3 separate experiments.
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Figure 3.2
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Figure 3 .3 . Differential patterns of Goa isoform 
expression in rat brain regions.
Panel A depicts a representative immunoblot of urea gradient SDS-PAGE 
analysis of 5pig of rat brain cortex membranes (lane 1) together with 5//g each 
of membranes from olfactory bulb (lane 2), frontal cortex (lane 3), parietal 
occipital cortex (lane 4), caudate putamen (lane 5), globus pallidus (lane 6 ), 
hippocampus (lane 7), thalamus (lane 8 ), hypothalamus (lane 9), pituitary (lane 
10), optic chiasma (lane 11) and cerebellum (lane 12). Immunoblots were 
probed with anti serum IM l at a dilution of 1:400. The identities of the 
i mm unreactive polypeptides and the mobility of the 37.5 kDa marker are 
shown.
Panels B C and D show the quantitative analyses of 3 such experiments for 
Go*a, Go la  and Gq 2Ct respectively The optical density of each 
immunoreactive polypeptide, corrected for amount of protein, was plotted 
against brain region. Results are shown as the mean ± SEM of these 3 
experiments.
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low in most areas of the brain with the exception of crude cortex membranes 
and membranes from the cerebellum. G o ia  expression was relatively high in 
crude cortex, cerebellum, hypothalamus and parietal occipital cortex. The 
expression of Go2a  in olfactory bulb was higher than in some other regions, 
and Go2a  expression was increased relative to other variants in the caudate 
putamen. Overall, the relative expression of G oa splice variants was
G o ia > G o 2 a > G o * a .
3. 2. 5. Regulation of G oa splice variant 
expression in NG108-15 cells.
Treatment of NG108-15 cells with agents which increase 
intracellular levels of cAMP such as nonhydrolysable cAMP analogues, for 
example dibutyryl cAMP, forskolin or agonists of adenylyl cyclase coupled 
receptors such as prostaglandin Ei (PGEi) acting at an IP prostanoid receptor, 
cause these cells to differentiate into neurone-like cells [Mullaney & Milligan, 
1989]. This differentiation produces a characteristic morphological change in 
these cells [Mullaney & Milligan, 1989]. The cells lose their rounded shape 
and flatten out. Neurone-like processes appear which form synaptic 
connections with each other.
NG108-15 cells were differentiated with 10/<M forskolin as 
described in section 2. 2. 6., membrane fractions prepared and analysed on 
urea gradient containing SDS-PAGE and probed with antipeptide antisera 
against G 02a  and all Go a  splice variants. Figure 3. 4. a. showed how the 
expression of G oa spliee variants of ehanges following differentiation. An 
increase in G o ia  expression and a lesser or negligible increase in Go2a
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expression was seen following forskolin treatment. These changes were 
quantified on a Bio Rad imaging densitometer and the results displayed in 
figure 3. 4. b. These indicated an approximately 200% increase in Goiot 
expression and an approximately 150% increase in Go2«  expression.
3. 2. 6. Urea containing SDS-PAGE can separate 
Gqa from Gllou
The phosphoinositidase C linked G protein a  subunits G qa and 
G lia  share 8 8 % homology at the amino acid level. They have 359 amino 
acids, as deduced from their cDNA sequences, and are both 42kDa in size as 
assessed by SDS-PAGE [Mitchell et al,, 1991]. This presents problems in 
designing antipeptide antisera with significant selectivity in discerning these 
two polypeptides. While an anti serum against their C termini has a high titre, it 
cannot distinguish between the two a  subunits [Mitchell et at., 1991]. Analysis 
of the primary amino acid sequence indicates few regions of the polypeptides 
which are significantly divergent to create more specific antisera. An attempt 
was therefore made to separate these two polypeptides by SDS-PAGE such 
that the antipeptide anti serum raised to their common C terminus would be a 
sufficient means of immunological detection.
When membranes of rat brain cortex were electrophoresed 
under urea gradient SDS-PAGE conditions as before and resultant 
immunoblots probed with the antipeptide anti serum CQ2, raised against the 
common C terminus shared between G qa and G n a ,  three immunoreactive 
bands were seen (figure 3. 5. a.).
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Figure 3. 4. Regulation of Goa splice variant 
expression in NG108-15 cells.
Panel A shows a representative immunoblot from rat brain cortex membranes 
{25}i% in lane 1 and 150/tg in lane 5), control NG108-15 cell membranes 
(50j4g in lane 2 and 150/<g in lane 6 ) and forskolin differentiated NG108-15 
cell membranes (50pig in lane 3 and 150/tg in lane 7) which had been analysed 
on a 4M-8M urea gradient polyacrylamide gel as before. Lane 4 contained 
prestained molecular weight markers. The resulting immunoblot was probed 
with antiserum IM l at a dilution of 1:400 (lanes 1-4) or antiserum AS201 at a 
dilution of 1:100 (lanes 4-7).The position of the 37.5kDa marker is shown, as 
is the identities of the immunoreactive polypeptides.
Quantitation of this experiment is shown in panel B The percent increase in 
the optical density of differentiated NG108-15 cell membranes, compared to 
control cell membranes, for each immunoreactive band was plotted against the 
identity of the band and the antiserum used to detect it.
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If samples were instead immunoblotted with the Gq« selective 
anti serum IQB only one band is observed (figure 3, 5. b.), the fastest 
migrating polypeptide not being observed. This indicated that this fastest 
migrating polypeptide probably represented G net while the slowest migrating %
àband represented Gqct. The nature of the polypeptide with intermediate 
mobility is unknown. It does not represent proteolysis of the proteins as G n a  
does not have a similar immunoreactive band beneath it and preparation of the
■t ';:samples in the presence of protease inhibitors does not prevent its detection ÿ
T[Milligan et a l,  1993]. |?i
3. 2. 7. Urea containing SDS-PAGE can discern 
between species variants of Giiou
Recently it has been demonstrated that a modified procedure for ;
urea containing SDS-PAGE can not only separate Gqu from G n a  but can also Idiscern between speeies variants of G ^ a  [Kim & Milligan, 1994]. I
fThis system was used to separate murine G n a  from primate
■/ -
G n a . Figure 3. 6 . demonstrates that if mouse brain cortex membranes and 
plasma membranes from simian COS-1 cells were eleetrophoresed on a 
polyaerylamide gel consisting of 10% acrylamide/0.24% bisacrylamide gel 
matrix eontaining 6 M urea as described in section 2. 6 , 3., murine G n a  
migrated more rapidly through the matrix than its simian equivalent. |
Figure 3. 5. Separation of Gqa and G n a  using 
urea gradient SDS-PAGE.
In panel A 40/<g (lane 1) and 20pig (lane 2) of CHO cell membranes, kindly 
prepared by Dr. I Mullaney, Division of Biochemistry and Molecular Biology, 
IBLS, University of Glasgow, were electrophoresed on a 4M-8M urea gradient 
SDS-PAGE gel as before and the resulting immunoblot probed with antiserum 
CQ2 at a dilution of 1:1000.
In panel B 40 jig of CHO cell membranes were electrophoresed on a urea 
gradient SDS-PAGE gel as before and probed with either anti serum IQB at a 
dilution of 1:200 (lane 1) or CQ2 at a dilution of 1:1000 (lane 2).
The identities of the immunoreactive bands are shown.
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Figure 3. 6. Separation of species variants of 
G n a  on urea containing SDS-PAGE.
40/^g of mouse brain membranes (lane 2), kindly prepared by Mr. G.-D. Kim, 
Division of Biochemistry and Molecular Biology, IBLS, University of 
Glasgow, were electrophoresed with membranes of untransfected COS-1 cell 
membranes (lane 3) or with membranes of COS-1 cells which had been 
transiently transfected with mouse G n a  in the mammalian expression vector 
pCMV (lane 4). Lane one contained prestained lactic dehydrogenase marker. 
The subsequent immonoblot was probed with antiserum CQ2 at a dilution of 
1:1000. The mobility of the lactic dehydrogenase marker and the identity of 
the immunreactive polypeptides are indicated. The question mark indicates a 
polypeptide of unkown identity.
The band visible beneath murine G ila  in lane 4 is thought to 
represent a truncated "read through" translation product.
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3 .3 . Discussion.
The high degree of similarity between G proteins has led to 
some difficulty in studying sections of the superfamily, especially if members 
are closely related as is the case for G qa and G n a  or the gene responsible for 
their production undergoes alternate splicing to create more diversity such as 
Gga and G oa.
As demonstrated in this Chapter, urea gradient containing SDS- 
PAGE conditions can be employed to give considerable separation of the only 
other G protein a  subunits known to be derived from a single gene and to 
undergo alternative splicing, GqCx. In rat brain cortex membranes 3 forms of
This tissue specific control of expression can be modelled in the 
neuroblastoma x glioma hybrid cell line NG108-15. These cells express no
122
ilVariants which arise from the splicing of the Gga mRNA are 
relatively easily discerned as they vary considerably in size due to the addition 
of an entire exon (exon 3) in the long form of the protein. This addition 
represents 15 amino acids and approximately 1.5kDa [Kaziro, e ta l ., 1990]. 
This difference has yet to have a functional significance assigned to it, even 
though there is a different expression pattern of the splice variants in various 
cell types and tissues.
the protein can be discerned under these conditions and, similarly to Gga, the
liexpression of these splice variants is under some form of tissue specific 
control as some variants are more highly expressed in some regions of the rat 
brain than others (figure 3.4. a.).
___________
Milligan [1990].
detectable Go*ct but do express considerable levels of the other two splice g
.1variants detectable under these SDS-PAGE conditions. These cells can be finduced to differentiate into neurone-like cells upon chronic treatment with
.icAMP elevating agents such as the diterpene forskolin [Mullaney et al., 1988;
Mullaney & Milligan, 1989]. If one follows the expression of GqO splice S
variants upon differentiation, we can see a concomitant increase in the
expression of the G o i«  splice variant with a lesser change in the expression of "Ithe Gq2«  splice variant. Similar results have been noted by Mullaney &
Complementary DNA molecules representing 2 splice variants 
of Go a  were first identified by Hsu et aU, [1990] and Strathmann et al.,
[1990]. Previously, heterogeneity of G q» had been demonstrated by SDS- 
PAGE and chromatographic analyses [Scherer et al., 1987; Goldsmith et al.,
1988]. Four forms of Go a  have been purified from bovine brain by Mono Q 
column chromatography [Kobayashi et aL, 1989]. Analysis of the kinetic 
parameters of the GTPase activities of these four forms indicated differences Iin their Km and Vmax values [Inanobe et al., 1990]. It is unknown which of 
these forms corresponds with the splice variants reported here and by others.
Inanobe et al., 1990 speculated that these different forms may represent a 
covalent modification of both of the G o i«  and Go2 0  polypeptides, thus
screating four proteins with distinct properties [Inanobe et at., 1990]. Exactly
%where Go* a  fits into this scheme is unclear. A third isoform of Go a , which
Breacts with a G o ia  directed antiserum has been identified in rat brain
membranes analysed on urea containing SDS-PAGE [Spicher et al., 1992].
MThis form of G oa is not G o*a however and has been termed Gosoc [Numberg 
et al., 1994]. Spicher et al. [1992] also postulated that post translational
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modification of the three forms could give rise to six forms detected 
electrophoretically.
The functional significance of the alternate splicing of Go a  
mRNA is a little clearer than that for the splice variants of Ggoc. Kleuss et al.
[1991] employed antisense oligonucleotides specific for Gq icc and Gq2«  in an 
attempt to assign specific functions to one or other of the splice variants 
expressed in the rat pituitary tumour cell line GH3 . Using this technique they 
determined that the G o ia  splice variant could couple to a muscarinic 
acetylcholine receptor but not to the somatostatin receptor while the converse 
was true of the Go2«  splice variant. As the G oa mRNA is spliced near what 
will become the C terminal region of the proteins [Hsu et al., 1990 and 
Strathmann et al., 1990], this result is not surprising as the C terminal region is 
thought to be the receptor contact site.
The splice site is also close to the putative effector interaction 
site and so differences may exist in the coupling of the G oa splice variants to 
effector systems. The classical effector to which Go couples is the inhibition of 
opening of the N-type Ca^+ channel [Hescheler et al., 1987]. It has been 
demonstrated, by microinjection of purified, activated Goiot and Go2Ct into 
neuronal somata of the pond snail Helisoma trivolvis, that only the Go2a  
polypeptide is capable of inhibiting a pertussis toxin sensitive, voltage 
sensitive Ca^+ current. The activated Goioc protein could not inhibit this Ca^+ 
current [Man-Son-Hing et al., 1992]. This again may reflect the different 
amino acid composition at the splice site such that this area is not recognised 
by the N-type channel, giving an insight into the effector activating regions of 
the G oa protein. However, it has been recently demonstrated that Gq l a  is
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indeed capable of inhibiting Ca^+ conductance in transfected cells. This may 
reflect a more physiological environment for the a  subunit [Charpentier et aL, 
1993].
Developmental regulation of the expression of Goicx and Gq2«  
splice variants in neonatal rat brain, similarly to those reported for NG108-15 
cells [this study and Mullaney & Milligan, 1990], has been demonstrated 
[Rouot et aL, 1991]. Over the time course studied (from the 15th day of 
gestation to 30th day post partum), the expression of the G o ia  variant 
increased, while the expression of the Gq2«  variant decreased. Taken together 
these pieces of information indicate another level of regulation of the 
signalling pathways involved in neuronal Ca^+ signalling. This differential 
regulation of expression of G oa splice variants may stem from a distinct 
metabolism of the two protein species. It has been previously noted that the 
rates of degradation of two G oa splice variants changes upon differentiation of 
neuroblastoma cells [Brabet a/., 1991].
Overall, there seems to be different levels of the Gqo splice 
variants in different tissues and cell types. As described here, areas of the rat 
brain have varying levels of the splice variants. In addition, various cultured 
cells vary in expression of G oa isoforms [Asano et aL, 1992].
It would be interesting to see how the changes in expression of 
the Goct splice variants relate to the development of the brain in general. Does 
expression of other parts of the Go-linked signalling cascade change in 
response to developmental stimuli?
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When rat brain cortex membranes were electrophoresed on urea 
gradient containing SDS-PAGE, three immunoreactive polypeptides were 
observed. The fastest migrating polypeptide is G n a ,  as the polypeptide is not
Another group has also recently reported a method for the 
separation of G qa and G n a  [Blank e ta l ,  1991], They employed an imidazole
The a  subunits of the phosphoinositidase C linked G proteins 
Gq and G n  share 8 8 % identity at the amino acid level and possess few linear 
regions useful for the production of selective antisera. A G qa selective 
antipeptide antisera, IQB, which does not identify G n «  has been generated, 
but one which can selectively identify G n «  has not been generated in this 
laboratory, even if the peptide sequence used was identical to that successfully 
employed by other groups [G. Milligan, personal communication]. We 
therefore attempted to separate G qa from G jia  such that we could use the 
non selective antiserum CQ2, which was raised against the predicted C 
terminal decapeptide of G qa, to detect G qa and G n a  independently.
recognised by antiserum IQB, which was raised against an internal sequence of 
G qa specific for that a  subunit. The slowest migrating polypeptide is therefore 
Gqa. Also purified G qa migrated with the slower moving species while 
purified G n a  migrated with the fastest migrating species [Milligan et aL, 
1993]. The nature of the polypeptide with the intermediate mobility is unclear. 
It does not represent a proteolytic clip of G qa as preparation of membranes in
, v : - ;the presence protease inhibitors did not eliminate its presence [Milligan et aL,
1993]. It may represent G 14a , another member of the Gq family of a  subunits, 
as the antisera employed in this study could theoretically cross react with 
G 14a .
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buffer system in a 13% acrylamide gel to achieve this separation. In the hands 
of our group, this method achieves a lesser degree of separation and is not as
reproducible as the urea gradient method employed here [Milligan et aL,
if1993]. fI
Recent work from our laboratory has demonstrated that G n a  fl
from different species can be separated from each other and from G qa [Kim &
Milligan, 1994]. This method employed a 10% acrylamide matrix into which 
6 M urea had been incorporated. It is technically less demanding than the urea 
gradient method previously employed and allows examination of exogenous 
G n «  which has been transfected into a suitable cell type. This is an very 
powerful technique given that the species of G n «  shown in figure 3. 6 ., 
namely mouse (rodent) and simian (primate) have so few amino acid
Idifferences that production of selective antisera is impossible. Indeed murine îf
and human (also primate) G n a  differ in only 9 amino acids over their entire | |
lengths.
fi:
Other groups have employed another technique to examine 
members of the Gq family of a  subunits. Bourne and co-workers i
[Wedegaertner, et aL, 1993], and Johnson and co-workers [Qian et aL , 1993] I'have created Gna cDNAs into which a peptide tag sequence has been inserted. ÏThis sequence encodes a stretch of amino acids recognised by a commercially 
available monoclonal antibody to the haemagglutinin protein (HA) of the 
human influenza virus. As this sequence is not present in the wild type
'?polypeptide, detection of transfected mutated G qa with the anti-HA antibody â
B;:will exclude any wild type G qa  or G n a .  Although this technique has 
apparently no effect on the function of a protein bearing this tag [Levis &
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different species variants of G n a  allows us to compare members of the Gq 
family without the need to mutate the wild type protein.
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Bourne, 1992; Wedegaertner, et aL, 1993; Qian et aL, 1993], the possibility
;
■■■=■'Still exists that insertion of the HA-tag sequence may affect some, as yet 
undefined, capacity of the polypeptide. The use of urea gels to separate
■.'"if%
I
Upon examination of figure 3. 1. a., it can be seen that the 
pertussis toxin substrates do not migrate according to the sizes reported for 
them by conventional SDS-PAGE or by analyses of their reported amino acid 
sequences. While G ^ a  and Gi20c, which are both approximately 40kDa in size, 
migrate according to their relative sizes, i.e. Gj2a  migrates faster than the
■larger G iia , G o ia  and G o2a  co-migrate with them despite being only 
approximately 39kDa in size. Indeed the prestained lactic dehydrogenase used 
to follow their mobility through the gel also migrates with G protein a  
subunits despite being only approximately 37kDa. Urea containing gels 
therefore do not separate protein purely on the basis of their sizes. The 
function of urea in such systems is to abolish hydrophobic interactions of 
polypeptides. Thus although there are so few amino acid differences between 
G qa splice variants and between G qa and G n a ,  these differences alter the 
level of hydrophobicity of the polypeptides sufficiently to allow their 
separation on such urea containing gels.
The use of urea gels to separate G proteins with identical 
electrophoretic characteristics is a very useful tool in addressing several 
questions. It allows the specific identification of G qa isoforms and the 
concurrent measurement of G qa and Gi l a . More importantly for this study, 
the ability to simultaneously detect two species variants of G n «  allows us to
..1
transfect the cDNA encoding murine G n a  1 into simian COS-1 cells. We can 
therefore go on to examine mutants of the protein in isolation.
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The effect of chemical and m utational 
depalmitoylation on G oia function.
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:SI
The effect of chemical and m utational 
depalmitoylation on G ot» function.
4 .1 . Introduction.
130
Chapter 4
The role of lipidation of intracellular proteins has been a 
contested point over the past few years. Many cellular and viral proteins have 
been shown to be modified by the addition of the 14 carbon fatty acid myristic
%acid (tetradecanoic acid). The role of this modification is controversial. Some 4%
,1myristoylated proteins are targeted to cell membranes, such as endothelial 
nitric oxide synthase, while myristate minus mutants are not [Busconi &
Michel, 1993]. Some myristoylated proteins, such as the catalytic subunit of 
cAMP dependent protein kinase, are cytosolic [Carr et al., 1982]. The free 
energy of myristic acid is barely sufficient to cause membrane attachment of a |
peptide [Peitzsch & McLaughlin, 1993]. Therefore the addition of myristic |
acid cannot per se lead to membrane association but the nature and 
environment of the modified polypeptide can also be important in governing 
what effect the modification has on membrane association.
Prénylation of proteins does have a definite effect on membrane 
association of the polypeptide. Mutational removal of the prenoid group 
precludes membrane association of members of the Ras and Rab families of 
small molecular weight G proteins and of the y subunit of heterotrimeric G 
proteins [Casey et al, 1989; Hancock et at., 1989; Kinsella & Maltese, 1991; 
Fukada et al., 1990; Finegold et al., 1990]. Indeed, if H-Ras is not prenylated,
1
4-
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it loses its transforming ability, so prénylation is a necessary modification for
function of target proteins. However, prénylation by itself may not be 
sufficient to anchor the protein to the membrane. Another factor is also 
required. This may be the addition of the 16 carbon unsaturated fatty acid, 
palmitic acid (hexadecanoic acid) to a position near the site of prénylation as is 
the case for, H-Ras, N-ras and K-Ras(A) or the presence of a long stretch of 
basic residues near the prenylated cysteine residue, as in K-Ras(B) [Hancock 
e ta l ,  1990]. These together may then facilitate full membrane association.
Recent evidence has pointed to the importance of another type 
of acylation in the function of proteins involved in intracellular signalling such 
as heterotrimeric G proteins. These, and other proteins, can be modified at 
their N-terminus by the addition of palmitic acid, in a process distinct from 
that which adds this fatty acid to the C-terminal region of Ras proteins. This 
modification is more widespread than the addition of myristic acid to G 
proteins, which is restricted to members of the G{ family of G proteins. Parenti 
etal., [1993], Linder et at., [1993], Degtyarev etal., [1993a], Wedegaertner et 
al., [1993] and Veit et al., [1994] have demonstrated the incorporation of pH] 
palmitic acid into Gga, Ggcx, Gii/i20c, G q /n a  and Gi2/i3a .  This modification 
is thought to occur via labile thio-ester bonds to cysteine residue(s) near the N 
terminus of the proteins. This modification was also simultaneously reported 
for p5 6 c^k and p59fyi^, members of the Src family of non-receptor tyrosine 
kinases [Paige et at., 1993; Shenoy-Scaria et al., 1993]. Other members of this 
non-receptor tyrosine kinase family also contain possible target cysteine 
residue(s) [Resh, 1994], The growth cone associated protein GAP-43 of 
neuronal cells has also been shown to be dually palmitoylated on cysteine
'
residues close to its N terminus [Skene & Virâg, 1989] and this contributes to
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its membrane association [Skene & Virag, 1989; Zuber et al., 1989]. 
Palmitoylation of GAP-43 also affects the function of the protein [Sudo et al., 
1992].
The effect of this modification on both G proteins and Src 
family members has since remained a hotly contested point. Parenti et al. 
[1993] reported that palmitoylation of Gqioc contributed to the membrane 
association of the polypeptide as mutation of the cys3 not only abolished 
detectable palmitoylation but reduced the ability of the polypeptide to interact 
with the plasma membrane. Degtyarev et al. [1993a] have also identified cys3 
of Gga as the palmitoylated residue in that protein. However substitution of 
this residue by serine causes no change in the ability of Gs« to interact with 
the plasma membrane. Mumby et al. [1994] have similarly shown no effect on 
the membrane interaction of G^a when cys3 was mutated to alanine, whereas 
Wedegaertner et al., [1993] have demonstrated an absolute requirement for 
palmitoylation for the membrane association of Ggoc. Wedegaertner et al., 
[1993] have also identified cysteines 9 and 10 of G qa as the palmitoylated 
residues in that a  subunit. If these residues are mutated to serines, G qa  loses 
all its ability to interact with the plasma membrane.
Functionally, mutants of Gga and G qa which lack detectable 
palmitic acid have little or no ability to activate their effector systems 
[Wedegaertner eta l., 1993]. Conversely palmitoylation of GAP-43 abolishes 
its ability to stimulate the guanine nucleotide exchange of G ga [Sudo et al., 
1992].
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Thus, the role of palmitoylation in regulating protein-membrane 
and protein-protein interaction is still unclear. This chapter assesses how 
palmitoylation affects membrane association, by chemically depalmitoylating 
G protein a  subunits, and assessing how mutationally depalmitoylated a  
subunits interact with the Py complex of heterotrimeric G proteins. Treatment 
of membranes from NG108-15 cells and Rat-1 cells with hydroxylamine, a 
substance known to remove thio-ester linked fatty acids from proteins, can 
induce the release of Gii/i2Ct, Go a , and G q /n a  from cell membranes to 
equivalent degrees while causing a lesser release of Gga. Also, when a C3S 
mutant of G o ia  was stably expressed in Rat-1 fibroblasts, this caused a 
significant release of immunodetectable G o ia  to the cytoplasmic fraction. 
Both wild type and C3S G o ia  could bind py in these Rat-1 transfectants.
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4 .2 . Results. 
4. 2. 1. Treatment of cell membranes with 
hydroxylamine causes release of G protein a  
subunits from the membrane.
4 .2 .1 .1 . Analysis of NG108-15 membranes.
It is well established that hydroxylamine (NH3OH) at neutral 
pH can cleave thio-esterified acyl groups from the cysteine residues of proteins 
by nucleophilic attack. To assess the effect of any thio-esterified acyl groups 
present on G protein membrane association, cell membranes from NG108-15 
cells were treated with IM  hydroxylamine at pH 8  as described in section 2. 5. 
2 . and separated into particulate and soluble fractions by ultracentrifugation at 
120,000x^av These fractions were then subjected to SDS-PAGE and 
immunoblotted as described in section 2. 8. These immunoblots were probed 
with antisera selective for Ggc, GqO, Gij/i2a  and G q /n a . Representative 
examples of these immunoblots are shown in figure 4 .1 .
As NG108-15 cells are known to express no G iia  [McKenzie 
& Milligan, 1990a], the immunoblot probed with antiserum SGI represents 
only the protein levels of Gi2«. It can be seen that hydroxylamine causes a 
relocation of a fraction of the immunoreactive protein. Quantitiation of this, as 
described in section  2. 9. and shown in f ig u re  4. 2., indicated that 
approximately 30% of immunoreactive G qa, Gi2«  and G q /n a . was released 
into the soluble fraction, once the amount of immunoreactivity present in the
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Figure 4 .1 . Hydroxylamine causes the release of 
G protein a  subunits from the membranes of 
NG108-15 cells.
lOO^g of NG108-15 cell membranes were treated with either IM 
hydroxylamine, pH8 , or IM Tris HCl, pH8 , as described in Chapter 2. 
Following centrifugation at 200,000x^^v> the resulting pellet and supernatant 
fractions from Tris treated samples (lanes 2 and 3 respectively) and 
hydroxylamine treated samples (lanes 4 and 5 respectively) were 
electrophoresed on a standard 10% SDS-PAGE gel along with lOOpg of 
membranes which had not undergone any treatment (lane 6 ) and prestained 
molecular weight markers (lane 1). The resulting immunoblots were probed 
with antisera CS3 (dilution 1:250), IM l (dilution 1:400), SGI (dilution 
1:1000) and CQ2 (dilution 1:1000) in panels A B C and D respectively. The 
identities of the immunoreactive polypeptides and the mobility of the 43kDa 
molecular weight marker are shown.
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Figure 4. 2. Quantitation of the amount of 
immunoreactive G so, G o a , G i ia  and G q o /G iia  
released from N G 108-15  cell membranes by 
hydroxylamine.
Immunoblots from the experim ent shown in figure 4. 1. were 
densitometrically analysed on a Bio-Rad GS670 imaging densitometer. After 
correction for the amount of immunoreactive polypeptide released by Tris 
HCl, the amount of polypeptide released by hydroxylamine was expressed as a 
percentage of the total amount immunoreactive polypeptide (the amounts in 
the pellet fractions + the amounts in the supernatant fractions) and graphed 
against the G protein a  subunit. Results are shown as the mean±SEM of 4 
independent experiments.
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soluble fraction of Tris-HCl treated control samples had been accounted for. A 
smaller amount, approximately 1 0 %, of GgO, was released by hydroxylamine.
Antisera CQ2, used to detect G qa and G n a , and IM l, used to 
detect G oa, cannot distinguish between G qa or G n a , or between the splice 
variants of G oa. Therefore, following treatment with hydroxylamine as before, ?Iparticulate and soluble fractions were electrophoresed by urea gradient SDS-
PAGE as described previously, in an attempt to determine whether both G qa |
and G n a , and G oa variants, are affected by chemical depalmitoylation, and to
€what extent. A representative experiment is shown in figure 4. 3. a. and the 
quantitation of this experiment is displayed in figure 4. 3. b. These 
demonstrated that hydroxylamine caused the release of G qa and G nct, and the 
G o ia  and G o^a splice variants to an equal degree, that is 30%.
1■4,
Î
Complementary DNAs encoding either wild type G o ia  or 
G oi« in which the codon for cysteine-3 has been mutated to encode serine 
have been stably transfected into Rat-1 fibroblasts [Grassie et al., 1993; 
Grassie et al., 1994]. This mutation has previously been shown to abolish 
detectable palmitoylation of the G o ia  protein upon transient expression in 
COS-7 cells [Parenti eta l., 1993].
In order to determine whether these transiently transfected 
proteins were equivalent to the G o ia  detected in rat brain as described in 
Chapter 3 , membranes of these transfectants, termed C5B and D3 for the wild
_________________
Figure 4. 3. Analysis of the ability of 
h yd roxylam in e to cause release of G o ia /G o 2 a  
and G q o /G iia  from NG 108-15 cell membranes.
Following treatment of lOO/^g of NG108-15 cell membranes with either IM 
Tris HCl, pH8 , or IM hydroxylamine, pH8 , pellet and supernatant fractions 
from the 2 0 0 , 0 0 0 x g a v  centrifugation step were analysed on a 4M-8M urea 
gradient SDS-PAGE gel. Panel A shows a representative immunoblot from 
such an experiment. Lane 1 contained prestained lactic dehydrogenase marker, 
lanes 2 and 3 and lanes 6  and 7 contained the pellet and supernatant fractions 
(respectively) of Tris HCl treated samples and lanes 4 and 5 and lane 8  and 9 
contained the pellet and supernatant fractions (respectively) of hydroxylamine 
treated samples. The resulting immunoblot was probed with antisera IM l 
(dilution 1:400; lanes 1-5) and CQ2 (dilution 1:1000; lanes 6-9. The mobility 
of the lactic dehydrogenase marker and the identities of the immunoreactive 
polypeptides are shown.
Panel B shows the quantitative analysis of several such experiments. 
Following densitometric scanning as before, the amount of immunoreactive 
G oia , Go%a, Gqa and G n a  released by hydroxylamine was corrected for that 
released by Tris and expressed as a percentage of the total immunoreactive 
protein from both pellet and supernatant fractions. These results were graphed 
against the G protein a  subunits of interest and expressed as the mean+SEM of 
3 independent experiments
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type and mutant cells respectively, were assayed by urea gradient SDS-PAGE 
as before. Figure 4. 4. indicated that both C5B and D3 cells express the same 
IM l immunoreactive polypeptide, and this co-migrated with the G o ia  splice 
variant of rat brain cortex membranes. It can also be seen that the absence of 
palmitic acid on the G o ia  protein expressed in 03  cells did not alter its 
mobility under urea gradient gel conditions as has previously been suggested 
[Nürnberg etal., 1994].
Membranes of these cells were subjected to hydroxylamine 
treatment as described for NG108-15 cell membranes above. The immunoblots 
were probed for the same range of a  subunits as for NG108-15 membranes. 
Figure 4. 5. shows representative examples of these immunoblots and 
quantification of several experiments is displayed in figure 4. 6. It can be seen 
that the amount of any given a  subunit is the same for each of the C5B and D3 
membranes, with the exception of G o ia , indicating that the transfection has 
not altered the level of expression of the endogenous a  subunits.
While the amount of immunoreactive G o ia  released by 
hydroxylamine in C5B cell membranes was equivalent to that for Gii/i2a  and 
G q /iia  (approximately 25%), only around 5% of immunoreactive G o ia  was 
released by hydroxylamine in D3 cell membranes. This would indicate that the 
C3S G oia in D3 cells is not palmitoylated. Also the amount of G^a released 
from the membranes was less than that for the other a  subunits as previously 
seen for Gga in NG108-15 cell membranes.
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Figure 4. 4. C5B and D3 cells both express an 
immunoreactive Goa species which co-migrates 
with rat brain G o ia  on urea gradient SDS- 
PAGE.
25pg of rat brain cortex membranes (lane 1) were electrophoresed on a 4M- 
8 M linear urea gradient gel with 50pg of D3 cell membranes (lane 2) and 50/^g 
of C5B cell membranes (lane 3). The resulting immunoblot was probed with 
antiserum IM l at a dilution of 1:400. The identities of the immunoreactive 
polypeptides are shown. This gel is a representative example of 3 independent 
experiments.
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Figure 4. 5. Analysis of the effect of hydroxylamine 
on the G protein a subunits expressed in C5B and D3 
cells.
100/fg of cell membranes from either C5B cells (lanes 2-5) or D3 cells (lanes 6-9) 
were either treated with IM Tris HCl, pH8 , or with IM hydroxylamine, pH8 , and 
separated into pellet and supernatant fractions by centrifugation at 200,000xgav. The 
pellet and supernatant fractions from Tris treated samples (lanes 2 and 3 and lanes 6  
and 7, respectively) were electrophoresed on a standard 10% SDS-PAGE gel along 
with the pellet and supernatant fractions from hydroxylamine treated samples (lanes 4 
and 5 and lanes 8  and 9, respectively). The resulting immunoblots were probed with 
antisera CS3 (dilution 1:250), IM l (dilution 1:400), SGI (dilution 1:1000) and CQ2 
(1:1000) as shown in panels A, B, C and respectively. The mobility of the prestained 
lactic dehydrogenase marker (lane 1) and the identities of the immunoreactive 
polypeptides are shown. These immunoblots are representative examples of 4 
independent experiments.
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Figure 4. 6. Quantitative analysis of the effect of 
hydroxylamine on the G protein a  subunits 
expressed in C5B and D3 cells.
Following correction for the amount of immunoreactive polypeptides released 
by Tris, densitometrically scanned analyses of samples from hydroxylamine 
treated samples were expressed as a percentage of total immunoreactive 
polypeptide and graphed against the G protein a  subunits examined; that is 
Gs«, Go«, G ii«/G i2a  and G q a /G n a  in panels A B Cand D respectively. 
The analyses are given as the mean+SEM of 4 independent experiments.
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î;4. 2. 2. Mutation of cysteine 3 to serine alters the membrane association of G o ia  when expressed 
in Rat-1 cells.
Mutation of target cysteine residues to serine has been shown to 
abolish detectable palmitoylation of several proteins including and
GAP-43 [Hancock et al., 1989; Zuber et at., 1989]. Recently this approach has 
been used to identify palmitoylated cysteine residues of G^a, G o ia  and G qa 
when transiently expressed in either COS-7 cells (G o ia  and G^a) or HEK 293 
cells (Gga and G q a )  [Parenti et al., 1993; Degtyarev et al., 1993a;
Wedegaertner, et al., 1993]. These experiments have demonstrated that both 
Gga and G o ia  are palmitoylated on cys-3 while, similarly to GAP-43, G qa is
'dually palmitoylated, on cys9 and cyslO.
The effect on membrane association of the addition of palmitic 
acid to these G protein a  subunits is still unclear. G qa is apparently wholly 
dependent on the addition of palmitic acid for its membrane interaction 
[Wedegaertner eta l., 1993], while the membrane association of G o ia  is less 
dependent on acylation [Parenti et ah, 1993] and the membrane association of 
Gga is not dependent on its palmitoylation state at all [Degtyarev et al., 1993a; 
Mumby et al., 1994]. These studies were carried out under transient 
transfection conditions. To prevent the necessity of repeated transfections the 
membrane association of G o ia  was assessed in stably transfected Rat-1 
fibroblasts expressing either wild type or C3S forms of the a  subunit. 
Particulate membrane and soluble cytosolic fractions were prepared and 
immunoblotted for the presence of immunoreactive G oa using the selective
anti serum IM l ( f ig u r e  4 , 7 . a ,). Quantification of several such experiments
.
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indicated that 27.2+5.5% of total immunoreactive Gqicx was present in the 
cytosol of the C3S mutant expressing D3 cells while in wild type Gqioc 
expressing cells, only 4.6+4.6 % of immunoreactive G o ia  was detectable in the 
cytosolic fraction (figure 4.7 . b.).
4. 2. 3. Both wild type and mutant G oia  are 
substrates for pertussis toxin in vivo.
The binding domain on a  subunits for the py dimer is thought 
to be located at the N terminus of the polypeptide, as enzymatic cleavage of 
the first 21 amino acids of G oa eliminates |3y binding [Winslow et al., 1986]. 
The presence of palmitic acid on cys3 may therefore affect a-fly interactions, 
as this modification has been shown to have a negative effect on the 
association of GAP-43 with Goa. [Sudo et ah, 1992]. Also as the C3S 
mutation decreases the ability of G oa to interact with the plasma membrane, it 
may not be in the correct environment to associate with Py all.
To address this point use was made of the Bordetella pertussis 
exotoxin, pertussis toxin, to assess the ability of the wild type and mutant 
G o ia  to interact with py. The toxin requires the a  subunit to be complexed to 
py in order to efficiently transfer the ADP-ribose group of NAD+ to the target 
C terminal cysteine residue. Therefore if the G oa from either C5B or D3 cells 
(or both) is complexed to py, pertussis toxin will be able to ADP-ribosyiate the 
a  subunits.
The addition of ADP-ribose to the a  subunits of the G{ family 
of G protein a  subunits causes a slight reduction in mobility of the subunit
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Figure 4.7. A G oia  immunoreactive polypeptide 
is present in the cytosolic fraction of D3 cells 
while all the immunoreactive G o ia  in C5B cells 
is present at the membrane.
C5B (lanes 2-3) and D3 cells (4-5) were homogenised and separated into 
membrane (particulate) and cytosolic (supernatant) fractions by centrifugation 
at 2 0 0 ,0 0 0 xgav. 100 /ig of the membmne fraction and an equivalent amount of 
cytosolic fraction (such that the amount of cell protein from membrane and 
cytosolic fractions was the same) from each cell type was subjected to SDS- 
PAGE on a standard 10% polyacrylamide gel and the resulting immunoblot 
probed with antiserum IM l at a dilution of 1:400 (panel A). This immunoblot 
is a representative example of 3 experiments. Following densitometric analysis 
of these immunoblots, the immunoreactive GqICi was expressed as a 
percentage of the total immunoreactive G o ia  present in each cell type and 
graphed against the cell type involved (panel B ). The results are expressed as 
the mean±SEM of 3 independent experiments.
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through acrylamide gels. This mobility shift can be exaggerated if the proteins 
are analysed by urea gradient SDS-PAGE. Therefore C5B and D3 cells were 
treated with 25ng/ml of pertussis toxin in vivo as described in section 2. 3. 6 . 
before membrane and cytosolic fractions were prepared by ultracentrifugation 
at 200,000xgav. Analysis of these toxin treated fractions on urea gradient SDS- 
PAGE is displayed in figure 4. 8 . It can be seen that all of the wild type G o ia  
was a substrate for pertussis toxin. Also, as expected from previous 
experiments, none of the immunoreactive wild type polypeptide was present in 
the cytosolic fraction of either pertussis toxin treated or untreated cells. In D3 
cells a fraction of the immunoreactivity was present in the cytosol of both 
treated and untreated cells, as was seen previously. All the immunoreactive 
G o ia  in these cells was, however, a substrate for pertussis toxin, as the Goioc 
present in both the membrane and cytosolic fractions derived from pertussis 
toxin treated D3 cells underwent a mobility shift under urea gradient SDS- 
PAGE. This indicated that either the GqIOc in these cells was at the membrane 
at some time and perhaps a cycling process ensured that all the Gq la  was 
complexed to a py dimer at some point, or that py was present in the cytosol of 
these cells and that Gqicx was complexed to it here. The Py complex has never 
been observed in the cytosol due to the prenylated C terminus of the y subunit, 
but the possibility does exist.
4. 2. 4. Only membrane associated G o ia  is a 
substrate for pertussis toxin.
s
In order to assess whether the cytosolic fraction of D3 cells 
contained heterotrimers of Goict which could support pertussis toxin catalysed
■ADP-ribosylation, membrane and cytosolic fractions of C5B and D3 cells
I
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Figure 4. 8. Ali the iuiuiuureactiye G oia  present 
in both C5B and D3 cells is a substrate for 
pertussis toxin catalysed mono ADP-ribosylation 
in vivo.
C5B and D3 cells were treated for 16hrs with 25ng/ml of pertussis toxin before 
membrane and cytosolic fractions were prepared. 100 /<g of membranes, and an 
equivalent amount of cytosol, from untreated C5B cells (lanes 2 and 3 
respectively) were electrophoresed on a 4M-8M linear urea gradient with 
1 0 0 /^g of membranes and the equivalent amount of cytosol from each of 
treated C5B cells (lanes 4 and 5, respectively), untreated D3 cells (lanes 6  and 
7, respectively) and pertussis toxin treated D3 cells (lanes 8  and 9, 
respectively). The resulting immunoblot was probed with antiserum ONI 
(dilution 1:1000). Lane 1 contained prestained lactic dehydrogenase marker, 
the mobility of which is shown. The experiment shown is a representative 
example of 3 independent experiments.
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were subjected to in vitro ADP-ribosylation in the presence of p^P]NAD+. 
Goioc was subsequently immunoprecipitated using antiserum O C l and 
subjected to SDS-PAGE.
A sample autoradiogram from these experiments is displayed in 
figure 4. 9. While the G o i«  in the membrane fractions of both C5B and D3 
cells was subject to ADP-ribosylation neither cytosolic fraction provided a 
substrate for pertussis toxin catalysed ADP-ribosylation indicating that the 
cytosolic fraction of Gqicx in D3 cells was not complexed to py dimers.
4. 2. 5. The cytosolic G oia  of D3 cells exists as a 
free a  subunit.
fraction of D3 cells was bound to another protein or found free in the soluble
IIn order to assess whether the Gqio. present in the cytosolic
fraction, this fraction was analysed on a Superose 12 gel filtration column as 
described in section 2. 10. The resultant fractions from the column were 
precipitated using TCA and subjected to SDS-PAGE and immunoblotting. 
Immunblots were then probed with antiserum OCl. The elution volume of the 
fraction with the highest level of G oa immunoreactivity (figure 4 .1 0 . a.) was 
compared to the elution volume of several standard proteins with known 
molecular mass (figure 4. 10. b.) This gave a value for the molecular mass of 
G oa of approximately 40kDa, which was close to the reported value for the 
molecular mass of the a  subunit.
To determine whether the free a  subunit of D3 cell cytosol was 
capable of binding the py complex, and thus forming a substrate for pertussis 
toxin. Exogenous Py, purified from bovine brain, kindly donated by Dr M.
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Figure 4.9. Only membrane associated G ol»  is a 
substrate for pertussis toxin in vitro.
SOpig of membranes, or an equivalent amount of cytosol, from C5B and D3 
cells were mono ADP-ribosylated with DTT activated pertussis toxin in the 
presence or absence of ImM Gpp(NH)p. Following this 150;^1 of 1.33% (w/v) 
SDS was added to each sample, to give a final concentration of SDS of 1% 
(w/v) and Goiot was immunoprecipitated from these samples using antiserum 
OCl. Immunoprecipitates were subjected to SDS-PAGE on a 10% (w/v) gel. 
This was then dried down and exposed to a phosphorimaging screen for Ihr. 
The lanes contained C5B membranes in the absence (1) or presence (2) of 
Gpp(NH)p, C5B cytosol in the absence (3) or presence (4) of Gpp(NH)p, D3 
membranes in the absence (5) or presence (6 ) of Gpp(NH)p and D3 cytosol in 
the absence (7) or presence (8 ) of Gpp(NH)p. The identity of Gqicc is shown. 
Similar results were obtained in 3 independent experiments.
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Figure 4.10. The G oia  in the cytosol of D3 cells 
exists as a free a  subunit.
To determine if the G o ia  of D3 cell cytosol was complexed to another protein, 
lOOptg of crude ctyosol from these cells was chromatographed on a Superose 
12 gel filtration column against standards of known molecular mass. 500/^1 
fractions from this column were TCA precipitated in the presence of lOjAg of 
BSA to prevent protein loss and subjected to electrophoresis on a 10% (w/v) 
SDS-PAGE gel. The resulting immunoblot (panel A) showed the presence of 
an immunoreactive polypeptide which eluted from the column and co­
migrated with G oa from rat brain membranes (lane 1). The eluted fraction 
(lanes 2 -6 ) were compared to the elution volumes of known proteins (panel 
B ). This gave an Mr for G oa from D3 cell cytosol of approximately 40kDa, 
close to that reported for G o« in the literature.
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Freissmuth, Department of Pharmacology, University of Vienna, Vienna,
Austria, was therefore added to samples of cytosol from C5B and D3 cells and 
in vitro pertussis toxin catalysed ADP-ribosylations performed in the presence 
of [32p]NAD+.
$A sample autoradiogram from this experiment is shown in §
:,;rf
figure 4, 11. Unfortunately it would appear that a considerable amount of GqO ■I*
was present in the purified brain py. This obscured any p^PjADP-ribose |
■flabelled G o ia  in the cytosolic samples. We were unable to obtain a 
sufficiently pure sample of Py from another source so were unable to resolve S
whether the Gqio  found in the cytosolic fraction of D3 cells was capable of |
binding py.
Figure 4. 11. Addition of purified bovine brain 
Py to the membrane and cytosolic fractions of 
C5B and D3 cells.
SOptg of membranes, or an equivalent amount of cytosol, from C5B and D3 
cells were mono ADP-ribosylated with DTT activated pertussis toxin in the 
presence or absence of ImM Gpp(NH)p following addition of Ing/ml final 
concentration o f purified bovine brain Py Samples were then 
immunoprecipitated using antiserum OCl and subjected to SDS-PAGE on a 
10% (w/v) gel. This was then dried down and exposed to a phosphorimaging 
screen for Ihr. The identity of Go a  is shown. Lanes 1 and 2 contained C5B 
membranes, lanes 3-6 contained C5B cytosol either with (lanes 5 and 6 ) or 
without (lanes 3 and 4) added bovine brain Py. Lanes 7 and 8  contained D3 
membranes, lanes 8-12 contained D3 cytosol either with (lanes 11 and 12) or 
without (lanes 8  and 9) Py. Lane 13 contained only purified bovine brain Py. 
Similar results were obtained in 3 other experiments.
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4 .3 . Discussion. "î,1si
B
Protein lipidation is thought to lead to a variety of effects on 
target proteins and their interaction with other proteins and with cellular 
membranes. Some extracellular receptors, for example folate binding protein, 
have no significant hydrophobic domains capable of forming any 
transmembrane a-helices, yet are located on the exofacial leaflet of the plasma 
membrane. These proteins are modified by a complex lipid moiety derived
:
from phosphatidylinositol. This glycerophosphatidylinositol (GPÏ) link 
achieves two things. It increases the hydrophobicity of the protein sufficiently 
to promote its membrane association alone. It also gives the protein the ability 
to transduce its activation state, via the GPI link, to proteins associated with 
the membrane and from them to the inside of the cell. This modification thus 
changes the proteins’ ability to interact with the plasma membrane and 
facilitates protein-protein interaction.
This dual effect has also been identified for other proteins. 
Members of the small molecular G protein superfamily undergo modification 
by a complex series of lipid modifications. The initial addition of prenoids and 
the subsequent proteolysis and carboxyniethylation are insufficient to promote 
full membrane association [Hancock, et al., 1989; Hancock et al., 1990]. 
Another factor is required. In some members, particularly some of the Ras 
family, another lipidation is required to promote membrane interaction. 
Palmitoylation of the protein, occurring on cysteine residues near the 
prénylation site, provides the additional hydrophobicity required to promote 
full membrane interaction [Hancock et al., 1990]. Other members, for example 
Rab and p2 ff^-^^(B), have no cysteine residues capable of supporting acylation
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:by palmitic acid near the isoprenylated C terminus [Hancock et al., 1990].
Instead, they have a long stretch of basic amino acids close to the prénylation 
site. This stretch is thought to contribute to membrane association by binding 
to the phosphate groups on lipid molecules [Hancock et al., 1990].
Ras proteins have been demonstrated to be transforming in a 
variety of cell lines and types. This ability to transform can be overcome by 
the elimination of prénylation, although it is unclear whether this is a reflection 
of a change in protein-membrane or protein-protein interaction. Mutagenesis i
of the prenylated cysteine residue obliterates the modifications of the proteins 
and prevents membrane association. Mutagenesis of either the site of 
palmitoylation or the polybasic domain did not prevent Ras' transformation 
ability indicating that these domains were not required for the proteins' 
function, whereas the addition of the prenoid group was required for 
transformation implying a role of prénylation in protein-protein interactions
I
[Hancock et al., 1989; Hancock et al., 1990]. Thus although prénylation per se 
does not lead to total membrane association, this modification has a significant 
role in promoting it [Hancock et al., 1990]. These proteins are important in 
several areas of intracellular trafficking and cellular signalling. The Ras 
proteins are important in activating Raf, the initial enzyme in the MAP kinase 
cascade [Van Aelst et a l ,  1993; Vojtek et al., 1993]. It is unclear whether 
prénylation and acylation of the proteins plays any direct role in coupling of 
these proteins to their targets.
The Y subunits of heterotrimeric G proteins are also subject to 
prénylation. The lipid is required for the proper function of the py complex 
[Fukada et al., 1990; Wedegaertner et a l ,  1995]. Mutation of the prenylated
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cysteine to serine does not preclude formation of the Py dimer. Once formed, 
however, the dimer cannot insert in the membrane [Simonds, 1994] or interact ||
with the a  subunit [Wedegaertner et al., 1995]. Thus it would appear that the i
ipresence of prenoid groups on proteins can affect protein-membrane as well as 
protein-protein intemctions.
G protein a  subunits are also subject to lipidation. Members of 
the Gj subfamily have been shown to be acylated by the addition of myristic
acid at gly2 [Jones et al., 1990; Mumby et al., 1990] Following removal of the s
initiating methionine, this residue becomes the N-terminal residue and is thus 
in the correct environment for myristoylation by N-myristoyl transferase 
[Sefton & Buss, 1987; Towler et al., 1988]. The exception to this is G ta, 
which is predominantly laurylated. This is due not to a separate enzyme but to 
a difference in the lipid environment of the retina making lauryl-CoA more 
prevalent than myristoyl-CoA [Kokame etal., 1992].
It appears that myristoylation also affects both protein- 
membrane and protein-protein interactions. Mutagenic alteration of the target 
glycine residue and inhibition of the N-myristoyl transferase enzyme using 2- 
hydroxymyristate [Paige et al., 1990], a substituted analogue of myristic acid,
Jvboth lead to a reduction of the membrane association of G ija  and GqO [Jones
and G iia  for the py dimer [Linder et al., 1991] and seems to interfere with the 
ability of G ia to inhibit adenylyl cyclase [Taussig et a l., 1993].
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et al., 1990; Mumby et al., 1990]. It also appears that myristoylation affects 
the function of the polypeptide. Myristoylation increases the affinity of Gqcx
I
Members of the Src family of non-receptor tyrosine kinases are 
also myristoylated on gly2. These proteins have recently been shown to be
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Mutations of the Gj2a  protein, which occur naturally in certain 
cancers, are known to function by inhibiting the GTPase activity of the 
polypeptide causing constitutive activation of the a  subunit [Graziano &
Gilman, 1989; Masters et al., 1989]. One of these mutations, the Q205L 
mutation, causes transformation and constitutively activates the MAP kinase 
cascade when stably expressed in Rat-1 fibroblasts [Pore et al., 1991; Gupta c/ 
al., 1992]. Transfection of a double mutant encoding both the Q205L and the
■iG2A mutations does not lead to cellular transformation or MAP kinase
:«activation [Gallego et al., 1992], indicating a role for myristoylation in the 
ability of Gj2a  to interact with target proteins.
I
Not all myristoylated proteins are membrane bound. For %
example the catalytic subunit of the cAMP dependent protein kinase and #
calcineurin (protein phosphatase 2B) are also modified by myristoylation yet !:
■;S:'
are located in the cytosol [Carr et al, 1982; Aitken et al., 1982}. Therefore an ,4
'rr'Tadditional signal may be required for a myristoylated protein to bind to the
membrane. This may reflect a lesser ability of myristate to anchor acylated I
peptides to lipid vesicles. Myristoylated peptides have barely enough energy to
anchor the peptides to membranes and the target protein would probably
require other factors, such as the presence of positive charges or a protein-
protein interaction to interact with the membrane [Peitzsch & McLaughlin,
1993]. Myristoylation of calcineurin and A-kinase catalytic subunit is
4presumed to affect the protein-protein interactions, perhaps by promoting the , ?I
interactions of catalytic and regulatory subunits of the proteins [Turner, 1992].
  :
GAP-43, a protein associated with the neurite growth cone 
[Basi et a l, 1987], is also known to be palmitoylated at two adjacent cysteine 
residues at positions 3 and 4 [Skene & Virdg, 1989]. This palmitoylation has
post-translationally palmitoylated as well [Paige et a l , 1993; Shenoy-Scaria et
%a l,  1993], a lipid modification capable of anchoring acylated peptides alone |
[Peitzsch & McLaughlin, 1993] thus providing an additional factor to provide
smembrane association. The purpose of these two independent acylations is 
unclear as yet. Members of the Src family function to couple extracellular and 
membrane bound receptors to transduce their signals. Src family members,
■'4like G protein a  subunits contain no hydrophobic domains capable of J
■4supporting membrane association alone. These twin acylations may play the 
key role in localising these proteins to the correct membrane compartment.
'"I:
44S
ttwo effects on GAP-43 function. It determines the membrane association of 4
GAP-43 [Skene & Virag, 1989; Zuber et a l, 1989] and also affects the ability 
of GAP-43 to interact with and regulate the guanine nucleotide exchange 
activity of GqO [Sudo et a l ,  1992]. The acylation apparently regulates the
Irelative amounts of inactive, membrane associated, palmitoylated protein and 
active, cytosolic, unmodified protein [Sudo et a l, 1992]. Palmitoylation 
appears therefore to affect both protein-membrane and protein-protein 
interactions.
"3'4
Serpentine receptors are also subject to post-translational |
modification by palmitic acid in their intracellular C-terminal tail. The effect 
this has on the function of the receptor is unclear. While some believe the 
modification has a positive effect on the receptor's function [Morrison et a l,
%1991] others think that it has no effect [Kamik et a l , 1988; Kamik et a l , 1993;
i
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Kennedy & Limbird, 1993] or even inhibit the receptors' ability to transduce 
signals [ O'Dowd et al., 1989]. The palmitic acid on rhodopsin has been shown
’■■Ito be in a lipid environment [Moench et al., 1994], therefore the palmitoylation 4
“Iof these receptors may induce the formation of a fourth intracellular loop
44[Karnik et al., 1988; Ovchinikov et al., 1988; Konig et al., 1989]. The
4palmitoylation of the adrenergic receptor has also been demonstrated to be 
reversible and regulated [Mouillac et ah, 1992]. The presence of this fourth 
loop is thus transient and regulatable. Bouvier and co-workers believe that the 
depalmitoylated receptor, thus possessing only 3 intracellular loops, is a target 
for desensitisation [Bouvier et al., 1995]. Consequently palmitoylation of 
serpentine receptors may have a role in the regulation of transmembrane 
signalling by receptors.
■J
Recently, the presence of palmitic acid has been found on G 
protein a  subunits. This modification differs significantly from myristoylation 
in several key areas. The presence of myristate is restricted to some members h
iof the Gi family, while palmitoylation is prevalent amongst ct subunits of the
4other families. Of the a  subunits studied to date, only Gta lacks the fatty acid
[Wedegaertner et al., 1995]. The post-translational addition of the fatty acid is |
'Ivia a labile thio-ester bond, making regulation of palmitoylation a possibility. ; ■
This regulation of palmitoylation has been demonstrated for G protein a  '
i-ii
subunits [Degtyarev et al., 1993b; Mumby et al., 1994; Wedegaertner et al.,
1994], receptors [Mouillac et al., 1992] and other proteins [Huang, 1989;
Paige et al., 1993]. Regulation of the co-translational addition of myristic acid 
is not possible as it is via a stable amide bond.
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interactions of these proteins.
Stable expression of wild type and C3S mutant forms of the 
Go ICC protein in Rat-1 cells produced an immunoreactive Gooc band in the 
cytosolic fraction of the mutant expressing cells. Here, following breakage of 
the cells, approximately 30% of immunoreactive, palmitate negative, C3S 
G o ia  was found in the cytosolic fraction of these cells. Three possible 
interpretations exist to explain this. First, 30% of C3S G o ia  is present in the
a
How palmitoylation of G protein a  subunits affects their 11
membrane association is a contentious subject at present. In this study it has 
been shown that chemical removal of palmitic acid releases approximately 
30% of immunoreactive Gj2a , G oia, Goza, Gqa, G n a  and a lesser amount of 
Gga from cell membranes. This would indicate that palmitoylation contributes 
to, but does not entirely govern, the membrane association of these a  subunits.
Clearly the presence of myristic acid may increase the hydrophobicity of the 
G ia and G oa proteins to cause a slight increase in corresponding membrane 
association, but as the G q a  and G n a  proteins are not subject to 
myristoylation, another mechanism must exist to promote the full membrane I
It is unclear why Gga was not as susceptible to release from the 
membrane following hydroxylamine treatment as other a  subunits under these 
conditions. Audigier et al. [1990] have hypothesised that a sequence, TENIR,
near the C terminus of Gga targeted the protein to the membrane. This theory |
%has recently been challenged [Degtyarev et al., 1994a], as mutagenesis of the 4
v:analogous site in G n a  to encode TENIR produces no change in the membrane
association of that polypeptide. Therefore, G^a may contain another factor |
A'which contributes to its membrane association. |
4
159
cytosol at all times in these cells in vivo. Secondly, all the C3S G oia is present 
at the membrane in the whole cell and the 30% found in the cytosolic fraction 
only redistributes there upon lysis of the cells in a hypotonic buffer. Finally, 
the C3S G o ia  may be cycling between membrane associated and cytosolic 
compartments and that these fractions are trapped when the cell is broken.
The experiments involving pertussis toxin (F ig u r e s  4 , 6 . and 4 . 
7 .) exclude the first possibility. Fractionation of wild type and C3S mutant 
G oia  expressing cells following in vivo pertussis toxin treatment indicate that 
all of the C3S G oia  in the cell, whether subsequently located in the membrane 
or cytosolic fraction following disruption, is a substrate for ADP-ribosylation 
by the toxin. Both the in vitro pertussis toxin catalysed ADP-ribosylation of 
cytosolic fractions from these cells and the gel filtration data (F ig u r e s  4 . 7 . 
and 4 . 8 .) , indicated that the cytosolic fraction of C3S G o ia  was present as a 
free a  subunit and that there were no py dimers present in the cytosol. Thus all 
the C3S G o ia  must have been located at the membrane at some point. 
Whether it was all bound to the membrane in vivo until the cell was lysed, or 
was cycling on and off the membrane cannot be addressed by these 
experiments. What is clear from these experiments is that palmitoylation of 
G o ia  increases the avidity of interaction of this a  subunit with the plasma 
membrane. Recent evidence points to the cycling hypothesis. Scanning laser 
confocal microscopic studies indicate that, while the G o ia  of wild type 
transfected cells is located only at the membrane, C3S G o ia  is present in the 
cytosol in the whole cell [M. A. Grassie & G. Milligan unpublished 
observations]
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Other groups have come to different conclusions. Experiments i
-by Bourne and co-workers, using mutants of GgO and Gqa, in which the target :|
cysteine residues were replaced by serines, demonstrated that these mutant a Isubunits were entirely cytosolic in cellular location, indicating that G sa and 
G qa were wholly dependent on palmitoylation for their membrane interaction 
[Wedegaertner et al., 1993]. Other groups have found that palmitoylation of 
Gga had no detectable part to play in the membrane association of the a
issubunit [Degtyarev e ta l, 1993a; Linder et al, 1993; Mumby e ta l, 1994].
These two groups employed a C3A mutant of Gga to answer this question,
îîwhilst Wedegaertner et al., [1993], like this report, employed a C3S mutation. f
Whether this discrepancy is responsible for the differences observed in terms f
of membrane interaction is unclear. 6"4
Wedegaertner et a l, [1993] have postulated that palmitoylation 
affects the function of G protein a  subunits by also affecting protein-protein 
interactions. Neither the palmitate negative Gga nor the palmitate negative 
G qa were able to interact with and stimulate their effector systems, adenylyl 
cyclase and phosphoinositidase C respectively. Thus it would appear that like 
the other lipidations described here, palmitoylation can influence both the 
protein-membrane and protein-protein interactions of G proteins I
sRecent work has shown that the palmitoylation status of G 
proteins, and indeed Src family members, can be regulated. The half life of 
palmitate on Gga is approximately 50-90mins [Degtyarev et al., 1993b;
W edegaertner & Bourne, 1994] while the half life of the protein is 
approximately ll-22hrs [Levis & Bourne, 1992; Degtyarev etal., 1993b]. The 
rate of turnover of palmitate on Gga can be increased to around 2 mins, beyond
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that of the polypeptide itself (approximately 6 hrs), upon stimulation of the P2 
adrenergic receptor of S49 cyc~ cells stably expressing epitope tagged GgO 
with isoprenaline [Levis & Bourne, 1992; Wedegaertner & Bourne, 1994].
Constitutive activation of Ggoc, either mutationally by the introduction of the
:R201C constitutively activating mutation or by treatment with cholera toxin, 
also led to an increase in palmitate turnover [Degtyarev eta l, 1993b; Mumby 
et al, 1994; Wedegaertner & Bourne, 1994]. Whether this means a net 
increase, or decrease, in the total pool of palmitoylated Ggcc over non- 
palmitoylated protein is unclear as yet. The kinetics of stoichiometry indicated 
that there was a faster depalmitoylation of G^a  [Wedegaertner & Bourne,
1994].
Treatment of intact S49 cyc~ cells with p 2 adrenergic agonists 
following introduction of epitope tagged Gga caused a change in the stability 
of the Ggcc protein and a translocation of the polypeptide from the membrane 
to a cytosolic fraction [Levis & Bourne, 1992]. Given that palmitoylation may 
increase the membrane association of Ggcc and that activation can cause an 
increase in turnover of palmitate on the protein, this may provide a molecular 
mechanism for this translocation [Wedegaertner & Bourne, 1994].
Of course the question of how Goict palmitoylation affects 
effector interaction and is affected by receptor occupancy cannot be answered 
by the C5B and D3 cell lines employed in this study, as the Rat-1 fibroblast is 
not known to express either the N-type calcium channel, to which the activated 
GoOt subunit couples, or any seipentine receptor which is known to activate
GqOc. The question of how palmitoylation affects the function of GoOt and how
'palmitoylation status of the protein is regulated could be addressed by
Ï
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transfection of other components of the signalling cascade into these cells.
Regulation of palmitoylation could be also addressed by the use of the 
neuronal cell line NG108-15 which are known to express GoOt isoforms and 
opioid receptors which activate them [Hamprecht et al, 1985; Mullaney &
Milligan, 1990; Chapter 3].
One recent fact to emerge from studies by a number of groups 
is the requirement of co-translational myristoylation of Gj family members for 
subsequent post-translational palmitoylation. It has been demonstrated that 
gly2  mutants not only do not incorporate myristic acid but are not substrates 
for the palmitoyl transferase either [Hallak, et al., 1994; Galbiati, et al., 1994].
However, Parenti and co-workers have demonstrated that it is not the lack of 
myristate which prevents the subsequent palmitoylation, but the presence of 
alanine at position 2, as opposed to glycine, which causes this effect. They 
have demonstrated that inhibition of NMT using 2-hydroxy myristate prevents 
myristoylation, but not palmitoylation, of Gjiot [F. Galbiati, F. Guzzi & M.
Parenti, personal communication]. The converse of this, that creation of the
4:|C3S mutant of G jia  or G oi«  prevents myristoylation, is not true however, as
the C3S mutants are still substrates for NMT [Parenti et al., 1993; Galbiati et
al., 1994]. This observation is important for the conclusions drawn in this
study. Recent observations indicate that the function of myristoylation of
members of the Gi family of a  subunits is to increase the hydrophobicity of 4
the molecules just sufficiently to cause a transient association of the I
polypeptide with the membrane. As has previously been mentioned
myristoylation provides barely enough energy to promote membrane
association [Peitzsch & McLaughlin, 1993]. This transient association may |
then allow a membrane associated palmitoyl transferase to post translationally
:.4163
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If this proves to be correct, another observation may be made. 
Given the requirement for gly2 for the addition of palmitate to Gj and Gg
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add palmitate to the proteins thus facilitating full membrane interaction 
[Degtyarev et al, 1994b]. It is not the presence of myristic acid or a glycine 
residue at position 2 , but the location of the a  subunit at the plasma membrane 
which allows palmitoylation of G^a subunits. This begs the question, what 
promotes the membrane association of non-myristoylated a  subunits such as 
GgO and GqO?
This insight calls into question much of the data concerning the 
effects of myristoylation on G a function, as many of the studies, including that 
of Gallego et al. [1992] using the Gip2 oncoprotein, as it utilised a G2A 
mutation. Indeed, only the observations of Linder et al, [1991] can be relied 
upon as these workers studied GoCt myristoylation by expression of the Go a  
polypeptide with or without co-expression of NMT in E.coli rather than 
creating G2A mutants. It also counsels caution in interpreting results obtained 
in mutagenesis studies; the correct controls must be performed in order to 
ensure that the observed effect is not artefactual.
This observation may also clear up a puzzle posed by van der 
Neut et al. [1993]. While Gga is not subject to co-translational myristoylation, 
generation of a G2A Ggoc nevertheless produces a protein with a reduced
V ' -capacity to activate adenylyl cyclase. The presence of the alanine at position 2 
of Ggcc may, as it does with G jia  and GoOc, prevent palmitoylation of Ggct and 
it may be that this is responsible for the observed reduction in effector 
coupling.
family members and the absence of this glycine residue at an analogous 
position in members of the Gq family may point to the presence of isozymes of 
the palmitoyl transferase. Analysis of the sequences of known palmitoylated 
proteins indicates little or no conservation which would reveal a consensus 
sequence for an individual transferase. Also given that the turnover of 
palmitate in response to activation is specific [Degtyarev et al, 1993b; Mumby 
et al, 1994; Wedegaertner & Bourne, 1994], the presence of isozymes of 
palmitoyl transferase with distinct and discrete specificities is possible. This 
specificity of palmitate turnover may also provide evidence for the presence of 
isozymes of the thio-esterase responsible for the cleavage of palmitate from G 
protein a  subunits. Therefore, either there exists specific isozymes of the thio- 
esterase or one thio-esterase enzyme can be differentially regulated to produce 
specific effects.
This study has demonstrated that palmitoylation of G o ia  
increases its avidity of interaction with the plasma membrane. It would appear 
that lack of palmitoylation of this a  subunit does not abolish membrane 
interaction, as it apparently does for GqOc, but instead affects the degree of its 
interaction. One thing is clear, although the palmitoylated residue lies in the 
proposed py binding site, the C3S G o ia  is still able to interact with Py to a 
degree indistinguishable from that of the wild type protein, as assessed by their 
ability to act as substrates for pertussis toxin. It may be that palmitoylation 
increases the affinity of G o ia  for py, as myristoylation does, but unfortunately 
the lack of a pure source of py prevented consideration of this point within 
these studies. It also remains to be seen whether palmitoylation of G o ia  
affects its protein-protein interactions with either receptors or effectors as it 
apparently does for other a  subunits.
I
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Chapter 5.
Dual palmitoylation of murine G n a  regulates its 
membrane association.
1
Chapter 5.
5.1. Introduction.
Some members of the Gj family of a  subunits are dually
1993; Hallak et aL, 1994; Galbiati et al., 1994; Casey, 1994; Wedegaertner & 
Bourne, 1995]. Ggct is also subject to palmitoylation on cys3 [Linder et at..
The neurite growth cone associated protein GAP-43 is dually 
palmitoylated on adjacent cysteine residues [Skene & Virag, 1989]. This 
modification has been shown to promote membrane interaction of GAP-43 
[Skene & Virâg, 1989; Zuber et aL, 1989] and to prevent the stimulation of the
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Dual palmitoylation of murine G iia  regulates its 
membrane association.
I
acylated by myristic acid on gly2 and palmitic acid on cys3 [Parenti et at., JÏ
Ï
1993; Degtyarev et aL, 1993a; Wedegaertner et aL, 1993; Casey, 1994;
Wedegaertner & Bourne, 1995]. Members of the Gq family of a  subunits, 
which have also been shown to incorporate [^H] palmitic acid [Parenti et aL,
I1993; Wedegaertner et aL, 1993], do not possess a cysteine residue at this
position however. Sequence analysis of Gqo, Gnct and G \^a  indicate the ÏIIpresence of only 2 cysteines near the N terminus [Strathmann & Simon, 1990;
Amatruda et aL, 1991]. These cysteine residues, located at positions 9 and 10 
in the primary amino acid sequences, do however align with the cys3 residue 3of GgO, G iia and Goot. Thus either cys9, cyslO, or both, may be the targets for |
palmitoylation. I
?!
GTPase activity of GoCt [Sudo et aL, 1992]. The possibility therefore exists for 
the dual acylation of members of the Gq family of a  subunits.
Recent evidence from Wedegaertner et al. [1993] indeed 
indicated that G qa is dually palmitoylated on cys9 and cyslO. Production of 
mutant forms of the a  subunit in which either cys9 or cyslO had been replaced 
with serine residues produced proteins with reduced ability to incorporate [^H] 
palmitic acid. Only approximately 30% of the detectable radioactivity of the 
wild type protein was found in these mutants. Production of the double 
C9SC10S mutant abolished detectable [^H] palmitate incorporation 
[Wedegaertner aZ., 1993].
This unpalmitoylated C9SC10S GqO was unable to bind to the 
membrane at all; all the immunodetectable protein was located in the cytosol.
•HIn addition, the C9SC10S protein was unable to stim ulate the |.i
phosphoinositidase C catalysed hydrolysis of phosphatidylinositol-4,5- 
bisphosphate, either upon stimulation with an « 2  adrenergic receptor agonist,
3or when the a  subunit was directly activated by introduction of the
constitutively active R183C mutant. The wild type and single mutant proteins 
were all able to stimulate phosphatidylinositol-4,5-bisphosphate hydrolysis.
The ability of the palmitate negative mutant to stimulate phosphoinositidase C 
was restored by mutational insertion of a consensus sequence for N- 
myristoylation [Wedegaertner et aL, 1993]. Therefore lipidation of GqO by 
palmitic acid is apparently obligatory for normal function of the polypeptide.
This chapter aimed to ascertain the effect of palmitoylation of 
G lia  on its membrane interaction. One problem in examining this question is
167
problem [Gallego et a l ,  1992; Wedegaertner et a l ,  1993]. This approach was 
mutational, and while no difference was found between wild type and HA 
tagged proteins, an effect on the function of the protein cannot be ruled out. 
Due to the lack of a G n a  selective antisera, this study employed the 
concurrent detection method described in Kim & Milligan [1994] and in 
C hapter 3, using a non-selective Gqoc/Gna antiserum.
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the ubiquity of both G qa and G n a  in all known cell types. Some groups have
Utilised an influenza virus haemaggluttinin epitope tag to overcome this 1
Using this system, wild type, C9S, CIOS and C9SC10S mutants ?!
of murine G n a  were analysed in simian COS-1 cells by transient transfection.
This chapter details the production of the mutants and assesses their membrane 
association and ability to incorporate pH] palmitic acid. Both cys9 and cyslO 
of murine G n «  are targets for palmitoylation. Furthermore, there may exist a 
degree of co-operativity during the palmitoylation; the C9S and CIOS mutants 
each incorporated less than 50% of the detectable radioactivity present on the
if
wild type protein. All three mutant proteins had a decreased ability to interact 
with the plasma membrane and their respective abilities to interact with the 
membrane were found to be indistinguishable. These studies indicate a 
difference between G qa and G ija  in terms of the effect of palmitoylation on 
their function.
vector pCMV. Lack of knowledge of this plasmid necessitated the sub-cloning
5 .2. Results.
5. 2. 1. Subcloning of murine G l i a  into pSV 
Sport 1.
Murine G n a  was kindly donated by Dr. Melvin I. Simon, ii
3California Institute of Technology, CA, USA, in the mammalian expression
of the cDNA insert into a vector for mutagenesis. To this end, the murine 
G lia  cDNA was excised from the pCMV vector using the restriction
endonucleases Cla I and Xho I, purified from an agarose gel slice (sections 2.
22 - 2. 24.) and the insert ligated into the vector pGEM 7Z(f+) (section 2.27.).
3Ligated DNA was then transformed into JM109 E .coli (section 2. 16.)
Ampicillin resistant clones were tested for the presence of the murine G n a  I-IcDNA by digestion of resultant plasmid DNA with Cla I and Xho I. A
photograph of the resulting agarose gel is displayed in figure 5 .1 .
3?:Clone number 2 was selected for expansion and further Isubcloning into the vector pSV Sport 1, a full nucleotide sequence for which 3?
was available. This was achieved by initial digestion of pGEM 7Z (f+ )-G na
twith Apa I, followed by treatment with Klenow DNA polymerase to create a 
blunt end (section 2. 26.). This was subsequently digested with Hind III and 
the fragment separated by electrophoresis on an agarose gel. Between each of 
these steps, the DNA was purified from enzymes and salts using Promega
•ilClean-Up columns. The G n a  insert was then purified from the agarose gel 
and ligated to pSV Sport 1 which had been digested with Sma I and Hind III 3?3'and purified from a gel slice. This ligated DNA was transformed into JM109
:'â
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Figure 5. 1. Subcloning of murine G n a  into pGEM 
7Zf(+).
IjAg of murine G n a  in the vector pCMV, donated by Dr. M.I. Simon, was cut with 5 
units each of the restriction enzymes Xho I and Cla I and the cDNA corresponding to 
G not was purified from an 0.8% (w/v) agarose gel using Promega PCR preps. This 
was then ligated into the vector pGEM 7Zf(+) which had been similarly digested and 
purified. Ligated DNA was then transformed into competent JM109 cells and 
ampicillin resistant colonies were expanded and plasmid DNA from these was 
assessed for the presence of murine G not by digestion with Xho I and/or Cla I. The 
resulting 0.8% (w/v) agarose gel from this digest is displayed. Lanes 1 and 14 
contained Ikb DNA ladder. Lane 2, 3 and 4 contained, respectively, 200ng pGEM 
7Zf(+) which was undigested, digested with Cla I and Xho I or digested with Cla I 
alone. Lanes 5-7 contained, respectively, 200ng of DNA isolated from clone 1 which 
was undigested, digested with Cla I and Xho I or digested with Cla I alone. Lanes 8 - 
10 contained, respectively, 200ng of DNA isolated from clone 2 which was 
undigested, digested with Cla I and Xho I or digested with Cla I alone. Lanes 11-13 
contained, respectively, 200ng of DNA isolated from clone 3 which was undigested, 
digested with Cla I and Xho I or digested with Cla I alone. The mobility of murine 
G lia  and of the DNA standards is shown.
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Figure 5.1
3054 bp 
1636 bp 
1018 bp 
506 bp
Murine G^ OC
1 2 3 4 5 6 7 8 9 1011 12 13 14
E .coli and ampicillin colonies expanded, plasmid DNA isolated and the 
presence of Gjicx cDNA detected by digestion of plasmid DNA with Cla I and 
Xho I. Samples of these digests are shown in figure 5. 2. Clone number 3 was 
selected for mutagenesis of the G net insert. These subcloning steps had one 
drawback in that the cDNA insert was now present in the anti sense direction 
with respect to the SV40 early promoter of the pSV Sport 1. This necessitated, 
as described in the following section, the further subcloning of resulting 
mutant G n a  cDNAs back into the original pCMV vector to allow expression 
in COS-1 cells.
5 .2 .2.  Generation of cys9 and cyslO mutants.
Clone 2 plasmid DNA was used as a template for mutagenesis 
of the murine G n «  cDNA. A pair of primers, from the list in table 5 .1 ., were 
first phosphorylated as described in section 2 . 28. before being used to amplify 
the entire pSV Sport 1 -G na plasmid. Pfu DNA polymerase was the enzyme 
of choice instead of Taq DNA polymerase as Pfii contains a 5-3' proof reading 
activity and lacks the adenylyl transferase-like activity of Taq. This not only 
results in an increase in fidelity of amplification but also results in the 
production of blunt -ended DNA.
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Figure 5. 2. Subcloning of murine G n a  into pSV 
Sport 1.
IjAg of clone 2 DNA was cut with Apa I, purified from an agarose gel, the 5 ’ 
overhangs filled in with Klenow DNA polymerase, cleaned up using Promega 
Cleanup columns and cut with Hind III. Plasmid pSV Sport 1 was prepared by 
digestion with Hind III and Sma I and purified from an agarose gel. Ampicillin 
resistant colonies from the resulting transformation of ligated DNA were expanded 
and plasmid DNA from these isolated. The presence of murine G n a  was assessed by 
digestion of this DNA with Cla I and/or Xho I. The resulting agarose gel is shown. 
Lanes 1 and 14 contained Ikb DNA ladder and the mobilities of some of its 
components are indicated. Lanes 2-4 contained 200ng of pSv Sport 1 which was 
undigested, digested with Cla I alone or digested with Cla I and Xho I respectively. 
Lanes 5-7 contained 200ng of DNA isolated from clone 1 which was undigested, 
digested with Cla I alone or digested with Cla I and Xho I respectively. Lanes 8-10 
contained 200ng of DNA isolated from clone 2 which was digested with Cla I alone, 
digested with Cla I and Xho I or was undigested respectively. Lanes 11-13 contained 
200ng of DNA isolated from clone 3 which was digested with Cla I and Xho I, 
digested with Cla I alone or was undigested respectively. The mobility of murine 
G n a  is indicated.
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Figure 5.2
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1636 bp 
1018 bp 
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Table 5. 1. Oligonucleotides used in tbe 
production of C9S, CIOS and C9SC10S mutants 
of G u o .
The oligonucleotides primers used to prepare the mutants of murine G n a  are 
displayed. For each mutant a pair of oligonucleotides were used, one sense 
primer and one antisense primer. These were first phosphorylated before being 
used in a PCR reaction using Pfu DNA polymerase. Phosphorylation of these 
primers was required to facilitate self-ligation of the amplified DNA. The 
mutagenic bases are shown in bold italics.
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The plasmid DNA was purified on a gel slice and self-ligated. 
This DNA was then used to transform JM109 E.coli and ampicillin resistant 
colonies selected. Plasmid DNA from these transformants was isolated and, in 
the case of the C9S and C9SC10S mutants, digested with a diagnostic 
restriction endonuclease, BsaH I, as the creation of these mutants introduced 
an additional site for this enzyme. These restriction digests are displayed in 
figure 5. 3. Ampicillin resistant clones resulting from the CIOS mutagenesis 
could not be assayed by restriction digestion as the mutagenesis did not 
introduce or remove any restriction sites.
All samples which were of interest were then subjected to DNA 
sequencing on an ABI automated sequencer to verify the integrity of 
amplification (see footnote*) . The relevant section of the sequences is 
displayed in figure 5 .4 . To prevent sequencing the entire plasmid, a short 
segment, covering the mutated stretch of the G n a  cDNA and some of the pSV 
Sport 1 backbone was excised using the restriction endonucleases Sac I and 
Nhe I and subcloned back into wild type pSV Sport 1 -G n a  which had not 
undergone PCR amplification.
The presence of the desired mutation was tracked by the 
diagnostic restriction digests and/or DNA sequencing. Following this, the 
entire G n «  cDNA was then subcloned back into the original pCMV vector by 
excision using Cla I and Xho I as before. Again, the presence of the required 
mutation was tracked by diagnostic restriction digests and/or DNA
Sequencing of mutant DNA in pS V Sport 1 was achieved using die T7 
promoter sequencing primer (TAATACGACTCACTATAGGG). Sequencing of mutant DNA 
in pCMV was achieved using an internal primer, in the antisense direction, 
CATCGACCTCCCGGATCAGG.
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Figure 5. 3. Preparation of C9S and C9SC10S 
mutants of murine G n a  alters its Bsa HI 
digestion pattern.
Following PCR amplification of pSV Sport 1 -G n a  with mutagenic 
oligonucleotides, the DNA was self ligated and amplicillin clones selected 
from the resulting transformation expanded. DNA from each of these was 
isolated and for C9S and C9SC10S mutants, this was digested with Bsa HI. 
The resulting agarose gel is shown. Lanes 1 and 8 contained Ikb DNA ladder 
with the mobilities of some fragments indicated. Lanes 2 and 3 contained wild 
type pSV Sport 1 -G n a  which was uncut or cut with Bsa HI respectively. 
Lanes 4 and 5 contained pSV Sport l-C 9S G na which was uncut or cut with 
Bsa HI respectively. Lanes 6 and 7 contained pSV Sport l-C 9SC 10SG na 
which was uncut or cut with Bsa HI respectively. The different restriction 
patterns of pSV Sport l-C 9 S G n a  and pSV Sport l-C9SC10SGna are shown.
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Figure 5.3
3054 bp 
1636 bp 
1018 bp 
506 bp different mobilities
1 2 3 4 5 6 7 8
Figure 5. 4. Sequence of isolated clones of G iia  
mutants.
Automated sequencing of pSV Sport l - C 9 S G n a ,  pSV Sport 1 - C lO S G n a  and 
pSV Sport l - C 9 S C 1 0 S G i i a  was carried out on DNA from colonies with 
different restriction patterns (pSV Sport l - C 9 S G n a  and pSV Sport 1- 
C 9 S C 1 0 S G n c t )  and all amplicillin resistant clones (pSV Sport 1 - C lO S G n a ) .  
The sequences of one clone used for further study from each mutant was 
aligned with wild type pSV Sport 1 -G n a  using Gene Jockey II on an Apple 
Macintosh Quadra 8 0 0 . This alignment is displayed. The sites of mutagenesis 
of G  n «  a-rc shown as arrows.
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Figure 5. 4.
10
n t i g #  1 
u s e  G l l a  
S a l i  
0S a l i  
SC 10S a l i
n t i g #  1 
u s e  G l l a  
S a i l  
0 5  a i l  
SC10S  a i l
n t i g #  1 
u s e  G l l a  
S a i l  
0 5  a i l  
S C 1 0 5  a i l
n t i g #  1 
u s e  G l l a  
S a i l  
0 5  a i l  
5 C 1 0 5  a i l
n t i g #  1 
u s e  G l l a  
5 C 1 0 5  a i l
20
I
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I
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TTCGGGGAACMGGRRAGAGGTNGGGNCGGNNCGGBGGGAVGCGGRRGVHCGCGACGATGACTCTGGAGTCC
TTCGGGGAACCGGGAAGAGGTAGGGCCGGGCCGGCGGCAGCCGGAGGACCGCGACGATGACTCTGGAGTCC
AGGAGGGTGGGGCCGGGNCCGGGGGANGCCGGGGGACCCCGNANGATGANTNTTGAGGTCC
AGAGGTNGGGNCGGNNCGGTGGNAGNCGGAGGATCGCGACGATGACTCTGGAGTCC
GGNGGNAGNCGGAGGACGCGANGATGACTCTGGAGTCC
8 0 9 0 100
I
110
I
120
I
1 3 0 1 4 0
I
ATGATGGCGT5TT5CCTGAGCGACGAGGTGAAGGAGTCGAAGCGCATCAACGCGGA6ATCGAGAAACAGCT
ATGATGGCGTGTTGCCTGAGCGACGAGGTGAAGGAGTCGAAGCGCATCAACGCGGAGATCGAGAAACAGCT
NTGATGGGGTCTTGGCTNANCGANGANGTGAAGGAGTCGNAGCGCATCAACGCGGGGATCGAGAAACANGT
ATGATGGNGTGTTCCCTGAGCGACGAGGTGAAGGAGTCGAAGCGCATCAACGCGGNGATCGAGAAACAGNT
ATGATGGCGTCTTCCCTGAGCGACGAGGTGAAGGAGTCGANGCGCATCAACGCGGAGATCGAGAANCAGCT
1 5 0 1 6 0 1 7 0
I
1 8 0
I
1 9 0
I
200 210
l
GCGGNGGGACAAGCGCGACGBCCGGCGCGAGCTCAAGCTGCTGCTACTTGGCACTGGCGAGAGCGGGAAGA
GCGGCGGGACAAGCGCGACGCCCGGCGCGAGCTCAAGCTGCTGCTACTTGGCACTGGCGAGAGCGGGAAGA
TNGGGGGGACAANCGCGACGGCCCGNGNGAACTCAANCTTCTTCTTCTTGGNANTTGCGANAGCGGGAAGA
GCGGNGGGACAAGCGCGACGTCCGGCGCGAGCTCAAGCTGCTGTTACTTGGCACTGGCGAGAGCGGGAAGA
GCGGNGGGACAAGCGCGACGCCCGGCGCGAGCTCAAGCTGCTGCTACTTGGCACTGGCGAGAGCGGGAAGA
2 2 0  2 3 0  2 4 0  2 5 0  2 6 0  2 7 0  2 8 0
I I I i I I I
GTACCTTCATCAAGCAGATGCGCATCATCCACGGGGGCGGCTACTCGGAGGAGGACAAGCGCGGCTTCACC  
GTACCTTCATCAAGCAGATGCGCATCATCCACGGGGCCGGCTACTCGGAGGAGGACAAGCGCGGCTTCACC  
GTTCCNTCANCAAGNAGGTNCGCATCANCCACGGGGGCGCGCTTCTCGCGAGGAGGNCAANNGCGG  
GTACCTTCATCANGCAGATGCGCATCATCCACGGGGGCGGCTACTCGGAGGAGGACANGCGCGGCTTCACC  
GTANCTTCATCANGNAGATGCGCATCATCCACGGGGGCGGNTACTCGGAGGAGGACAAGNGCGGNTTCACC
2 9 0  3 0 0
I I
AAGTTGGTGTACCAGAACA  
AAGTTGGTGTACCAGA  
ANGTTGGTGTACCAGAACA
sequencing. The mutants were then ready for transient transfection into COS-1 
ceils.
5. 2. 3. The effect of mutation on the 
incorporation pH] palmitate to marine G u o .
SOjAg of either wild type, C9S, CIOS or C9SC10S murine G n a  
in pCMV was transfected in COS-1 cells as described in section 2. 2 .11 . Cells 
were labelled with p H ]  palmitate as described in section  2. 2. 8. 
Immunoprecipitates (section 2. 5. 3.) of whole cell lysates were subsequently 
analysed on a 6M urea/10% acrylamide gel to separate murine G n «  from the 
endogenous simian protein. Gels were then dried and autoradiographed 
(section 2 ,11 .) This is displayed in figure 5. 5. a. These autoradiograms were 
then quantitated on a GS-670 densitometer. These show that both single 
mutants incorporate less than 50% of the radioactivity of wild type G jia ;  both 
incorporated around 20% of the radiolabelled pH] palmitate (figure 5 .5 . b.) 
The double mutant incorporated no detectable radioactivity at all. This was not 
a reflection of different amounts of protein loaded onto the lanes as there was 
no difference in the incorporation of [^H] palmitate into endogenously 
expressed simian G q a /G ija  (figure 5. 5. c.).
5. 2. 4. The effect of palmitoylation on the 
membrane interaction of G n a.
Following the attenuation of palmitate incorporation into the 
G ^ a  mutants, the effect of this on the membrane interactions of the 
polypeptides was assessed. Following transfection, cells were left for
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approximately 72hrs before membrane and cytosolic fractions were prepared 
as described in section 2. 3. 2. These were analysed by urea containing SDS- 
PAGE for the presence of immunoreactive G qa and G n a  in each fraction. An 
example of this experiment is displayed in figure 5. 6. a. Quantification of this 
experiment (figure 5. 6. b.) indicated that all three mutants had a decreased 
ability to interact with the plasma membrane; approximately 30% of the 
detectable murine G n a  immunoreactivity in each of the three mutant 
expressing transfected cells was present in the cytosolic fraction.
J
Î
Ii
178 a
' '  -   i _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ' _ _ _ _ _ _ _ _ _ _ _  ' .  _  _ _ _ _ _ _ _  _ . . . . . . . . . . . .    . .  '
Figure 5. 5. Incorporation of [3H] palmitic acid 
into wild type and mutant G u o .
SOpig of DNA encoding either wild type G jia ,  C9S G n a ,  CIOS G n «  or 
C9SC10S G not was transiently transfected into COS-1 cells for 68 hrs before 
being labelled with 200/<Ci/ml of [^H] palmitic acid for a further 4 hrs. Whole 
cell lysates of these transfected cells were i mmunoprecipi tated with anti serum 
CQ2 and these immunoprecipitates analysed by SDS-PAGE on a 6M urea 
containing 10 % (w/v) gel. The gel was then treated with ENTRANCE and 
fluorographed for 50 days, this is shown in panel a. Lane 1 contained 
immunoprecipitates from mock transfected cells (no DNA), lane 2 contained 
immunoprecipitates from wild type G n a  transfected cells, lane 3 contained 
immunoprecipitates from C9S G n a  transfected cells, lane 4 contained 
immunoprecipitates from CIOS G n a  transfected cells and lane 6 contained 
immunoprecipitates from C9SC10S G n «  transfected cells. The mobilities of 
endogenously expressed G q a /G n a  and of heterologously expressed G n a  are 
indicated. Quantitation of the amount of incorporated [^H] palmitate was 
carried out for endogenously expressed G q a /G n a  ( panel B.) and for 
heterologously expressed murine G n a  ( panel C ) on a Bio-Rad GS670 
imaging densitometer. The results are shown as the mean+half the difference 
of two separate experiments.
179
Figure 5.5
kDa
36.5 -
j  Simian G<,{X/Gna 
1Murine G ,.a
Optical density 
(arbitrary units) 20
Transfection
B
30 n
2 5 -
Optical density 
(arbitrary units) 20-
1 5 -
1 0 -
3 1 T
w «3 CO
CA CA CA0 \ O O
U U g
UT ransfection
Figure 5. 6. Cellular distribution of wild type and 
mutant murine G u o  following transient transfection.
SOjAg of DNA encoding either wild type G n a , C9S G n « , CIOS G n a  or C9SC10S 
G lia  was transiently transfected into COS-1 cells for 72 hrs before membrane and 
cytosolic fractions of each transfection were prepared. These fractions were analysed 
on a 6M urea containing 10% (w/v) polyacrylamide gel and the resulting immunoblot 
(panel A.) was probed with antiserum CQ2 at a dilution of 1:1000. Lane 1 contained 
40}Ag of mouse brain membranes, Lanes 2, 4, 6, 8 and 10 contained SOptg of 
membranes from mock, wild type G n a , C9S G n a , CIOS G n a  and C9SC10S G n a  
expressing cells respectively, while lanes 3, 5, 7, 9, and 11 contained equivalent 
amounts of the cytosolic fractions of these transfectants. Lane 12 contained prestained 
lactic dehydrogenase marker. The identities of the endogenously expressed simian 
G q a /G n a  and the heterologously expressed murine G n a  are shown. Quantitation of 
the amount of murine G n a  present in the cytosol of each transfectant (panel B.) was 
expressed as a percentage of the total immunoreactive murine G n a  present in each 
transfectant. These results are shown as the mean±SEM of 4 separate experiments.
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5 .3 . Discussion.
Wedegaertner et al. [1993] indicated that G qa had to be 
palmitoylated in order to interact with the plasma membrane. Results 
presented here indicate that this may not be true for G n a ,  at least in COS-1 
cells. It has been found that G n a  is only partially dependent on palmitoylation 
for its membrane association. This may reflect a different cellular environment 
from that employed by Bourne and colleagues; they utilised the human 
embryonic kidney cell line HEK 293 as opposed to the simian COS cell 
system employed here.
Evidence has also been found for co-operativity in transfer of 
the palmitate from the transferase to the a  subunit; less than 50% of the 
radioactivity associated with wild type murine G n a  was found attached to 
either of the two single mutants. Similar levels of pH] palmitate incorporation 
of G qa were found by Wedegaertner et al. [1993], who found that both C9S 
and CIOS single mutants of G qa incorporated less than 50% of the pH ] 
palmitate found in the wild type protein.
The observed synergism of palmitoylation of G n a  may simply 
be due to the presence of the serine residues, as opposed to the cysteine 
residues normally found at these positions, causing a slight yet significant 
alteration in the conformation of the polypeptide preventing the palmitoyl 
transferase from properly recognising the intact cysteine residue. It is notable 
that palmitoylation of G%a and G ^ a  requires the presence of a glycine 
immediately prior to the target cysteine in order for the transfer of the palmitic 
acid to the a  subunit [Hallak, et al., 1994; Galbiati et al., 1994]. The presence
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Iof an alanine residue at this point, as has been discussed in the previous :!
chapter, prevents palmitoylation. The transferase responsible for the 
palmitoylation of G jia  is obviously very sensitive to even relatively 
conservative changes in the peptide environment. This of course does not 
preclude the possibility of synergism of palmitoylation of G n a , but caution in 
rushing to this conclusion should be exercised.
The recent discovery that myristoylation, or the presence of 
alanine at position 2, does not per se govern the subsequent palmitoylation of 
G iia  [Degtyarev et aL, 1994b] but that the protein requires to be localised to 
the plasma membrane in order to be palmitoylated lends weight to the co- 
operativity theory of palmitoylation of G ija .
It would appear that however much palmitic acid is present on
the mutant a  subunits, the ability of these polypeptides to interact with the 
plasma membrane is essentially identical, perhaps indicating that a certain 
threshold of palmitoylation must occur to promote full membrane association. 
Approximately 30% of immunoreactive murine G n a  is present in the 
cytosolic fraction of transfected COS-1 cells, while all endogenous simian 
immunoreactivity is present in the membrane fraction. The value of 30% 
agrees well with that obtained for chemical depalmitoylation using 
hydroxylamine in section 4. 2 .1 .
This system has several advantages over systems employed by 
other groups to study the process of palmitoylation. Many groups are now 
employing an epitope tagging technique to allow unambiguous detection of G 
protein a  subunits in the absence of background levels of the particular G
■s
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status of the protein, and therefore represents a more physiologically relevant 
model. The endogenous Gq« and G n a  provided useful controls in all
Both Degtyarev et al. [1993a] and Mumby et at. [1994] have 
found that mutagenesis of G^a to prevent palmitoylation does not alter the
protein [Gallego et at., 1992; Levis & Bourne, 1992; Wedegaertner et at.,
1993; Wedegaertner & Bourne, 1994]. While these groups maintain that the
mutagenesis of both Gga and G qa does not interfere with the normal
functioning of the polypeptide, it may be that altering the a  subunit to encode
the tag sequence does indeed affect the polypeptide in some way, as yet not |
understood. The system employed in this study benefits from not having to
introduce any mutations other than those required to study the palmitoylation
experiments. In the immunoblotting experiments, the endogenous G qa and
; %G lia  presented a useful control in ensuring that both the amount of protein ï|
■■Sloaded onto each lane was equivalent and that the transfection efficiency in 
these transiently transfected cells was the same for each murine G n a  cDNA g
which was introduced into the simian COS-1 cells. The endogenous proteins I
also ensured homogeneous labelling of the COS-1 cells with pH ] palmitic 
acid. This was important in ensuring that the differences observed in the
amounts of palmitic acid incorporated into the mutant murine cDNAs as T
'Iopposed to the wild type proteins was a true reflection of the ability of these
.-■sproteins to be palmitoylated and was not simply due to differences in the 
amounts of labelled [% ] palmitate which were available for each transfected 
protein. This is something which other groups have not been able to
J’idemonstrate as easily [Degtyarev et aL, 1993b; Wedegaertner et aL, 1993].
Indeed, Degtyarev et al. [1993b] resorted to solubilisation of excised bands 
from their gels followed by liquid scintillation counting.
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membrane association of the polypeptide. They employed a C3A mutation in 
order to assess this question, while this study, as well as that of Wedegaertner 
et al. [1993] have used C3S mutations. As the groups using serine mutations 
have found a translocation to the cytosol, it may be that the presence of alanine 
rather than serine increases the proteins’ membrane affinity. The difference in 
membrane association of the various mutants may also be a reflection of the 
different cell types used by the various groups. While this study and 
Wedegaertner et al. [1993] used fibroblasts, Degtyarev et al. [1993a] and 
Mumby et al. [1994] used S49 lymphoma cells and insect Sf9 cells. Indeed 
Mumby et al. [1994] found a slight difference in the membrane association of 
C3A Ggcc upon expression in Sf9 cells as opposed to S49 cells. Also recent 
work has shown that expression of the G n a  mutants employed in this study in 
HEK 293 cells are found entirely in the cytosol in agreement with the report of 
Wedegaertner et al. [1993] for G qa, although the G n a  located in the cytosol 
can still activate phosphoinositidase C [A. Wise & G. Milligan, unpublished 
observations].
Recent work by Degtyarev et al., [1993b], Mumby et al. [1994] 
and Wedegaertner & Bourne [1994] have indicated that activation of G^a 
leads to regulation of the palmitic acid present on the protein. Activation of 
Gga by either incubation of cells with (32 adrenergic agonist or by treatment 
with cholera toxin lead to an increase in the amount of [% ] palmitic acid on 
the protein [Degtyarev et al,, 1993b]. This effect has been demonstrated to be 
due to an increase in the rate of turnover of the palmitate on the protein and 
may not reflect an actual increase in the amount of palmitate attached to the 
polypeptide [Mumby et al., 1994; Wedegaertner & Bourne, 1994] as the 
stoichiometry of attachment is unknown [Mumby & Muntz, 1995]. This would
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muscarinic receptor.
As stated earlier, the COS-1 cells employed in this study are not 
known to express Gq linked receptors. Therefore it was not possible to 
address the questions of the effect of palmitoylation on a  subunit activation of
of the protein.
1
indicate that an activated Gga leads to a change in its own palmitoylation 
status and perhaps this may give rise to a change in the subcellular location of 
the protein. In the present study we have not attempted to assess the rate of 
turnover of palmitate on G n a ,  due to the lack of a suitable endogenously
aexpressed receptor, but given that receptors can alter the palmitoylation status
1|of G qa [Wedegaertner & Bourne, 1994], this phenomenon may reflect a more 
widespread effect on G protein a  subunits.
W edegaertner et al. [1993] also indicated a functional 
implication for depalmitoylation of G qa and Gga. Mutated, palmitate negative
forms of these proteins were found to be incapable of activating their |
€respective effector enzymes. At least in the case of G q a ,  they employed a
Ireceptor (the a%A adrenergic receptor) which was artificially introduced at high levels into the HEK 293 cells by transfection. There are several possible 
problems with this approach. First the a2A adrenergic receptor is not thought f
to normally interact with G qa, and only overexpression of the receptor by 
transfection may be responsible for the activation of the G protein. A better
approach to this question may have been to employ a receptor which normally iactivates Gq family members, such as the a i  adrenergic receptor or the M l
■
I
effector systems or the effect of agonist activation on the palmitoylation status |
I
■
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There are two possible methods to address these questions using the 
mutants created in this study. One would be to co-transfect a cDNA encoding 
a Gq linked receptor into COS-1 cells along with the various G n a  cDNAs, 
Another would be to create stable transfects of cells known to express Gq 
linked receptors with the G n a  cDNAs. The second system would be more 
advantageous. The transfection would result in the production of a clonal cell 
line, thus all experiments would use cells which were identical, rather than the 
heterogeneous cell population of COS-1 cells expressing varying amounts of 
receptor and G n «  protein. These cells would also be utilising an 
endogenously expressed receptor and the system would therefore represent a
more physiological model.
The use of the endogenously expressed G qa and G jia  proteins 
may enable another important control to be used. As described, it was not 
possible to use these transiently transfected cells to address the questions of 
the effect of receptor activation on G n a  palmitoylation, due to the lack of 
suitable receptor. Had this been possible, either by transient co-transfection of 
a suitable receptor into the COS-1 cells or by stably transfecting these cDNAs 
into cells expressing a receptor known to activate G qa and G ija ,  then the 
endogenously expressed Gq family members would have provided easily 
comparable controls to determine any changes in the rate of turnover of 
palmitic acid following agonist challenge on these endogenous proteins as 
compared to the heterologous proteins transfected into them. It would also be 
possible to compare the half-lives of the endogenous G qa and G ^ a  proteins 
with the heterologously expressed wild type and mutant G jia s  upon agonist 
treatment. Direct comparisons with the endogenous and transfected proteins
would show any changes in the ability of the cell to regulate the transfected 
proteins
In this study we have assessed whether murine Gj la  is dually 
palmitoylated, as is Gq«, on adjacent cysteine residues near its N-terminus. By 
a PCR based strategy, we have created site-directed mutants in which the 
cysteine residues thought, by sequence analysis, to be the targets for 
palmitoylation were altered to serines. This mutagenesis prevented all 
detectable pH] palmitic acid incorporation only into the mutant in which both 
cys9 and cyslO were changed. Single mutants, where either cys9 or cyslO was 
mutated, incorporated approximately 20% of the [^H] palmitate of wild type 
G lia ,  which may point to a level of co-operativity in palmitoylation which has 
not previously been observed.
Removal of palmitic acid by this means from murine G n a  led 
to a release of mutant G n a  into the cytosolic fraction of cells indicating that 
palmitoylation increases, but does not solely govern, the affinity of G n «  for 
the plasma membrane. Given the apparently absolute requirement for 
palmitoylation of G qa for membrane interaction, this may indicate a 
functional difference between the two a  subunits, something which has been 
hitherto unproven. This difference of apparent affinities for the plasma 
membrane is not a reflection of the choice of serine for mutagenesis as the 
presence of alanine at this position has no effect on the resulting fractionation 
pattern of the G n a  mutants.
This model is only in its infancy, yet has already provided new 
insight into the palmitoylation of G protein a  subunits. Indeed utilising this
187 ,
system has demonstrated that the presence of palmitic acid on Gi i«  is required
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for the proper folding of the protein. Gel filtration carried out on extracts of 
COS-1 cells transfected with wild type and mutant G ^ a  cDNAs indicate that 
the C9SC10S G n a  in these cells is present as aggregated protein whereas the 
endogenous simian G n a  is not, indicating that the absence of palmitate may 
lead to a totally non-functional protein [McCallume? al. , 1995].
r'"
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Final Discussion.
Heterotrimeric G proteins are responsible for transmitting 
signals from membrane bound serpentine receptors to various effector systems 
which subsequently results in changes in the levels of a second messenger 
molecule or ion [Gilman, 1987]. The mechanism by which G proteins remain 
at the membrane, in close proximity to the receptor and effector systems they 
interact with, has been a subject for debate for several years; all three subunits, 
a , p and y, are predominantly hydrophilic and contain no stretches of 
hydrophobic amino acids which could form putative transmembrane helices.
The discovery of isoprenoid groups at the C terminus of the y 
subunit [Fukada et al., 1990] prompted speculation that the py dimer, which 
remains as a tightly associated complex under non-denaturing conditions, 
acted as an anchor for the a  subunit. However agonist activation of the 
receptor, which subsequently causes dissociation of the a  subunit from py does 
not also lead to release of the a  subunit from the plasma membrane. Also, 
overexpression of Gj2«  in COS-7 cells, in excess of p y , does not lead to the a  
subunit being found in the cytosol of such cells [Simonds et al, 1989]. The 
emergence of p y  as a facilitator of G protein signals in its own right [Clapham 
& Neer, 1993; Stemweis, 1994] would also indicate that this original sedentary 
role for the dimer was incorrect.
Acylation of proteins involved intracellular signalling has been 
recognised for several years. Many viral proteins contain myristic acid
;
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covalently attached via amide bonds to N terminal glycine residues and this 
modification is required for proper assembly of virus particles [Tashiro et a l ,  
1989; Weaver & Panganiban, 1990]. Normal cellular proteins are also 
modified by myristoylation, notably the catalytic subunit of PKA and 
calcineurin [Carr et al, 1982; Aitken et al, 1982]. The discovery of myristic 
acid on the a  subunits of heterotrimeric G proteins was thought therefore to 
play a role in the membrane interactions of a  subunits [Buss et al., 1987; 
Jones et al., 1990; Mumby et al., 1990] However only members of the Gi 
family have the target glycine residue in the proper environment at their N 
terminus [Casey, 1994], and so another, more general mechanism must exist to 
explain the interactions of the other a  subunits with the plasma membrane. In 
addition not all myristoylated proteins are membrane associated; the catalytic 
subunit of PKA is a soluble protein [Carr et al, 1982]. Work using acylated 
peptides throws further doubt on the theory that myristoylation is required for 
membrane association. It may be that myristoylation by itself cannot promote 
full membrane association as myristoylated peptides have insufficient free 
energy to stably bind to lipid bilayers [Peitzsch & McLaughlin, 1993]. The 
recent discovery of palmitic acid at the N terminus of G proteins [Parenti et 
al., 1993; Linder et al., 1993] and Src family [Paige et al., 1993; Shenoy- 
Scaria et al., 1993] members may provide the necessary hydrophobicity for 
membrane attachment of these acylated proteins.
This study has demonstrated both by chemical treatment with 
hydroxylamine, under conditions known to remove thio-ester linked palmitic 
acid from proteins [Magee et al., 1984; Mage & Courtnedge, 1985], and by 
mutating target cysteine residues, that palmitoylation of proteins does not 
entirely govern the membrane association of G o ia  and G n a . It does however
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still present [Galbiati et al., 1994] and may allow transient association with the 
membrane [Degtyarev et al., 1994b] would suggest the first hypothesis.
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contribute to their ability to interact with the membrane as approximately 30% 
of the protein is found in the cytosol following cell disruption or 
hydroxylamine treatment of isolated cell membranes. Recent work suggests *
that this is not an artefact caused by disruption of the cells in a hypotonic
buffer as unpalmitoylated C3S Goiot is found in the cytosol of intact 03  cells
s[M.A. Grassie & G. Milligan, unpublished observations]. This would suggest,
given the fact that pertussis toxin can ADP-ribosylate all the C3S, non- ?
palmitoylated G o ia  in 03  cells, that a cycling process is occuring in these
,r':cells. Whether this is simply an on/off occurrence or whether it is directed |
somehow by another protein which binds to non-palmitoylated Goiot and %
herds it away from the membrane in unknown. The fact that myristic acid is
The role of palmitoylation of G n a  may be different. Chemical 
treatment of NG108-15 and Rat-1 cell membranes released approximately 
30% of G n a  from the membrane. This value is similar to the amount present 
in the cytosolic fraction of COS-1 cells which had been transiently transfected 
with mutants of murine G net, in which either cys9 or cyslO or both had been 
altered to serine. Thus it would seem reasonable that the function of G not 
would be intact, but it has been found that the mutated G not was not present 
as free a  subunits but as aggregated protein [McCallum et al., 1995].
'■'=1Therefore acylation of G n a  would appear to be necessary for proper 
targetting of the polypeptide to specific areas of the membrane; that is 
prevention of polymerisation of the protein. In this state G not would not be 
able to contact other proteins and thus would be functionally dead. Recent 
work suggests that this aggregation of protein is due to the specific cell
background of the COS-1 ceil as similar experiment in HEK-293 cells 
indicates that all the immunoreactive mutant G n a  present in transiently 
transfected HEK-293 cells is present in the cytosol and is capable of activating 
phosphoinosi tidase C [A, Wise & G. Milligan, unpublished observations].
It was also seen that the single mutants of G n «  did not 
incorporate pH ] palmitate to 50% of the amount found in wild type G n a . 
This would suggest one of two things: one, that a level of cooperativity exists 
in palmitoylation of G n a  such that palmitoylation of one cysteine is required 
to promote full palmitoylation of the other cysteine or two, that mutation of 
one cysteine has rendered the palmitoyltransferase less able to add the acyl 
chain to the second cysteine due to steric considerations. In either case it 
would appear that the single mutants behave essentially the same as the double 
mutant in that all three are present in the cytosolic fraction to the same degree, 
and all three form aggregated clumps rather than free a  subunits [McCallum et 
al., 1995]. A similar pattern of palmitoylation has been observed for G qa 
following transient transfection into HEK-293 cells. The two single mutants 
C9S and CIOS incorporated [^H] palmitate to less than 50% that of wild type 
G q a  and no pH] palmitate was incorporated into the C9SC10S double mutant 
[Wedegaertner et al., 1993].
What then is the wider function of acylation and how does it 
affect function of target proteins. Recent work has demonstrated a high 
concentrations of signalling proteins in membrane invaginations termed 
caveolae. These areas are high in a protein, termed caveolin, which may help 
define the structure of caveolae by forming a cholesterol and pH dependent 
interaction with GPl linked proteins. Cholesterol is found in high
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concentrations in caveolae, perhaps due to a “filler” function to help plug gaps 
in the lipid bilayer formed by lipidated proteins such as G proteins [Lisanti et 
al., 1994]. It has been proposed that dual acylation of proteins either by 
myristic acid and palmitic acid (Src family members and Gi family members) 
or dual palmitoylation (Gq family members) may target such modified proteins 
to caveolae. These membrane invaginations are rich in many of the signalling 
proteins, including G proteins and the non-receptor tyrosine kinases. Lisanti et 
al. [1994] have speculated that the lipidation of these proteins may serve to 
target them to caveolae where caveolin could mesh together a complex.
Recently Shenoy-Scaria et al. [1994] have shown that palmitoylation targets 
src family members to caveolae.
If dual acylation is required to target these proteins to caveolae, 
it is reasonable to suggest that removal of one or both of acyl chains could 
prevent proper association with these complexes. One problem with this theory 
is that Ggo is only singly acylated. Chemical removal of this does not affect 
the membrane avidity of the protein as severely as it does the other G proteins 
investigated in C h a p te r  4. Also several groups have attempted to ascertain the 
role of palmitoylation of GgOt in its membrane association. While one group 
determined that palmitoylation was absolutely required for the membrane 
association of Gga [Wedegaertner et al., 1993] this has not been the case for 
others who found that mutation of the palmitoylated cysteine to alanine caused 
no change in the ability of Gga to interact with the membrane [Degtayrev et 
al., 1993a; Mumby et al., 1994], although this may simply reflect the different 
cell lines employed. The possibilty therefore exists that another mechanism 
exists to target Gga to the plasma membrane and caveolae.
,
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The addition of palmitic acid to proteins is generally via a thio- 
ester bond to cysteine residues. The lability of the thio-ester bond raises the 
possibility of regulation of protein palmitoylation and indeed the 
palmitoylation status several proteins has been shown to be regulated by 
various stimuli [Huang, 1989; James & Olson, 1989; Mouillac etaU,  1992;
Paige et al. , 1993]. The palmitoylation status of Gga has also been shown to be 
regulated by agonist activation of P2 adrenergic receptors [Degtyarev et al. ,
1993b; Wedegaertner & Bourne, 1994] and direct activation by cholera toxin 
[Degtyarev et al., 1993b]. Treatment of cells with these agents caused an 
increase in the rate of turnover of palmitic acid on Gga. How this turnover of 
palmitic acid is facilitated and regulated is as yet unknown. A palmitoyl- 
protein thio-esterase has been identified [Camp & Hofmann, 1993] was 
thought to represent a part of this puzzle, however this enzyme has been 
shown to be secreted [Camp et al., 1994] and so cannot be not the enzyme 
responsible for the regulation of palmitoylation of G proteins and other cellular 
signalling polypeptides. The pal mi toyl-CoA: protein 5"-palmitoyl transferase 
responsible for addition of palmitic acid to the various proteins has not yet 
been identified.
Recently the possibilty of self-regulation of the palmitoylation I.status of a protein has been observed. Like G{ family members and scr family
members, the endothelial cell nitric oxide synthase is dually acylated by %
myristoylation [Busconi & Michel, 1993] and palmitoylation [Robinson et al.,
1995; Busconi & Michel, 1995]. However it has been shown that NO inhibits 
the palmitoylation of GAP-43, a growth cone associated protein [Hess et al.,
1993], and that this causes growth cone collapse and inhibits the extension of 
the neurite growth cone [Hess et al., 1993; Patterson & Skene, 1994]. The
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palmitoylation of nitric oxide synthase would thus be inhibited by the activity 
of the enzyme. How this would then affect the enzyme is unclear, but it may 
represent a self-limiting enzyme regulation.
In conclusion, this thesis presents data which demonstrates the 
role of palmitoylation of rat G oa and murine G ^ a . While using the systems 
described, it is apparent that the membrane association of these two G protein 
a  subunits is not solely governed by the addition of palmitic acid. Evidence 
has been presented which suggests that unpalmitoylated G ga is present in the 
cytosol of the whole cell, and that this cycles between the membrane and the 
cytosol. Unpalmitoylated G oa is still a substrate for pertussis toxin catalysed 
mono ADP-ribosylation. The use of urea containing SDS-PAGE to separate 
species variants of G n a  has provided a system to allow unambiguous 
detection of a ubiquitously expressed G protein a  subunit. This system differs 
from that used by other investigators in that the polypetide of interest was not 
mutationally tagged in order to detect it. This system also provides a readily 
accessible control in every single experiment, namely the presence of the 
endogenously expressed G qa and G n a  as a benchmark for levels of [^H] 
palmitate incorporation and purity of membrane and cytosolic fractions.
Much work remains to be done in the field of G protein 
palmitoylation and several important questions remain to be answered. Does 
palmitoylation affect the localistaion of G proteins to caveolae? How does 
palmitoylation of G oa and G n «  affect their interaction with other proteins. 
Given that unpalmitoylated GqU can still interact with Py, the palmitoylation 
status of G oa may not affect this interaction (although the observation that 
myristoylation of G oa increases it affinity for py [Linder et al., 1991] may
195 1SI
indicate a more subtle affect of palmitoylation). The question of how 
palmitoylation affected both the abilities of Go« and G n a  to interact with 
receptors and to activate or inhibit effectors could not be assessed due to a lack 
of receptors known to couple to the a  subunits on the cells used in this study.
These are questions which would require the transfection of the polypetides
&into cells which expressed these receptors or co-transfection of such receptors -3
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into cells which lacked them. These studies are currently underway in our 
laboratory. One intriging question is how does the process of depalmitoylation 
correlate with the down regulation of G protein a  subunits? Is 
depalmitoylation a signal for degradation of the protein? One way in which to
ianswer this question would be to examine the rate of turnover of the wild type 
and palmitate negative mutant G oa and/or G n a  polypeptides in the basal 
state, and given an appropriate receptor, in the agonist activated state. The 
increase, or otherwise, in the rate of degradation of the a  subunits may resolve 
this question.
3%
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